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Abstract 
Home-based robotic technologies may offer the possibility of self-
directed upper limb exercise after stroke as a means of increasing the 
intensity of rehabilitation treatment. The aim of this research project was to 
develop and evaluate a robotic device hCAAR that can be used 
independently at home by stroke survivors with upper limb weakness. The 
project had two stages: Stage 1, hCAAR development using a user-centred 
design process; Stage 2, A feasibility clinical study in the home setting.  
Stage 1: Nine stroke survivors with upper limb weakness and six 
healthcare professionals were involved in the concept and design stages of 
device development. hCAAR consists of a powered joystick with a computer 
interface, which is used to direct the movement of the upper limb to perform 
therapeutic movements as directed by tasks on the screen. hCAAR also 
provides controlled assistance when the user’s voluntary upper limb 
movement is insufficient to complete the prescribed task. 
Stage 2: In the feasibility study, 19 participants (stroke survivors with 
upper limb weakness) were recruited and 17 participants used hCAAR in 
their homes for eight weeks. No serious adverse events were reported. All 17 
participants were able to use the device independently. A statistically 
significant improvement was observed in the kinematic and clinical 
outcomes. Three participants showed clinically significant improvement in all 
clinical outcomes. Five participants reported improvement in functional ability 
in daily activities. Participants, family members and therapists were satisfied 
with the usability of hCAAR in the home setting. 
This research project also demonstrated that the International 
Classification of Functioning, Disability and Health (ICF) Comprehensive 
Core Set for stroke provides a useful basis to structure interviews to gather 
feedback from end-users and healthcare professionals in different stages of 
the rehabilitation device development. 
In summary, hCAAR is a home-based rehabilitation robotic device that 
can be independently used by stroke survivors with upper limb weakness and 
has the potential to improve upper limb movement and function. 
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Chapter 1: Introduction  
Stroke is a major public health problem with an annual incidence 
estimate of 15 million people worldwide [1], between 200 and 300 per 
100,000 people in Europe [2] and around 130,000 in the United Kingdom 
(UK) [3]. Globally, it is the third leading cause of mortality (after coronary 
heart disease and cancer) and results in 5 million deaths annually [4]. Stroke 
is the leading cause of adult onset disability worldwide, and annually, leads to 
5 million people developing long-term disability and dependency [1, 2, 4]. In 
the UK, the estimated direct and indirect costs of stroke care are £ 9 billion a 
year, accounting for approximately 5% of the total National Health Service 
(NHS) costs [3]. With a progressively ageing population and improved stroke 
survival rates, the number of survivors with disability is expected to increase 
in the coming decades. 
Stroke is defined as acute neurological dysfunction of vascular origin 
with rapid onset of symptoms according to the affected regions of the brain 
[5]. Depending on the location and severity of the stroke, stroke survivors can 
experience problems such as motor weakness, sensory disturbances, 
communication difficulties, visual disturbance, cognitive difficulties, reduced 
mobility or difficulty in performing daily activities.  
1.1 The ICF framework 
The last century has witnessed various conceptual models describing 
the relationship between diseases and their functional consequences. The 
initial models that described disability as an attribute of the individual 
(medical model, original Nagi model) faced criticism from societies of 
individuals with physical impairments and led to the development of models 
that describe disability being related to the environment (social model of 
disability) [6, 7]. The recent models (Modified Nagi model, International 
Classification of Impairments, Disabilities and Handicap ICIDH, National 
Centre for Medical Rehabilitation Research NCMRR model, International 
Classification of Functioning, Disability and Health ICF) depict the interaction 
better by linking disability to the person-environment relationship [8-11]. The 
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World Health Organization’s (WHO) ICF framework is the most widely 
accepted model and used officially in more than 190 countries [7].  
The ICF [11] provides a useful framework to understand the impact of 
the condition on the individual and helps plan rehabilitation interventions to 
improve function and reduce disability. The domains of the ICF framework 
are as below:  
 (a) Body functions and structures: Functions refers to physiological 
functions of body systems including psychological function. Structures are 
anatomical parts or regions of the body and their components. Impairments 
are problems in body function or structure. 
 (b) Activity: Activity refers to the execution of a task by an individual. 
Limitations of a task are defined as difficulties an individual might experience 
in completing a given activity. 
 (c) Participation: Involvement of an individual in a life situation. 
Restrictions to participation describe difficulties experienced by the individual 
in a life situation or role. 
 (d) Contextual factors: These include the personal and environmental 
factors that influence the relationships between the different components. 
 Figure 1 shows some examples of the impact of stroke on survivors in 
the different domains of the ICF framework. 
 Figure 1. Examples of the impact of stroke on stroke survivors using the WHO ICF framework 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HEALTH CONDITION 
Stroke 
ENVIRONMENTAL FACTORS 
Products or substances for personal consumption, 
drugs, assistive technology, health professionals, 
health services, systems and policies 
PERSONAL FACTORS 
Sex, Age, Race, Religion, 
Culture, Beliefs, Motivation 
PARTICIPATION 
Family relationships, 
work, community life 
ACTIVITIES 
Personal care, transferring 
oneself, walking, 
communication, cooking, 
shopping, driving 
BODY FUNCTIONS AND STRUCTURES 
Motor weakness, sensory problems, pain, 
spasticity, vision problems, speech and 
language problems, cognitive impairment, 
mood problems, sexual function, bladder 
and bowel function 
 1.2 Upper limb weakness after stroke 
The incidence of stroke survivors experiencing some degree of 
paresis of the upper limb at the onset has been reported to be between 70 
and 85% [12, 13]. The incidence is reported to be lower (48%) in dedicated 
acute stroke units including thrombolysis [14]. Only 20% to 56% of survivors 
regain complete functional use of the affected upper limb in spite of 
therapeutic intervention at 3 months [15-18]. Recovery of upper limb function 
is generally slower and less complete than return of mobility. This is partly 
due to the complexity of movement required for upper limb function [19, 20]. 
Motor recovery has been shown to be the most influential factor in 
determining well-being one year after stroke [21] and hence the emphasis of 
rehabilitation interventions is to improve upper limb function and reduce long-
term disability [18]. A meta-analysis of prognostic variables related to upper 
limb recovery after stroke found initial upper limb impairment or function to be 
the most significant clinical predictive variable for upper limb recovery [22]. 
Age, sex, lesion size, time since stroke, side of stroke, handedness, upper 
limb sensation and comorbidities all had either no association or inconclusive 
evidence for any association with upper limb recovery [22]. 
The term “arm” is often used in stroke rehabilitation literature and 
layperson terms to represent the “upper limb”. The use of the term “arm” in 
this thesis means the “upper limb”, unless specified as the arm section of the 
upper limb. 
1.3 Motor learning principles and post-stroke upper limb 
rehabilitation 
The neuroanatomical basis of motor recovery after stroke in the early 
stages comprises resolution of the neurogenic shock with reduction of 
oedema, and in the later stages neural reorganisation or brain plasticity [23]. 
Plasticity is the capacity of the brain to modify its structure or function in 
response to brain damage or learning [24]. This property of the brain allows 
motor relearning to occur in response to engagement either in therapy or by 
resuming activities in virtual reality or in the real world.  
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The two-stage model of skill acquisition proposed by Gentile et al. 
suggests a) an initial stage of learning where the individual learns the basic 
movement patterns needed to achieve the goal and identify components of 
the environment important to the task (explicit learning) and b) a later stage 
of learning where the individual learns to improve motor efficiency and 
movement flexibility (implicit learning) [25, 26]. 
Three stages of skill acquisition have been proposed by other authors: 
a) skill acquisition, b) skill retention and c) transfer of skills [23, 27].  Skill 
acquisition is the initial practice of a new skill; for example, using the 
hemiplegic upper limb to reach and grasp a glass in a sitting position in a 
therapy session. Skill retention is the ability to demonstrate skill in the same 
task after a break during which the task is not practised. Transfer of skills is 
the ability to perform a task similar to the practised task but in a different 
context; for example, reaching and grasping a jacket in a standing position in 
the real world. The skills acquired need to progress from closed skills (where 
the performer can start and stop at any time because the regulatory features 
of environment remain constant) to open skills (where the performer needs to 
conform to the dynamic changes and challenges in the environment [28].  
Rehabilitation interventions promote skill acquisition, retention and transfer 
by promoting practise of closed and open skills.  
Rehabilitation therapies differ in the amount of practice, the types of 
tasks, the training schedule and the feedback given to the individual. The 
evidence available for the effectiveness of the duration and intensity of 
practice suggests there is a dose-response for therapy, as observed in 
constraint-induced movement therapy (CIMT), even though some authors 
argue that task specificity is more important than intensity of practice. Motor 
tasks practised in their entirety [29] are believed to be more effective than 
those broken up into separate parts, for example reach and grasp practised 
as a single task is more effective than practicing reach alone [23, 30]. Also, in 
a treatment session, variability within the task practised makes it more 
effective than constant repetition of same task in terms of retention and 
transferability of the skill [31-34]. Feedback within these interventions can be 
gained as a) internal or task-intrinsic feedback gained through sensory, visual 
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and auditory experiences related to the task or b) extrinsic augmented 
feedback by the therapist or the system delivering the intervention that can 
be verbal, visual or physical. It is well established that these feedback 
strategies enhance skill acquisition in practice [23]. 
Upper limb rehabilitation interventions can be broadly categorised as 
impairment-based upper limb ability training, CIMT, bilateral training, 
electromyogram (EMG)-triggered neuromuscular stimulation, virtual reality-
based rehabilitation and interactive robotic therapy [35]. Upper limb ability 
training is designed for individuals with mild upper limb weakness and aims 
to improve movement characteristics such as handgrip, coordination, tracking 
and wrist-finger speed. Traditional CIMT aims to overcome learned non-use 
by restraint of the less-affected upper limb for 90% of waking hours and 
massed practice of the affected upper limb for at least 6 hours a day [36]. 
Modified CIMT involves training of affected upper limb for 30 minutes – 2 
hours/day and restraint of unaffected upper limb for less than 6 hours a day 
[37]. Modified CIMT has been shown to be more effective than conventional 
physiotherapy in improving upper limb movement and function in a recent 
meta-analysis [38]. Bilateral training involves practising simultaneous 
synchronous and asynchronous activities with both upper limbs. It is believed 
to enhance stimulation of the damaged cerebral hemisphere through 
enhanced interhemispheric inhibition [39, 40]. The current evidence is 
inconclusive in terms of superiority over conventional physiotherapy or 
unilateral upper limb training [41]. 
EMG-triggered neuromuscular stimulation is used for individuals with 
severe weakness and involved triggering muscle contractions when EMG 
activity in the muscle reaches a chosen threshold [42]. Virtual reality-based 
rehabilitation simulates the real world using a human-machine interface so 
that three-dimensional real life activities can be practised, it is used by the 
individual with or without the assistance of technology to help movement [43, 
44]. Interactive robotic therapy provides repetitive assistive therapy to the 
affected upper limb in a varying and engaging environment. It aims to 
improve basic movement patterns and helps the acquisition of skills, which 
could be transferred to real world functional activities. The usability of robotic 
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therapy spans varying degrees of upper limb impairment and can be used to 
augment any of the above therapies or used on its own. 
1.4 Robotic technology for upper limb rehabilitation 
 
Novel robotic technology provides repetitive meaningful tasks, greater 
intensity of practice, stimulating and engaging environments for users and 
alleviates the labour-intensive aspects of hands-on conventional 
physiotherapy. There are a number of complex robotic devices that have 
been developed over the years to assist upper limb exercises in 
rehabilitation; these include the Massachusetts Institute of Technology (MIT-
Manus), Mirror Image Movement Enabler (MIME), Bi-Manu-Track, Assisted 
Rehabilitation and Measurement (ARM) Guide, ARMin, GENTLE system and 
intelligent Pneumatic Arm Movement (iPAM) [45, 46]. The characteristic 
features of these devices and the clinical studies examining the use of these 
devices by stroke patients are summarised is described in Table 1. 
1.4.1 User-centred design approach in device development 
User-centred design (UCD) is a technique that focuses on users’ 
needs, and designs according to these needs [47, 48]. UCD is an iterative 
process; its key principles include: a) using the work practices of the user to 
control the development, b) the active involvement of the users’ 
representatives early and continuously throughout development, c) the 
requirement for the development to undergo many iterative cycles to come 
up with the requirements of the users, d) the early and continuous creation of 
prototypes to visualise and evaluate ideas and e) the involvement of 
interdisciplinary teams in the development process [49, 50]. 
   
  
Table 1. Overview of existing robotic devices tested in upper limb rehabilitation after stroke 
Robot Country Upper limb 
(UL) joint 
movements 
Modes Tested in 
environment/ 
supervision 
Total 
pts. 
Nature of 
patients 
tested 
Effect on UL movement Refere
nces 
MIT-Manus USA Shoulder and 
elbow (wrist 
in additional 
module) 
Assistive 
Resistive 
Passive 
Research centre 
and Hospital/ 
Therapist 
> 300 Subacute 
and 
chronic 
Improvement in UL 
movement and strength 
at shoulder and elbow 
[51-58] 
MIME USA Forearm 
(pronation/ 
supination) 
Active assist 
Bimanual 
Passive 
Research centre 
and Hospital/ 
Therapist 
> 100 Subacute 
and 
chronic 
Improvement in UL 
movement kinematics, 
strength 
[59-62] 
Bi-Manu-
Track 
Germany Forearm and 
wrist 
Active assist 
Active resist 
Passive 
Research centre/ 
Therapist 
> 100 Subacute 
and 
chronic 
Improvement in wrist and 
finger power and UL 
function, reduction in 
spasticity 
[63-67] 
NeReBot Italy Shoulder and 
elbow  
Passive 
Active assist 
Hospital/ 
Therapist 
> 50 Subacute Improvement in shoulder 
and elbow strength and 
UL movement  
[68, 69] 
ARMin 
(Exoskeleton) 
Switzerland Shoulder, 
elbow and 
wrist  
Passive 
Active assist 
 
Research centre/ 
Therapist 
> 40 Chronic Improvement in UL 
movement and ADL 
ability 
[70-72] 
   
  
Robot Country Upper limb 
(UL) joint 
movements 
Modes Tested in 
environment/ 
supervision 
Total 
pts. 
Nature of 
patients 
tested 
Effect on UL movement Refere
nces 
REO system Israel Shoulder and 
elbow  
Active assist 
Passive 
Research centre/ 
Therapist 
> 40 Subacute 
and 
chronic 
Improvement in UL 
movement 
[73-75] 
BATRAC USA Shoulder and 
elbow  
Active 
 
Research centre/ 
Therapist 
> 30 Chronic Improvement in shoulder 
and elbow movement, 
range and power  
[76, 77] 
REHAROB Hungary Shoulder and 
elbow  
Passive Research centre/ 
Therapist 
> 30 Subacute 
and 
chronic 
Shoulder and elbow 
movement improved and 
reduction in spasticity  
[78, 79] 
GENTLE UK Shoulder and 
elbow  
Active 
Active assist 
Passive 
Research centre/ 
Therapist 
20 Chronic Improvement in shoulder 
and elbow movement 
and range  
[80] 
BFIAMT Taiwan Shoulder and 
elbow  
Active 
Passive 
Research centre/ 
Therapist 
20 Chronic Improvement in UL 
movement kinematics  
[81] 
ARM-Guide USA Shoulder and 
elbow  
Active 
Active assist 
Research centre/ 
Therapist 
19 Chronic Improvement in UL 
kinematics 
[82] 
BdF Italy Shoulder and 
elbow 
Active assist Research centre/ 
Therapist 
14 Chronic Improvement in UL 
movement kinematics 
[83, 84] 
   
  
Robot Country Upper limb 
(UL) joint 
movements 
Modes Tested in 
environment/ 
supervision 
Total 
pts. 
Nature of 
patients 
tested 
Effect on UL movement Refere
nces 
ARAMIS 
(Exoskeleton) 
Italy Shoulder, 
elbow and 
wrist  
Passive 
Active assist 
Active 
Hospital/ 
Therapist 
14 Subacute Improvement in UL 
movement and function 
[85] 
HWARD USA Wrist and 
finger  
Active assist Research centre/ 
Therapist 
13 Chronic Improved movement of 
wrist and fingers 
[86] 
HapticKnob Singapore Forearm and 
hand 
 
Active assist Research centre/ 
Therapist 
13 Chronic Improved UL movement 
and hand function 
[87] 
Haptic Master Netherlands Shoulder, 
elbow, wrist 
and hand 
Active assist Research centre/ 
Therapist 
11 Chronic Improvement in UL 
movement and function 
in daily activities 
[88] 
ACRE Netherlands Shoulder and 
elbow  
 
Active assist Research centre/ 
Therapist 
10 Subacute Improvement in UL 
movement 
[89] 
L-Exos 
(Exoskeleton) 
Italy Shoulder and 
elbow  
Active assist Research centre/ 
Therapist 
9 Chronic Improvement in UL 
movement and 
kinematics, reduction in 
spasticity 
[90] 
   
  
Robot Country Upper limb 
(UL) joint 
movements 
Modes Tested in 
environment/ 
supervision 
Total 
pts. 
Nature of 
patients 
tested 
Effect on UL movement Refere
nces 
RUPERT 
(Exoskeleton) 
USA Shoulder, 
elbow, 
forearm and 
wrist  
Active assist  Research centre 
and home/ 
Therapist 
8 Chronic Improvement in UL 
movement kinematics 
[91, 92] 
AMES USA Wrist and 
fingers 
Active assist Home/ Self 8 Chronic Improvement in wrist and 
finger strength and range 
[93] 
Reha-Digit Germany Fingers Passive Research centre/ 
Therapist 
8 Subacute Reduction in spasticity, 
no change in strength 
[94] 
MEMOS Italy Shoulder and 
elbow 
Passive 
Active assist 
Active 
Research centre/ 
Therapist 
8 Chronic Improvement in strength 
and range in shoulder 
and elbow 
[95] 
Amadeo Austria Fingers  Passive 
Active assist 
Hospital 7 Subacute Improvement in UL 
movement and function 
[96] 
HEXORR 
(Exoskeleton) 
USA Fingers Active assist  Research centre/ 
Therapist 
5 Chronic Improvement in range of 
finger movement 
[97] 
REHA-SLIDE Germany Shoulder, 
elbow and 
wrist 
Passive Research centre/ 
Therapist 
2 Subacute Improvement in UL 
movement and strength 
[98] 
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Involvement of users in medical device technology development has 
been shown to influence the safety, usability, quality, cost, and clinical 
effectiveness in the target group [99-101]. Groups such as the 
Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) 
in the UK promote the process of user involvement by developing formal 
methods for evaluating users perspectives and engaging the community in 
technology development [102].  
Only a few upper limb rehabilitation robot studies in the current 
literature report on the actual UCD process undertaken in the development of 
the devices [50, 103]. There is a need for the research team to include 
multidisciplinary members, understand the engagement methods, explore the 
breadth of feedback content and undertake multiple iterative cycles to 
develop robotic devices that are fit for purpose.   
1.4.2 Principles of robot mechanical design 
Based on the mechanical structure of the robot, two categories are 
recognised: end-effector based robots and exoskeleton-based robots [104]. 
End-effector based robotic devices contact the user’s limb only at its most 
distal part; for example, MIT-Manus and MIME. Exoskeleton-based devices 
have a structure that mirrors the skeletal structure of users’ upper limb and 
support the range of movements of each joint; for example, ARMin and 
RUPERT. Exoskeleton-based devices use a more complicated algorithm and 
need adjustment of their segments to the user’s upper limb length so that the 
joints of the device match those of the user. They are cumbersome to put on 
and take off but provide better stability to limb movements and promote a 
larger range of motion of the limb at multiple joints [71]. Some robotic 
devices, such as ArmeoSpring, use a combination of both approaches [105].  
The actuator(s), or motor(s), drives the assistance force provided by 
the robot to the limb movement. It is generally located in the constrained part 
of the robotic device to reduce the weight and inertia of the moving part of the 
device. Most of the actuators of robotic devices are electric [104]. Some 
devices have pneumatic actuators which are lighter and have lower 
impedance than their electric counterparts, such as iPAM [106], Pneum-
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WREX [107] and RUPERT [92].  A third category of hydraulic actuators 
(powered by hydraulic energy using oil) is being tested in some newer 
devices [108].  
A robotic device can promote either three-dimensional movement or 
movement in one plane. Most of the robotic devices listed in Table 1 allow 
movement in three dimensions; for example, GENTLE, ARMin and NeReBot. 
The planar robots allow movement of the distal piece attached to the limb in 
one plane only. The original version of MIT-Manus is a planar device but with 
the addition of the anti-gravity module it allows movement in two planes 
[109]. The BdF planar device allows the working space to be changed 
between horizontal and vertical planes [83]. ARM Guide is a planar device 
where the forearm slide angle can be adjusted to enable working in multiple 
workspace regions [82]. A planar robot is less complex and easier to build, 
which reduces the cost of the device [104].  
The total number of axes of movement allowed by the device in 
different joints is referred to as the Degrees of Freedom (DOF) of the robotic 
device. The planar device MIT-Manus has two DOF. The end-effector robotic 
devices (as listed in Table 1) that provide movement only to the proximal 
joints (shoulder and elbow) of the upper limb have lower DOF.  The 
exoskeleton-based robots generally have higher DOF, as they allow 
movements in different planes. The robots for finger or hand rehabilitation 
have higher DOF, the hand exoskeleton developed in the Technical 
University has 20 DOF [110]. The higher number of DOF increases the 
complexity of the algorithm used by the system and makes the device more 
expensive and needs assistance from therapists for use [104]. 
1.4.3 Principles of robotic exercise therapy 
An assistive robotic system can sense the movement or force of the 
user, use that information to make decisions and plan subsequent motion or 
output, and provide force feedback to the user via actuators (motors) in the 
system [46]. The movements generated by robots are gross movements 
such as reaching, bilateral training, fine hand skills, activities of daily living or 
a combination of these movements. The system may also provide audio, 
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visual and proprioceptive feedback to the user that makes the movements 
more interactive and engaging.   
1.4.3.1 Gross movement training 
A typical robotic system aims to shape the reaching movement 
towards the target. The user is required to move their arm to reach the target 
endpoint. The robotic system (attached to the arm) contributes to make the 
movement efficient and complete the task. It can passively move the upper 
limb towards the endpoint (passive mode), provide extra force to help 
complete the task (active assistance), resist force applied by the user to the 
robot (active resistance), or assist in the direction of the movement and 
redirect strayed movements towards the target (active constraint). Not all 
robotic systems have all these modes (Table 1). The GENTLE robotic system 
can operate in three modes (passive, active assistance, active resistance) 
and a clinical study in chronic stroke participants observed that the active 
mode was more beneficial than the other modes in improving upper limb 
movement [80]. The force-feedback function of MIT-Manus assists 
movement in the direction appropriate for task completion and has been 
shown in several studies involving acute and chronic stroke subjects to 
produce improvement in upper limb movement [51, 111].   
1.4.3.2 Bilateral robotic training  
The understanding of cortical reorganisation and motor recovery, 
particularly the understanding of bihemispheric plasticity after stroke has led 
to the development of therapy that simulates the bilateral movement of the 
paretic and nonparetic upper limbs at the same time. The belief is that 
bilateral training enhances the interhemispheric motor cortex disinhibition and 
facilitates cortical overflow from the undamaged hemisphere [81, 112]. This is 
contrary to the principles of constraint therapy where the unaffected upper 
limb is deliberately constrained and the affected upper limb is intensively 
exercised. However, both therapies promote intensity and repetition of 
meaningful movements. The current evidence is still inconclusive whether 
bilateral therapy is superior to unilateral therapy in terms of motor recovery 
[113].  
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Some robotic devices are able to provide bilateral symmetrical upper 
limb training to [59, 77, 81, 83]. In subacute and chronic stroke patients, 
robots delivering bilateral therapy, such as BFIAMT [81], BATRAC [77], 
MIME [59] and BdF [83] have showed improved upper limb movement 
kinematics and function. MIME device can provide both unilateral and 
bilateral therapy where the device assists the paretic upper limb to move in a 
mirror fashion to movement of the unaffected upper limb. In a sample of 
subacute stroke patients, Lum et al. found bilateral therapy improved function 
but was not superior to unilateral therapy [60].   
1.4.3.3 Robotic training for fine hand skills 
In the latest versions of the robotic devices MIT-Manus and GENTLE, 
there are additional modules to address distal muscle movements in their 
latest versions [29, 114]. The Hand Wrist Assistive Rehabilitation Device 
(HWARD) is a robot built specifically to improve hand grip/release and wrist 
movements in a real time virtual environment [86]. Rutgers Master II-ND 
glove is a robotic system that applies force to fingers and helps promote 
movement in the fingers and maintain the range of movement [115]. Clinical 
studies of these devices with stroke survivors have shown improvements in 
finger movement kinematics and hand function [86, 116].  
1.4.3.4 Robotic training for Activities of Daily Living (ADL) 
One of the criticisms of most end-effector robotic systems is that the 
hand is holding the handle of the robotic arm while performing reaching 
movements and is not engaged in grasping and manipulating objects as it 
would be in daily activities. The ARMin robot is an exoskeleton robot that 
supports the movement of the arm leaving the hand free to perform daily 
activities in a virtual reality three-dimensional environment. The hand would 
not be able perform the activities without the support of the robotic device. A 
study involving chronic stroke subjects using ARMin showed improvements 
in motor function but no significant change in their perceived-change in ability 
in daily activities [70]. Timmermans et al. used a Haptic Master robot to guide 
upper limb movement with the free hand actively training in daily activities 
and found that robot training improved functional ability in daily activities [88]; 
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however, the effect was however not superior to video-instructed task-
oriented conventional training.  
1.4.3.5 Feedback to the user 
Most robotic devices involve performing reaching tasks to play games 
on a computer screen. Some devices involve reaching and manipulating 
things in the real (Haptic Master) or virtual environments (ARMin) [70, 88]. 
Robotic devices control force feedback to the user either using the  
impedance control approach (where movement is measured and the force 
feedback adjusted such as MIT-Manus and most robotic devices) or using 
the admittance control approach (where the force exerted by the user is 
measured and the movement displacement adjusted; for example, iPAM). 
Haptic devices interact with the user through the sense of touch and are able 
to adjust assistive forces based on the force applied by the user; for example, 
the T-WREX exoskeleton device [117]. As well as assisting the upper limb 
movement, the feedback provided to the user can be visual, tactile, audio, 
electrical or a vibratory stimulation [104].  
1.4.4 Comparison of robotic therapy and conventional therapy 
A meta-analysis of randomised controlled studies investigating robotic 
therapy versus usual care, conventional therapy or electrical stimulation 
showed a significant improvement in upper limb movement with robot 
therapy, measured using the Fugl Meyer – Upper Extremity [FM-UE] 
outcome measure [118]. There was however no significant improvement in 
activities of daily living (ADL) when compared to control therapy, measured 
using the Functional Independence Measure (FIM). The review included nine 
randomised controlled studies with a combination of proximally acting robots 
(such as MIT-Manus, MIME) and distally acting robots (such as Bi-Manu- 
Track). The authors recommended future studies to consider specific 
outcome measures (kinematic analysis of upper limb movement) and 
subsections of outcome measures (proximal and distal subsection of FM-UE) 
to capture the real effects on proximal or distal muscles. Functional outcome 
measures such as the Action Research Arm Test (ARAT) or the Wolf Motor 
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Function Test (WMFT) were recommended, as they are more sensitive than 
the FIM for this type of intervention [118]. 
A later systematic review of 11 randomised controlled studies 
investigating six robotic devices (providing unilateral therapy only) drew two 
important conclusions (a) when robot therapy and conventional therapy are 
matched in duration and intensity, there was no significant difference in motor 
recovery, strength, motor control and activities of daily living between the 
robot therapy and conventional therapy groups; and (b) when robot therapy is 
used as an additional therapy to regular conventional therapy, the gains are 
significantly higher in the combination group and these gains remain 
significant at an 8-month follow-up [119]. The authors suggested that robotic 
devices could be used to fill the gap in provision of intense therapy caused by 
therapist resource constraints in most rehabilitation settings. They observed 
that most devices were planar robots (two-dimensional) designed for 
proximal therapy and lacked the function-based approach and future 
research should focus on these aspects of robot therapy.   
1.4.5 Cost-effectiveness of robotic therapy 
An economic analysis of robotic technology is difficult as most clinical 
studies recruit small numbers, involve a heterogeneous group of participants 
and there is often no uniform outcome of intervention across participants 
(except for use of FM-UE). The cost-effectiveness of robotic therapy when 
compared to intensive comparison conventional physiotherapy has been 
analysed in only one study so far [120]. A multicentre study (the VA robotic 
study) studied the cost-effectiveness of the MIT-Manus in 127 participants 
across four sites. The cost of the robotic device was $ 230,750 with 
additional maintenance costs ($15,000 per year). With a life-span of 5 years, 
the cost of the robot per one-hour session was estimated to be $20. The cost 
of therapist time was $120 for robot therapy (15 min of therapist contact time 
per session) and $218 for a 60 min session of conventional therapy. The total 
average cost per person over the 12-week treatment period including travel 
costs was $5152 for robot therapy and $7382 for conventional therapy. The 
study based on clinical outcomes concluded that robot therapy did not 
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demonstrate superior cost-effectiveness but did demonstrate similar cost-
effectiveness [53, 120]. This demonstrates that robotic therapy has the 
potential to address the shortage of therapist manpower in healthcare 
services.  
1.4.6 Home-based robot technology and telerehabilitation 
Common features of most robotic systems (Table 1) are that they are 
complex, are deployed within a hospital or research centre setting and need 
therapist supervision in therapy sessions. Patients need to travel to hospital 
or to a research centre to access robotic therapy. Some patients are unable 
to do this due to transport costs, lack of carer support or severe disability 
after stroke. In current healthcare systems, including the NHS, the inpatient 
rehabilitation length of stay for patients with stroke is decreasing with 
increasing emphasis being placed on community-based rehabilitation. Home-
based conventional physiotherapy is effective but can be resource-limited 
due to therapist availability and is generally provided only for a fixed period 
after stroke (generally up to 6 months post-stroke). Home-based robotic 
therapy is an attractive alternative option but has a number of technical and 
clinical challenges to overcome.  
The technical challenges of home-based robotic therapy are to make 
the technology safe to be deployed and usable in a home setting. The 
footprint of the device needs to be acceptable to the patient, family and 
carers. The user should be able to easily set-up and use the device without 
the therapist being present for each session. The user would need access to 
engineering support for technical issues and would need to be remotely 
supervised by a therapist to ensure appropriate therapy is being delivered.  
The clinical challenges are many; the technology needs to be able to match 
conventional physiotherapy principles and provide the relevant therapy to the 
user. There is a risk of dehumanisation of the rehabilitation therapy if there is 
little interaction with the therapist and other patients. The therapy will need to 
address personal functional needs and will need to be tailor-made for each 
individual user. 
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There have been a few devices developed to provide home-based 
robotic upper limb rehabilitation for stroke patients. RUPERT is a wearable 
exoskeleton robot that helps direct the upper limb to perform functional 
activities in a three-dimensional virtual reality [92]. It has been tested in the 
home setting in two chronic stroke subjects with improvement in the accuracy 
and smoothness of their movements [92]. The impact on daily activities was 
not reported. The exoskeleton needs to be fitted to the user’s upper limb by 
the family member or carer. The acceptability of the device needs to be 
tested in a larger heterogeneous sample of stroke subjects in a home setting. 
Johnson et al. [121] developed an upper limb stroke therapy suite 
(intended for home use) consisting of affordable hardware platforms, such as 
the force-reflecting joystick (Therajoy) and wheel (TheraDrive) working on a 
customisable universal software platform (UniTherapy). A sample of 16 
chronic stroke subjects with mild to moderate upper limb weakness tried the 
system; simultaneous EMG recording of the upper limb muscles 
demonstrated that the robot therapy can be personalised in terms of the 
muscles targeted or activated by using a choice of joystick and wheel tasks. 
The system also has the ability to accurately track movement kinematics that 
can be useful to monitor progress. The system is yet to be tested in a clinical 
study in a home setting. 
The Java therapy system is based on wrist exercises using a low-cost 
commercial force feedback joystick connected to a customised computer 
program of therapeutic activities available on the web [122]. The system has 
been designed for home use and the therapy can be monitored remotely by a 
therapist using a low-cost web camera and teleconferencing software. One 
stroke survivor used the system for a 12-week period and showed 
improvements in movement speed and movement control. The low-cost 
system (estimated to cost $240 for the joystick, upper limb rest, splint and 
base) received high satisfaction scores from the user and his carer. This is 
yet to be tested in a larger clinical study in the home setting. 
Wood et al. have developed a simple ‘Palanca’ sliding lever device 
used to play an electronic ping-pong game on the computer and have shown 
improvement in the functional abilities of four stroke subjects after using the 
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device [123]. This feasibility study was conducted in the research centre and 
showed that the low-cost device helped maintain high level of interest, 
motivation and enjoyment in therapy. A larger scale study in the home setting 
is being planned.  
The Assisted Movement with Enhanced Sensation (AMES) device 
provides assistance to uniaxial flexion and extension movements of the wrist 
(and fingers) or ankle joint. The device also provides vibration sensation to 
the antagonist muscle-stretching tendon when the agonist muscle is 
performing the desired action to provide somatosensory feedback during 
movement. The device provides visual feedback on the torque exerted by the 
user. A study of upper limb exercises in the home setting, involving eight 
chronic stroke participants, showed improvements in the strength and range 
of movement in the wrist and fingers after six months of home use. The effect 
on functional abilities of the upper limb was not reported. During the home-
use period, three participants needed additional training with EMG feedback 
in the research laboratory as they could not generate adequate torque to be 
able to use the device.  The system lacks variation in tasks that can affect 
long-term usage (engagement in therapy) and this needs to be explored in a 
larger sample of patients [93]. 
1.4.6.1 Future research in home-based robotic technology 
Micera et al. have put forward a simple hierarchical system of 
classifying robotic devices for upper limb rehabilitation after stroke 1) 
Exoskeleton devices with greater range of movement and complex design 
suited for use in hospitals and research laboratories for users with severe 
disability, and 2) Operational devices which are less complex, end-effector 
and suitable for use by users with moderate disability [95]. The operational 
devices group can be further sub-classified as a) Class 1 devices that have 
low mechanical friction, high back-driveability, fine tuned visco-elastic 
properties and high cost that can be used in the laboratory setting and b) 
Class 2 devices that have a simple mechanical structure, compensation of 
inertia/friction, no back-drivability and low cost to be used in telerehabilitation 
settings at home. From our review of robotic devices tested in clinical 
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settings, there is a plethora of exoskeleton and Class 1 devices that have 
been manufactured and tested. However, there is an obvious paucity of 
Class 2 devices that have been tested in the home setting. Future research 
clearly needs to explore the challenges of making low-cost home-based 
robots that are simple, acceptable and effective in improving upper limb 
function.  The number of people needing upper limb rehabilitation post-stroke 
is increasing worldwide and there is growing emphasis of moving 
rehabilitation resources to community settings and peoples’ homes.  
1.4.7 Conceptual models for assistive technology outcomes 
research 
Various models exist that help assessment of assistive technology in 
terms of matching to the users needs, measuring impact on user and 
predicting usability. The Human Activity-Assistive Technology (HAAT) model 
[124], the ICF-AT model [125] and the Matching Person and Technology 
(MPT) model [126] are some of the popular models in the current literature. 
These models offer descriptive frameworks to explore the complex 
relationship between assistive technology, personal traits and environmental 
factors that determine the usage and impact of the technology. These models 
have been primarily utilised for assistive technology outcome assessment, 
but their use can potentially be extended to providing basis for user 
involvement in device development.   
1.5 Project objectives 
The purpose of this project is to develop and undertake preliminary 
evaluations of a low-cost restorative rehabilitation robotic system that assists 
stroke survivors to undertake independent upper limb exercises at home. The 
project has two stages: Stage 1, Developing the home-based Computer 
Assisted Arm Rehabilitation (hCAAR) device development using a user-
centred design process; Stage 2, A proof of concept clinical feasibility study 
of hCAAR in people with upper limb weakness after stroke. 
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1.5.1 Stage 1: hCAAR device development  
The objective of the user-centred design process is to understand user 
needs and involve them in the different stages of device development. Stroke 
survivors with upper limb weakness (end-users) and healthcare professionals 
providing therapy to stroke survivors (professional users) are both involved in 
this process. Feedback is gathered in the concept, design and testing stages 
of hCAAR development.   
1.5.2 Stage 2: Feasibility study 
The objective of the feasibility study is to test whether hCAAR can be 
safely used in a home setting with minimal supervision and whether using the 
device improves upper limb movement and function. Stroke survivors with 
upper limb weakness will use the device for upper limb exercises in their 
homes for 8 consecutive weeks. Kinematic and clinical outcome measures 
will be used to capture movement characteristics and functional abilities to 
indicate efficacy. Qualitative feedback is used to indicate acceptability (for 
example, how it looks, how it fits into the home environment, quantity of use) 
and impressions (for example, efficacy, future developments to the device).  
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Chapter 2: Systematic review of the outcome measures used 
in robot-assisted exercise studies and using the ICF 
framework to select outcome measures  
The landscape of upper limb rehabilitation technology has been 
changed by the advent of robotic devices that have been evaluated in clinical 
studies with stroke participants. A meta-analysis of randomised controlled 
studies showed a significant improvement in upper limb motor function but no 
significant change in ADL function with upper limb robotics [118]. The failure 
to achieve a significant effect on real life activities may relate to either the 
lack of impact of the intervention, or the poor responsiveness of the outcome 
measures used in the studies, or both. Larger robot studies are needed to 
confirm or refute the findings of the smaller scale robot studies done so far. It 
is also vital that appropriate outcome measures are used in these larger and 
more expensive studies. 
There is no consensus on the combination of outcome measures that 
should be used in robot studies. Most published clinical studies have used 
FM-UE to enable comparisons to be made between studies and pooling of 
data for meta-analyses. In the past, there was greater emphasis on 
measuring change at the impairment level (by kinematic assessment or 
impairment-based rating measures) than measuring change at the activity 
level. Clinical studies published recently have incorporated outcomes that 
reflect day-to-day activities. There is limited literature describing how to 
select outcome measures based on the nature of the intervention and the 
patient’s clinical features. 
The ICF could be used as a framework to analyse the content of 
outcome measures and to develop a system that enables the selection of 
appropriate outcomes in a study. Although the domains described in the ICF 
conceptual framework of health condition, i.e., body functions (and 
structures), activities and participation, and personal and environmental 
factors, are related, they do not necessarily have causality between them, 
making measurement of all the domains necessary [127]. This implies that 
  
  
- 24 - 
  
outcomes capturing these different domains need to be included in future 
robot studies.  
The aims of this chapter are a) to identify and evaluate outcome 
measures currently used in robot studies b) to determine selection criteria for 
outcome measures in robot studies and c) to select suitable outcomes for the 
hCAAR feasibility study. 
2.1 Methods 
A systematic review of outcomes used in robot studies was undertaken 
in three stages. 
2.1.1 Identify outcome measures used in robot studies in stroke 
patients   
The first stage was a search of the MEDLINE, EMBASE, CINALH, 
PUBMED and PsychINFO databases to identify relevant robot studies. These 
databases were selected because published robot clinical studies are 
captured in searches of these databases. The keywords used were: stroke, 
upper limb, arm, rehabilitation, motor, recovery, robot, computer, training, 
therapy, physiotherapy, function and study. From the initial search, all 
abstracts were reviewed. The inclusion criteria for this review were  
1. Study involved participants with diagnosis of a stroke. 
2. Study involved at least 10 participants. 
3. Upper limb exercise assisted by a robot device. For the review, a robotic 
device was defined as any technology that has the ability to assist upper limb 
movement for therapeutic exercises.  
4. At least one outcome measure used in the study. 
Studies of robot devices involving only healthy volunteers and those 
with fewer than 10 participants were excluded. The reason for having the 
number of participants as one of the criteria was to facilitate an appraisal of 
the performance of the outcome measure utilised in the study.  
This stage was primarily undertaken by the main author MS. The 
authors SM, ML and BB also searched databases and cross-referenced with 
MS search list to ensure all relevant studies had been identified. 
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2.1.2 Classify outcome measures using the ICF framework  
In the second stage of this systematic review, the individual items 
within each identified outcome measure were categorised into the one of ICF 
domains based on their ICF code. The ICF online database of codes was 
used to identify the most suitable code. Based on the distribution of the 
items, each outcome measure was then categorised as representative of one 
of the ICF domains.  
This stage was primarily undertaken by the author MS. The author 
ROC checked the ICF codes for items and categorisation of outcomes to the 
different domains. 
2.1.3 Evaluate measurement properties of outcome measures  
The third stage of the systematic review involved a search of the same 
databases, which were used in first stage, to identify clinical studies involving 
stroke participants that described the measurement properties of the 
identified outcome measures. The keywords used were: the name of the 
outcome measure, stroke, validity, reliability, questions, items, consistency, 
minimal clinically important difference (MCID), responsiveness, floor effect, 
ceiling effect and agreement. Standard criteria were used to define and 
classify the measurement properties of reliability, validity, responsiveness 
and acceptability for the outcome measures (Table 2). These criteria are 
widely used in outcome measure research [128, 129]. A measurement profile 
for each outcome measure was constructed based on the evidence for the 
different properties.  
Participants were considered being in the subacute stage of recovery 
if within 6 months of their stroke and the chronic stage if more than 6 months 
since their stroke.  
This stage was undertaken by the authors MS. The author ROC 
ensured the standard criteria were used appropriately to construct the 
measurement profile for the outcome measures. 
  
  
  
Table 2. Definition and standards for the evaluation criteria 
Criterion 
 
Definition Standard 
Reliability Reproducibility is the extent to which the same results are 
obtained on repeated administrations of the same 
questionnaire by same person (test-retest) or different 
people (inter-rater). Internal consistency assesses the 
homogeneity of the scale’s items [128]. 
Reproducibility (test-retest or inter-rater) - Intraclass 
correlation coefficient  or kappa value - excellent or high > 
0.75, moderate 0.4 – 0.74 and poor < 0.40 [128, 130].  
Internal consistency – Cronbach’s α excellent > 0.8, 
adequate 0.70 – 0.79 and low < 0.70 [129, 131]. 
Validity The extent to which the scale measures what it intends to 
measure. Content validity is extent to which the measure is 
representative of the conceptual domain.  Criterion validity 
(concurrent, convergent, predictive) is the degree to which 
the measure correlates with a gold standard. For most of 
the functional scales, there is no gold standard, so construct 
validity is used. Construct validity is determined by 
examining the hypothetical relationship between the 
measure and other similar measures [128]. 
Correlation coefficient value (r) – excellent > 0.60, 
adequate 0.3 – 0.6 and poor < 0.3 [129]  
ROC analysis –  Area under curve (AUC) excellent > 0.9, 
adequate 0.7 – 0.9 and poor <0.7 [132].  
 
 
  
  
  
Criterion 
 
Definition Standard 
Responsiveness The ability of the instrument to accurately detect changes 
which have occurred over time [133].  
Minimal clinically important difference (MCID) - The smallest 
difference in the scores in the domain of interest that 
patients perceive as beneficial or that would be clinically 
meaningful 
Floor and ceiling effects - The extent to which scores cluster 
at either the bottom or the top of the scale range 
Change in score - The effect size is calculated by the 
observed change in score divided by the standard 
deviation of baseline score. Large > 0.8, Moderate 0.5-0.8 
and small < 0.5 [134, 135]. 
Other methods:  
Standardised Response Mean, ROC analysis – area under 
curve, Statistical significance p value, Correlation values of 
observed change compared to change in other scales 
MCID - described as a score value 
Floor and ceiling effects - Expressed as percentage of the 
number of scores clustered at bottom / top. Excellent 0%, 
Adequate <20%, poor > 20% [129]. 
Acceptability Respondent burden - Is the length and content of scale 
acceptable to the intended participants (participants with 
disability)? 
Administrative burden - How easy is the tool to administer, 
score and interpret? Cost implications? 
Respondent burden - Excellent: Brief (< 15 min) and 
acceptable, Adequate: either longer or some problems of 
acceptability. Poor: both lengthy and problems of 
acceptability [129]. 
Administrative burden - Excellent: scoring by hand, easy to 
interpret, Adequate: computer scoring, obscure 
interpretation, Poor: costly and complex scoring/ 
interpretation [129]. 
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2.2 Results 
2.2.1 Outcome measures used in robot studies 
The initial search yielded 642 articles. After reading the abstracts and 
applying the inclusion criteria, 36 studies were identified as suitable for 
inclusion in the review. Table 3 summarises the outcome measures used in 
these studies. The most common outcome measure used was the Fugl 
Meyer- Upper Extremity (motor section) that was recorded in 33 studies. The 
outcome measures that were used in at least 10 studies were the Ashworth 
Scale/Modified Ashworth Scale, Medical Research Council and Functional 
Independence Measure. Each of the remaining outcome measures was used 
in less than seven studies in total. Kinematic measures that require separate 
motion capture system to calculate upper limb movement characteristics 
while the user performs standard reaching tasks were used in three studies. 
Kinematic variables derived from the robotic device were reported in three 
studies.   
2.2.2 Classification of outcome measures using the ICF 
framework 
Most of the items of each outcome measure corresponded to an ICF 
code and were matched to the relevant ICF domain (Table 4). A few items 
did not correspond to any ICF category and were described as “not yet 
categorised”. A few examples of such items are “feel you are a burden” and 
“control life as you wish”. These items correspond to the “personal factors” 
domain of the ICF framework, which is not yet categorised. 
Figure 2 summarises the classification of all the outcome measures 
into the different ICF domains of body function, activity, participation and 
contextual factors. The majority of the outcome measures represented the 
body function or structure domain, followed in order of decreasing frequency 
by the activity domain, then the participation domain and finally the 
contextual factors domain.  
  
  
  
 
Table 3. Outcome measures used in robot studies (in the order of total number of patients involved in studies with each named 
robot and then year of publication) 
Robot 
device 
Study
year 
n Type of 
patients 
FM-
UE  
AS/ 
MAS 
MRC FIM Kinematic 
measures 
Robot 
measures 
Others Referenc
es 
MIT Manus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2011 
 
62 Chronic +      WMFT, SIS [58] 
2010 
 
127 Chronic + +     WMFT, SIS [53] 
2009 
 
20 Chronic  +     MSS, ROM, VAS (pain) [54] 
2008 
 
47 Chronic  +       [57] 
2008 
 
30 Subacute +  + +   MSS, FM – pain  [55] 
2005 
 
12 Chronic +      AMAT [136] 
2003 
 
20 Subacute + + +    MSS [52] 
2000 
 
56 Subacute +  + +   MSS [56] 
1997 20 Subacute +  + +    [51] 
  
  
  
 
Robot 
device 
Study
year 
n Type of 
patients 
FM-
UE  
AS/ 
MAS 
MRC FIM Kinematic 
measures 
Robot 
measures 
Others Referenc
es 
Bi Manu 
track  
2012 
 
20 Chronic +   +   ABILHAND, MAL [67] 
2011 
 
18 Chronic +  +    ABILHAND, MAL [66] 
2008 54 Subacute + + +    BBT 
 
[65] 
2005 
 
44 Subacute + + +     [64] 
2003 12 Chronic  +     RMA, Patient 
impressions 
[63] 
MIME 2011 
 
54 Subacute + + + +   WMFT [62] 
2006 23 Subacute 
 
+  + +   MSS [60] 
2002 27 Chronic +   + Reach extent  BI, Muscle power MVC 
 
[59] 
2000 21 Chronic + 
 
      [61] 
ARMin 2014 77 Chronic + +    Mean 
strength  
Grip strength, MAL, 
WMFT, SIS 
[70] 
  
  
  
 
Robot 
device 
Study
year 
n Type of 
patients 
FM-
UE  
AS/ 
MAS 
MRC FIM Kinematic 
measures 
Robot 
measures 
Others Referenc
es 
NeReBot 
 
2007 35 Subacute + + + +    
 
[68] 
2007 24 Subacute +  + + 
 
  MSS [69] 
Reo system 2011 19 Chronic + +  +   VAS (pain), BBT, FAT, 
ABILHAND, EQ-5D, VAS 
(satisfaction) 
[75] 
2009 14 Chronic + +  +   VAS (pain), BBT, FAT, 
ABILHAND, EQ-5D 
[74] 
2008 10 Subacute +      MFT, Patient satisfaction 
 
[73] 
BATRAC 
 
 
2004 21 Chronic +      WMFT, fMRI, Grip 
strength 
[76] 
2000 14 Chronic +      WMFT, Grip strength 
  
[77] 
REHAROB 2007 30 Mixed + +  +   RMA, ROM, VAS 
(patient acceptance), 
VAS (pain) 
[79] 
Haptic 
Master 
2014 22 Chronic +      ARAT, MAL, EQ-5D, SF-
36 
[88] 
  
  
  
 
Robot 
device 
Study
year 
n Type of 
patients 
FM-
UE  
AS/ 
MAS 
MRC FIM Kinematic 
measures 
Robot 
measures 
Others Referenc
es 
GENTLE 2008 20 Chronic + +     ROM, Motor AS, SCT, 
VAS (pain), NSA 
[80] 
BFIAMT 2007 20 Chronic + +   Peak speed, 
Time, Jerk  
Push-pull 
strength 
FAT, Grip strength [81] 
ARM Guide 2006 19 Chronic     Range, 
Smoothness, 
Path length 
Stiffness 
Range  
Velocity 
CMSA 
 
[82] 
ARAMIS 
 
2012 14 Subacute +   +    [85] 
Haptic Knob 2011 13 Chronic + +     Motor AS, NHPG, Grip 
strength, VAS (pain), 
Patient satisfaction scale 
[87] 
HWARD 
 
2008 13 Chronic + +     ARAT, NHPT, BBT, SIS [86] 
BdF 
 
2009 10 Chronic + +    Force, 
time, error 
 [84] 
ACRE 2007 10 Subacute +      Patients and therapists 
impressions 
[89] 
 
           
  
  
  
 
Table 4. ICF categorisation of items 
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b710 Shoulder movements + +   + +     + +      
b710 Elbow movements + +   + +     + +      
b710 Pronation/supination + +   +      + +      
b710 Wrist movements + +   +       +      
b710 Finger movements + +                
b730 Power + +  +  +            
b735 Tone    +        +   +p   
b735 Spasticity    +              
b1470 Speed +   +  +            
b7651 Tremor +     +            
b7651 Jerk      +            
b7602 Coordination +   +              
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b750 Reflexes +   +              
b280 Pain    +            +p +p 
b7305 Posture    +       +       
b130 Energy or drive                +p  
b152 Anxiety                +p +p 
b152 Depression               +p +p +p 
b152 Concentrate               +p   
b175 Problem solving               +p   
b144 Memory               +p   
b399 Name objects correctly               +p   
b4552 Fatiguability                +p  
d4459 Contribution to bilateral 
activity 
        + +        
d440 Grasp + + +  +      +       
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d440 Pinch  + +               
d440 Grip   +  +      +    +p   
d4401 Grip glass to pour water    +      +    +p     
d4400 Pick and lift objects   +  +     + + +     +p  
d440 Open jar         + +    +p +p   
d440 Dial number          + +     +p   
d3352 Draw line         +         
d2102 Put toothpaste on brush         +     +p    
d5201 Brushing/ caring for teeth             +p     
d2102 Cut putty         + + +   +p    
d2100 Zip up zipper         +     +p    
d2101 Dry back with towel         +         
d2101 Clean eyeglasses         +         
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d540 Put on shirt          +        
d5400 Do buttons         +    +p +p    
d430 Carry bag         +    +p  +p   
d5402 Putting on footwear             +p     
d2101 Hammering a nail              +p    
d2101 Threading a needle              +p    
d2101 Peeling potatoes/onions              +p    
d2101 Cutting/Filing one’s nails              +p    
d2101 Wrapping gifts              +p    
d2101 Shelling hazelnuts              +p    
d2101 Opening a pack of chips              +p    
d2101 Spreading butter on bread              +p    
d2100 Washing hands             +p +p    
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d5400 Buttoning up trousers              +p    
d2101 Opening mail              +p    
d2101 Stack checkers      +             
d2100 Flip cards over     +             
d550 Hand to mouth/eating   +    + +  +  +  +p     
d4400 Pick up and hold pencil           + + +p     
d145 Write on paper            +  +p     
d4400 Pick up paper            +       
d2101 Pat a cake           +       
d2101 Tie shoelace          +     +p   
d2101 Tie bow           +       
d2100 Wipe spilled water          +        
d2100 Operate light switch          +   +p     
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d2100 Operate door handle          +   +p  +p   
d2100 Turn key in lock     +        +p     
d5202 Comb hair        +  +  +  +p     
d540 Grooming       + +  +   +p     
d510 Bathing       + +       +p  +p 
d540 Dressing       + +       +p  +p 
d530 Toileting       + +       +p  +p 
d530 Bowel       + +       +p  +p 
d530 Bladder       + +       +p   
d420 Transfer    +   + +     +p  +p   
d4103 Supine to sitting    +              
d4104 Sit to stand    +        + +p     
d450 Walk    +   + +    +   +p +p +p 
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d4551 Stairs    +   + +       +p +p  
d640 Vacuum, laundry, 
gardening 
              +p +p  
d6200 Shopping               +p +p  
d860 Managing finances               +p   
d839 Study                 +p 
d840 Work               +p  +p 
d920 * Enjoy life               +p   
d710 Social activities                +p  
d920 Recreational activities               +p +p +p 
d9308 Religious/spiritual 
activities 
              +p   
d760 Role in family               +p   
d6605 Ability to help others                +p   
* Feel you are a burden               +p   
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* Control life as you wish               +p   
* Pt. perceived health state                +p +p 
* Pt perceived recovery                +p   
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ICF code b Body function/structure 
ICF code d Activity and participation 
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Figure 2. ICF categorisation of outcome measures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Upper limb outcome measures in 
robot studies 
ENVIRONMENTAL FACTORS 
Therapist impressions,  
Carer/ family impressions 
PERSONAL FACTORS 
Patient impressions/ acceptance 
Patient satisfaction 
 
PARTICIPATION 
SIS, EQ-5D, SF-36 
ACTIVITIES 
ARAT, WMFT, BI, FIM, 
FAT, RMA, AMAT, 
MotorAS, ABILHAND, 
MAL 
BODY FUNCTIONS AND 
STRUCTURES 
FM-UE, MSS, CMSA, MRC, MAS, 
Range of Motion, Grip strength, NHPT, 
BBT, VAS, Muscle power, fMRI, NSA, 
Kinematic measures, Robot measures 
  
  
  
 
Table 5. Psychometric properties of 'body function' outcome measures 
Characteristics 
 
FM-UE 
 
MSS CMSA 
 
MAS MRC Kinemat
ics 
Grip 
strength 
NHPT BBT 
Time taken (min) 20 n/a 60  varies varies varies < 1 2 1  
Number of items 33 29 6  1 1 varies 1 1 1 
Options per item 3 point 6 point 7 point 6 point 6 point varies timed timed timed 
Score range 0 - 66 0 - 82 6 - 42 0 - 5 0 - 5 varies varies varies varies 
Test-retest reliability +++ +++ n/a ++ n/a +++ +++ n/a n/a 
Inter-rater reliability +++ +++ +++ ++ +++ n/a +++ +++ +++ 
Construct validity +++ +++ +++ + n/a ++ n/a +++ +++ 
Responsiveness ++ n/a n/a n/a n/a +++ n/a n/a n/a 
MCID 7 n/a n/a n/a n/a n/a 2.9kg 32 sec 6 / min 
Floor effect adeq n/a n/a n/a n/a n/a n/a n/a n/a 
Ceiling effect adeq n/a n/a n/a n/a n/a n/a n/a n/a 
Burden adeq adeq poor adeq adeq adeq nil nil nil 
References [128, 137, 
138, 141, 
154-164] 
[139] [141, 
165, 
166] 
[167-
177] 
[178-
180] 
[143, 
144, 181, 
182] 
[183-185] [183-
186] 
[185, 187] 
 
Scoring criteria as defined in Table 1: +++ High / Excellent; ++ Moderate; + Low / poor; n/a – not applicable (evidence not available yet);  
adeq - adequate (acceptable) floor / ceiling effect / burden; poor - poor (unacceptable) floor / ceiling effect / burden; nil - Minimal / no burden
  
  
  
 
Table 6. Psychometric properties of 'activity' and 'participation' outcome measures 
Characteristics 
 
BI FIM 
motor 
ARAT WMFT CAHAI AMA
T 
RMA 
arm 
FAT Motor 
AS 
ABI
LHA
ND     
SIS 
Partic. 
EQ5
D 
SF-36 
Time taken (min) 10 - 15 20 10 10 - 12 25 45 20 3 20 - 30 n/a n/a 2 - 3 10 
Number of items 10 13 19 15 13 17 15 5 9 23 8 5 36 
Options per item 2 - 4  7  4  6  7  6  2  2  7  3  5  3  2-6  
Score range 0 - 100 13 - 91 0 - 57 0 - 75 13 - 91 0 - 85 0 - 15 0 - 5 0 - 54 logit 0 - 100 0 - 1 0 - 100 
Test-retest reliability +++ +++ +++ +++ n/a +++ +++ +++ +++ n/a +++ +++ ++ 
Inter-rater reliability +++ +++ +++ +++ +++ +++ n/a +++ +++ +++ n/a n/a n/a 
Construct validity +++ +++ ++ +++ +++ n/a ++ n/a +++ ++ +++ ++ ++ 
Responsiveness ++ ++ ++ ++ +++ n/a n/a n/a n/a n/a n/a n/a n/a 
MCID 16 11 6 12 6.3 n/a 3 n/a n/a n/a n/a n/a n/a 
Floor effect poor n/a poor poor n/a n/a n/a poor n/a n/a n/a adeq adeq 
Ceiling effect poor adeq poor poor n/a n/a n/a poor n/a n/a n/a adeq poor 
Burden nil adeq adeq adeq adeq poor adeq nil adeq adeq nil adeq adeq 
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2.2.3 Measurement properties of outcome measures 
The evidence for the important measurement properties such as the 
number of items, the time taken to complete, reliability, validity, 
responsiveness, MCID, floor effect, ceiling effect and administrative burden 
are summarised in Table 5 and 6. 
Some of the measurement properties are yet to be investigated in 
stroke populations and are indicated as “n/a” in the tables. CAHAI was 
included in the analysis as it is an outcome measure developed from CMSA 
and it is an activity-based measure. It is also reported to be more responsive 
than ARAT [209]. CAHAI was included as it had the potential to be one of the 
measures for the hCAAR feasibility study and the analysis of its measures 
when compared to other measures would be useful in making an informed 
decision on measures for the feasibility study.   
2.3 Discussion 
The knowledge of the severity of impairments does not allow an 
accurate prediction of the limitation in activities and participation experienced 
by the individual, due to the varied interplay between these domains and the 
influence of contextual factors. Such differences may also be seen in relation 
to the effects of any intervention (e.g. change at the body function level does 
not necessarily translate into change in the other domains, e.g. activity or 
participation). The selection of outcome measures is therefore crucial in the 
design of robot studies and should aim to capture the changes in all the 
aspects of the health condition (in this case, stroke). Using the ICF to 
describe the outcome measure content should enable researchers to 
compare the different outcomes measures and select the most appropriate 
ones for any clinical study. Appraising the measurement properties may allow 
targeting of the most appropriate outcome measure to the study participants. 
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2.3.1 Using the ICF framework to select outcomes for future 
studies 
Published reports of robot studies indicate that a criterion to categorise 
the study participants would be useful to target the interventions. The 
‘severity of impairment’ and ‘time since stroke’ are two important variables to 
be considered for devising such a criterion. Some studies have considered 
FM-UE scores of less than 20 or 25 to indicate severe impairment and more 
than 20 or 25 as moderate impairment [59, 76]. In acquired brain injury 
studies, participants are considered as being in the subacute stage of 
recovery if within 6 months since the event and chronic stage if more than 6 
months [59, 63, 81, 230]. Time since stroke has been used to indicate speed 
of recovery during rehabilitation. Based on the variables of severity and time 
since stroke, we can therefore conceptualise participants for robot studies as 
belonging to four categories (Figure 3). 
The first category includes severely impaired participants in the 
subacute stage of recovery. Outcome measures with minimal floor effects will 
be needed for these participants to be able to discriminate the scores of 
individual participants. Kinematic measurement and the FM-UE or MSS 
would be appropriate body function outcome measures for this group. 
Kinematic measures captured with external equipment can be time 
consuming and require the relevant expertise and resources. Kinematic 
measures captured by the robotic device are easier to record and need to be 
included in the analysis of the effects of the intervention. The FM-UE scale 
has been used for almost all the robot studies so far and has been shown to 
be responsive for this group of participants. Even though the FM-UE is not as 
responsive as kinematic or robotic measures, it allows comparison across 
robot studies and meta-analysis of the available data from different robot 
studies. Among the activity measures, the FIM motor subscale or CAHAI are 
suitable activities for use in this category. ARAT has a large floor effect and 
hence would not be the best activity measure for this group. 
  
   
Figure 3. Proposed algorithm for selection of the outcome measures based on patient characteristics and ICF domains 
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The second category includes participants with moderate impairments 
in the subacute stage of recovery. These participants require outcome 
measures with minimal ceiling effects to be able to discriminate between 
score changes observed in individual participants. Kinematic measurement 
and the FM or MSS are again suitable body function outcome measures for 
this group. Among the activity measures, the ARAT and WMFT might be 
limited by their ceiling effects. ABILHAND and CAHAI would be suitable 
activity measures and EQ-5D would be a suitable participation measure for 
this group.  
The use of FM-UE, FIM motor subscale or BI is limited by their 
moderate responsiveness in the third category of participants, those with 
severe impairments in the chronic stage of recovery after stroke. Kinematic 
or robotic measures would be ideal body function measures. The MSS scale 
even though it was developed for the reason to be more responsive than FM-
UE, has not been extensively researched in the stroke population and some 
of its measurement properties are still not known (Table 5). ARAT and 
CAHAI would be the preferred activity measures. ARAT may be limited by its 
floor effects when compared to the CAHAI. CAHAI has not been used in 
robot studies so far. EQ-5D would be a suitable participation measure. 
The final category of moderately impaired participants in the chronic 
stage will need outcome measures with high responsiveness and acceptable 
ceiling effects. Kinematic or robotic measures would be ideal body function 
measures to capture the small changes with intervention. The ARAT or 
WMFT or CAHAI would be suitable activity measures along with ABILHAND 
as a patient-reported measure. The use of EQ-5D or SF-36 would be a 
suitable participation measures, SF-36 would be limited by its poor ceiling 
effect when compared to EQ-5D. The floor and ceiling effects of SIS are not 
yet known. 
Economic evaluations should be considered as an important part of 
any large scale clinical investigation of robot-assisted exercise. Therefore 
when designing the study, it is important to include the use of a health utility 
measures and health resource utilisation questionnaires within the context of 
robot studies. The EQ-5D can be used for economic evaluations as well. One 
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robot study involving chronic participants did not observe any statistically 
significant improvement in EQ-5D scores although statistically significant 
improvements were found in the FM-UE and FIM motor scores [74]. It is 
possible that the EQ-5D has lower responsiveness than the FM-UE and FIM 
motor. The responsiveness of EQ-5D in stroke participants is currently 
unknown. Other measures such as the Northwick Park Dependency Scale 
(NPDS) that capture dependency and provide an estimate of the care cost 
savings through the reduction in dependency for physical assistance should 
be considered [231] 
Personal and environmental factors have a huge influence on any 
intervention in rehabilitation. Patient, carer and therapist perceptions of robot-
assisted exercise are important outcome measures to allow design iteration 
and gain information on satisfaction with the delivery of robot-assisted 
therapy relating to the look and feel of the system [63]. Achievement of 
personalised goals can be used to capture changes following intervention at 
an individual level (e.g. Goal Attainment Scale, Canadian Occupational 
Performance Measure) [232]. These are suitable for individual person 
monitoring but are not appropriate for group analysis and have poor 
measurement properties [233, 234], which limits their usefulness in robot 
studies.  
The selection of outcome scores also depends on the type of 
intervention in terms of whether it is aimed at proximal or distal upper limb 
muscle groups. The effects are believed to be generalised in the subacute 
stage, whereas they are specific to the trained muscles in the chronic stage 
of recovery [52, 59, 64, 68, 89]. The three hand function tests (grip strength, 
NHPT and BBT) are quick to administer and may be suitable for studies 
where the intervention is directed at distal limb and hand function. The hand-
based robot HWARD study showed a greater increase in BBT and NHPT 
scores when compared to proximal shoulder and elbow scores, FM-UE and 
ARAT [86]. 
One aspect of recovery, which is neglected in robot studies, is the 
measurement of change in the perceptual (sensory) function arising as a 
result of robot-assisted upper limb exercise. Perceptual function is a vital part 
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of normal movement and evidence suggests that recovery of functional motor 
ability is dependent on intact sensation, spatial awareness and attention. 
Interactive robot-assisted sensori-motor training may improve perceptual 
deficits or potentially confound the benefits that might be identified in robot 
studies. Only one robot study used a sensory assessment tool as one of the 
outcome measures [80]. The extent of sensory impairment did not seem to 
influence the overall benefit from robot-assisted therapy in this study. 
Changes in the perceptual function need to be further researched in robot 
studies.  
We propose that at least four suitable outcome measures covering the 
different domains of ICF domains could be considered as essential to 
understand the effects of robot-assisted exercise on movement and 
functional use of upper limbs in daily activities and the impact on various 
aspects of health. Apart from the factors mentioned in the algorithm in Figure 
3, other factors that should be considered in selecting outcome measures are 
the type of intervention that the robot provides (proximal, distal or both) and 
the resources required (e.g. trained healthcare professionals for clinical and 
kinematic measures, external optical tracking equipment to record movement 
patterns in simple tasks). This selection will also depend on the outcome 
measures the team is already used to and have a commitment to use in 
terms of the purchase license.   
The future of robot-assisted upper limb exercise will be influenced by 
accurate capture and interpretation of the observed effects. This approach 
based on the ICF framework should help in identifying and selecting 
appropriate outcome measures for any robot studies [235]. The main 
limitation of this review is that we have analysed in detail only those outcome 
measures that have been used in previous robot studies. CAHAI was the 
only external outcome measure included as it had been developed based on 
CMSA, which has been used in robot studies. This does not necessarily 
mean that outcome measures not previously used in robot studies are not 
suitable for use in future robot studies. However, this review provides an 
approach based on the ICF for selection of outcome measures, which should 
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enable the researchers to apply this approach to any outcome measure they 
wish to explore in future studies.  
2.3.2 Selection of outcomes for the hCAAR feasibility study 
For the hCAAR device, participants and therapists will be involved 
throughout the various stages of device development based on the principles 
of user-centred design. Once the device is ready to be tested in a clinical 
setting (home), the participants recruited to the study are likely to be those 
with moderate impairment and in the chronic stage of recovery after stroke. 
The participants likely to be recruited will be those who have been 
discharged to the community and are attending stroke rehabilitation clinics, 
hence are likely to be in the chronic stage of recovery. As this is a home-
based robot with limitations to its size and the power of the actuators, only 
participants with moderate impairments are likely to be able to use the 
system to performed assisted movements with their affected upper limb. The 
outcome measures that will be suitable for the feasibility study include (a) 
Body function measures: optical tracking device kinematic measurements 
during standard reaching tasks, robot kinematic measures, MRC, MAS and 
FM-UE (b) Activity and Participation measures:  ARAT, CAHAI and 
ABILHAND and (c) Contextual factors: Participant, family, carer and therapist 
impressions of the device. 
2.4 Limitations 
The limitation of this review is that it includes only those outcome 
measures, which have been used in robot studies so far. This does not 
necessarily mean that outcome measures not used in robot studies are not 
suitable for use in future studies. However, this review provides a system for 
selection of outcome measures, which should enable the researchers to 
apply these criteria to the outcome measures they wish to explore in future 
studies. The future of robot-assisted upper limb rehabilitation exercises after 
stroke will be influenced by accurate analysis and interpretation of the 
observed effects. This can be accomplished by using the most appropriate 
outcome measures.  
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2.5 Conclusions 
In conclusion, there is so far no consensus on the outcome measures 
that must be used in robot-assisted upper limb exercise clinical studies. A 
unique approach has been proposed in this chapter to assist researchers in 
selecting outcome measures in the design of future robot studies. A basket of 
outcome measures covering all domains of the ICF framework is crucial as it 
is important to measure change in each domain. The selection of outcome 
measures should also be based on the focus of the intervention, severity of 
upper limb weakness, time since stroke and the psychometric properties of 
the outcome measures. The outcome measures for the hCAAR feasibility 
study have been selected based on the above approach.  
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Chapter 3: User-centred design process for developing 
hCAAR 
The success of any medical device depends on how well it matches 
the purpose intended by the healthcare professional and the needs and 
expectations of the individual being investigated or treated. This makes the 
perspectives of both patients and healthcare professionals paramount in the 
development process of medical device technology. It is now well established 
that the needs of users (patients and healthcare professionals) should drive 
product development, rather than technological and commercial pressures, 
and that users should be involved early in device development [236]. The 
involvement of users at the initial stages is associated with devices with 
higher market usability [237], improved equipment safety and efficiency [238], 
higher chances of successful user use [239] and overall reductions in 
development time and costs [240, 241]. This has also led to an increased 
regulatory requirement of user involvement in device development [242].  
The involvement of users can be considered at various stages of 
device development from the stage of idea generation to the final stage of 
market deployment. Current literature supports the concept that users needs 
should drive product development, not technology and commercial pressure 
and that users should be involved in all stages of device development [236]. 
Models of medical device lifecycle stages have been described by Cooper 
and Kleinschmidt (13 stages) [243], Rochford and Rudelius (12 stages) [244] 
and World Health Organisation (seven stages) [245]. A recent 
comprehensive model proposed by Shah et al. comprises of four stages in 
the rehabilitation assistive technology development process: Concept, 
Design, Testing and Deployment [246] (Figure 4). Early involvement of 
different types of users in the concept and design stages can facilitate the 
development of technology with improved usability, higher customer 
satisfaction and reduced modification costs and time in comparison to 
involving users later in the device lifecycle [101, 247]. 
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The concept stage starts with idea generation and includes technical, 
financial and commercial assessment [101, 246]. The design stage involves 
product development from (re)design to prototype development. The testing 
stage starts with prototype testing in-house and includes studies in the field. 
The deployment stage includes product marketing, launch and use in the 
field [101, 246]. 
 
Figure 4. Medical device technology development: for a device new to market 
(Reproduced from Shah et al. 2009) [230]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
International Organization for Standardization 9241-210:210 set out 
the international standard for user-centred design, and specified six 
principles for user-centred design: that it is based on explicit understanding of 
users, tasks and environments; that users are involved throughout 
development; that design is driven by user-centred evaluation; that the 
process is iterative; that the design must address the whole user experience; 
and that the design team should include multidisciplinary skills and 
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perspectives. It also set out an iterative process for user-centred design, 
which involves understanding and specifying the context of use; specifying 
user requirements; producing design solutions; evaluating the design against 
the user requirements and iterating as necessary until the user requirements 
are satisfied [248]. 
There are a variety of direct and indirect methods that can be used to 
involve users throughout the device development process (Figure 5). 
Usability tests, interviews and questionnaire surveys are the most commonly 
used methods across all stages of device development [101]. The methods, 
which are most useful in the concept stage are brainstorming sessions, 
ethnography, user meetings, interviews, focus groups and seminars [246]. In 
user-centred design literature, there are currently no sufficiently detailed 
models described to help researchers understand their target population’s 
needs in the concept stage.  
The Cambridge “design exclusion calculator” developed based on the 
disability follow-up survey of 1996/97 [249], is used to give an estimate of the 
number of people in a population who would be excluded by a particular 
design and helps researchers to develop more inclusive designs [250]. The 
calculator is based on seven impairments disabled people might have: 
locomotion, reach, dexterity, vision, hearing, communication and intellectual 
function. This model could be used to help design technology for stroke 
survivors but the above impairments do not provide the breadth of factors 
that help to understand this population. This model does not take into 
account extended functional activities; personal factors, such as sex, race, 
ethnicity, interests and motivation; and environmental factors, such as 
therapy resource, carers and vocation. Cook and Hussey’s Human Activity 
Assistive Technology (HAAT) Model also provides a process for structuring 
considerations of users’ needs in prescribing and designing assistive 
technology to place them in the context of a given activity, environment and 
level of ability [251]. 
 Figure 5. Theoretical framework for involving users in the medical device technology development  
process: streams, methods and stages (Reproduced from Shah et al. 2009) [230]. 
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One framework that is commonly used in the health sciences to 
understand and capture the different aspects of any health condition is the 
World Health Organization’s ICF. The ICF classifies the health condition into 
domains of body structure/functions, activities, participation, and the personal 
and environmental factors relevant to each individual [11]. This framework is 
internationally accepted and used extensively in research. Researchers have 
developed disease-specific ICF Core Sets for specific health conditions such 
as rheumatoid arthritis, multiple sclerosis and stroke. The Comprehensive 
ICF Core Set categories for stroke put forward by an international consensus 
group is widely used in stroke-related research (Appendix A) [252].  
We undertook the process of user involvement and feedback in all the 
stages of device development. The concept and prototype design stages of 
device development are described in this chapter and user feedback from 
testing stage is described in Chapter Six. We have investigated the 
usefulness of the stroke-specific Comprehensive ICF Core Set to guide 
researchers in understanding user needs in all the stages of developing 
hCAAR.  
The aims of the home-based Computer Assisted Arm Rehabilitation 
(hCAAR) user-centred design process described in this chapter are: 
 1) To understand user needs and expectations of a home-based 
upper limb rehabilitation device (concept stage). 
 2) To determine whether the ICF framework can be used as a 
template to understand user needs in the concept stage of the development 
of technology. 
 3) To get feedback on the device prototype (design stage) and 
develop the definitive hCAAR device which could then be tested in a 
feasibility study. 
 4) To provide a description of the definitive hCAAR device.  
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3.1 Methods 
The user-centred design study had approval from National Research 
Ethics Committee (REC) and the local Research and Development (R&D) 
departments. 
3.1.1 Sample  
Stroke survivors with upper limb movement difficulties and who were 
attending local NHS stroke rehabilitation out-patient clinics were recruited to 
this study. The participants needed to have some voluntary movement in the 
affected upper limb and have no cognitive or speech difficulties to be able to 
engage in interviews. The nature of the study was explained to them by the 
researcher MS and they were given the patient information sheet, and, if 
interested in the study, were given a further appointment in the Charterhouse 
Rehabilitation Technologies (CRT) laboratory for the team to obtain their 
written informed consents.  
Healthcare professionals (physiotherapists and occupational 
therapists) involved in the care of individuals with stroke were identified from 
local stroke rehabilitation services. The nature of the study was explained to 
them by the researcher MS and they were given the healthcare professional 
information sheet, and, interested healthcare professionals were invited to 
the CRT laboratory for the team to obtain their written informed consents. 
The users in the context of this study were considered in two groups: 
end-users and professional users. The “end-user” group comprised of stroke 
survivors with upper limb weakness (including those with communication 
difficulties, visual impairments, mobility problems and varying degrees of 
upper limb weakness) and their carers. In the “professional user” group, 
physiotherapists and occupational therapists experienced in assessing and 
treating stroke survivors were included.  
3.1.2 Interview process (concept stage) 
All participants were offered a mutually convenient time to attend for 
face-to-face interviews undertaken by the main author MS. The aim of 
interviews was to understand users’ perspectives and expectations of robotic 
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technology (to provide upper limb exercises) in a home setting and the 
barriers to such technology. The research team (two clinicians and four 
engineers) initially identified the broad interview topics by brainstorming ideas 
and discussion in research team meetings. The topics were based on 
previous experiences in the user-centred design process [103, 253] and the 
existing literature on the development of assistive technology for upper limb 
rehabilitation [254, 255]. The interviews were comprised predominantly of 
open-ended questions based on the interview checklist of topics prepared by 
the research team. The nature of the interviews allowed the discussion to 
deviate from these topics to those that were identified by the end-users’ 
relevant to the technology design. Written notes were taken by MS during the 
interviews. There was no audio or video recording undertaken. 
For the interview format and the content of the questions, patients and 
their carers were considered as the ‘end-user’ group (Appendix B: Patient 
interview topics checklist). Physiotherapists and occupational therapists were 
considered as the ‘Healthcare professionals’ group (Appendix C: Healthcare 
professional interview topics checklist). End-users and healthcare 
professionals were asked questions on the intensity and type of upper limb 
therapy that patients receive after stroke, the home upper limb exercises, 
functional goals, the role of technology to provide upper limb exercises, 
Information Technology (IT), computer skills, and the perceptions of home-
based technology and its comparison with hands-on conventional 
physiotherapy. 
3.1.3 Extracting interview concepts 
ICF linking rules have been developed to link health measures and 
interventions to the ICF framework. These rules were initially published in 
2002 [256] and later updated in 2005 [257]. The authors suggested 
identifying meaningful concepts within items and responses of measures and 
linking to the most precise ICF category. Meaningful “concepts” are those 
that describe the health condition, the person, functional activity or any of the 
environmental factors. For example, consider the statement/item “Pain 
doesn’t prevent me from walking any distance”. Two different meaningful 
concepts can be identified in this statement, “pain” and “walking”.  
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Meaningful concepts referring to “quality of life” are assigned “Not 
definable- quality of life”. If a meaningful concept is not contained in the ICF 
and is clearly a personal factor, it is assigned “personal factor”. If a 
meaningful concept is not contained in the ICF and is not a personal factor, it 
is assigned “not covered”. If the meaningful concept refers to a diagnosis or a 
health condition, it is assigned “health condition” [257].  
Based on the above linking rules, meaningful concepts were extracted 
from our interview topic questions and responses. 
3.1.4 Matching interview concepts to the ICF Core Set for stroke 
The interview concepts, which resulted from the semi-structured 
interviews were matched to the categories within the Comprehensive ICF 
Core Set for stroke. The Core Set has 130 categories in total, which 
comprise 46 categories from the body function and structure domain, 51 
categories from the activities and participation domain, and 33 from the 
environmental factors domain [252]. The personal factors domain has no 
categories as yet. 
The process of extracting interview concepts and matching them to 
ICF categories as proposed by Cieza et al. [257] can be explained with the 
following example from our interviews. 
a) The participants were asked “Describe the home arm exercises you 
do (end-users) / prescribe (professional users)”. The two meaningful 
concepts which can be extracted from the question are – “home setting” and 
“arm exercises”. 
b) A sample end-user response was “I have private physical therapy at 
home performing squeezing exercises with the affected hand, wheel hand 
cycling and working with weights”. A sample professional user response was 
“Lack of motivation and cognitive problems could contribute to poor 
compliance with home exercises”. The meaningful concepts that can be 
extracted from above two responses are – “private therapy”, “fine hand 
skills”, “stretching exercises”, “strengthening exercises”, “motivation”, 
“cognitive problems” and “compliance”. 
c) The extracted concepts are linked to one or more of the 
Comprehensive ICF Core Set categories, which convey the same meaning 
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Home setting – e210 “Physical geography”; 
Private therapy – e580 “Health services, systems and policies”; 
Cognitive problems – b110 “Consciousness functions”, b114 “Orientation 
functions and others.   
3.1.5 Prototype (design) stage feedback 
Our research team has successfully developed a dual-user assistive 
joystick system (K005) for use by children with cerebral palsy in schools 
(Figure 6) [258]. Based on our understanding of user needs in the concept 
stage, we chose to use the K005 device as a prototype to develop hCAAR. 
The aim of this stage (design stage) was to enable us to make the necessary 
modifications to the prototype and develop the definite hCAAR device that 
will be tested in the feasibility study.  
 
Figure 6. K005 robotic device designed for children with cerebral palsy 
 
 
The users were introduced to the prototype design (K005 system) and 
feedback was gathered on what a single user hCAAR system for home use 
should look like. Feedback was obtained on the hardware and software 
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components of the prototype system using user interviews. The feedback 
from these interviews was further explored in the research team meeting to 
inform the final design of the hCAAR system. 
3.2 Results 
Nine stroke survivors with residual arm weakness, and six experienced 
physiotherapists and occupational therapists in neurological practice were 
enrolled in the user-centred design process. We will refer to stroke survivors 
as “end-users” in this thesis. 
3.2.1 End-users 
The time since stroke ranged from 1 year to 3 years. Five participants 
had left side weakness and four had right side weakness. Five participants 
had weakness in their non-dominant arm and four in their dominant arm. Five 
participants had problems with speech and language, four of them had word 
finding difficulty (expressive dysphasia) and one had problems with 
articulation (dysarthria). All participants had problems with weakness in the 
affected arm, five of them had stiffness (spasticity) and three of them had 
problems with sensation in the affected arm. Four participants had 
experienced problems with vision (field defects) after stroke, which had 
improved by the time of recruitment. One participant had visual inattention on 
the affected side at the time of recruitment. Three participants had mild to 
moderate pain in the affected arm; one of them had previously received an 
injection in the shoulder area in the past for pain and all three were on 
analgesic medication for pain. Pain limited the range of movements in their 
arms. One participant had cognitive problems in areas of short-term memory 
since the stroke. Two participants reported ongoing problems with their mood 
since the stroke. None of the participants was in employment. 
3.2.2 Healthcare professionals  
The six healthcare professionals enrolled in the user-centred design 
process all had at least five years of experience of working with individuals 
with stroke. Four of them were physiotherapists and two were occupational 
therapists. Four of them provided therapy in both inpatient and outpatient 
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settings. Two therapists provided therapy in community settings. All of them 
were involved in providing and advising home-based arm exercise programs 
for their patients with stroke.   
3.2.3 Interview results (concept stage) 
The interview topic results were grouped as comments made by the 
end-user group and the healthcare professional group. Similar comments 
made by more than one individual are reported in third person in this 
Chapter. Individual comments are reported as direct quotes (using quotation 
marks and italics).  
3.2.3.1 Therapy received after stroke  
3.2.3.1.1 End-user group 
All participants (nine) felt that there was a need for continuing therapy 
at home once inpatient and outpatient therapy had finished. Participants on 
average received 3-4 sessions of 45-min long physiotherapy sessions per 
week while they were inpatients after stroke. Following discharge from 
hospital, outpatient or community-based rehabilitation therapy varied from 
one session per week to four sessions a week and continued up to 12 weeks. 
All participants felt they would benefit from additional therapy for their 
arm movement difficulties: 
“I felt I needed more therapy for my arm but did not receive it in the 
long term.”  
“There was more emphasis on walking (lower limb function) than 
upper limb exercises in the initial therapy after stroke.”  
“NHS resources are limited and the waiting time for outpatient therapy 
is long.”  
“I wish to perform more arm exercises and want to improve arm 
function for better performance in daily activities and better quality of 
life”.  
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3.2.3.1.2 Professional user group  
All six healthcare professionals agreed that there was a gap between 
acute/subacute therapy and long-term therapy after stroke in the current 
NHS. 
“The waiting list for outpatient therapy could be up to 6 months from 
the time of accepting a referral.” 
Up to 3 months to 2 years after stroke was reported as the time period 
when maximal recovery of arm function was likely to occur, although all 
professionals indicated that there is continued recovery even beyond this 
period, depending on the type and intensity of the therapy received by 
patients.  
“There is scope for change up to 5 years post-stroke.”  
“Additional therapy would result in improved recovery of functional arm 
movement”.  
3.2.3.2 Types of arm exercise  
3.2.3.2.1 Professional user group  
All healthcare professionals commented that their therapy plans are 
personalised to individual patient goals. The interventions are targeted at 
maintaining a pain-free passive range of arm movement and improving arm 
weakness. 
“The intensity of community therapy is based on the initial 
assessment, the patients can be considered in three categories: high 
need (therapy three times in a week), moderate need (twice in a week) 
and low need (once a week). The sessions are one hour each.” 
“Distraction and stimulation techniques are used for visual sensory 
inattention or neglect. ”  
“Patients are advised to exercise within their pain-free range of 
movement”.   
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3.2.3.3 Home exercises 
3.2.3.3.1 End-user group 
All participants had been given home-based arm exercises by their 
therapists, which involved passive stretching exercises and active 
involvement in daily activities of living.  
“I use hand beads for fine hand control exercises and also baking.” 
Seven participants were no longer practicing home exercises on a regular 
basis  
“I did not continue doing home exercises after few months as lost 
motivation.”  
“I have private physical therapy at home performing squeezing 
exercises with my affected hand, wheel hand-cycling and working with 
weights”. 
Two participants occasionally went to the gym and worked with cross-
trainer exercise machines and lifted weights. 
3.2.3.3.2 Professional user group 
Prescribed home exercises were based on the functional daily 
activities goals in discussion with patients.  
“The exercise program includes stretching and sensitisation exercises 
as well as trunk stabilisation and balance exercises to optimise arm 
movement.” 
“Digital photos of exercises are given to patients to remind them how 
to do the exercises”.  
Patients varied in their compliance with home exercises. 
“A compliance rate of one-third of the recommended amount of 
exercises is acceptable.”   
“Lack of motivation and cognitive problems after stroke could 
contribute to poor compliance.” 
“I recommend patients to do arm exercises (on top of their daily 
activities) for at least 15 minutes every day”. 
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3.2.3.4 Functional activity goals 
3.2.3.4.1 End-user group 
All participants did not use their affected arms as much in daily 
activities as much as before stroke. They had developed compensatory 
strategies to perform daily tasks. 
“I lift the kettle with my unaffected arm now.” 
“I use the affected arm only to hold things in place while the unaffected 
arm does most of the activity”.  
The participants wanted to improve their ability to use their affected 
arm in daily activities, such as combing their hair, washing, dressing, 
cooking, and eating with a knife and fork. 
“I want to improve my writing.” 
“I want my affected arm to be less tight while doing activities.” 
“I want to get back to swimming and driving a manual car (currently 
driving an automatic car)”. 
3.2.3.4.2 Professional user group 
The healthcare professionals directed therapy based on individual’s 
functional activity goals and encouraged patients to use their affected arms 
as much as possible in daily activities and as early as possible after stroke.  
“Therapy is tailored to patients’ needs.” 
3.2.3.5 Use of technology at home for arm therapy  
3.2.3.5.1 End-user group 
Two participants have used the Wii video game console for 
entertainment and therapy at home.  
“I use my unaffected arm to operate the Wii remote device as the 
affected arm does not have sufficient strength to operate the device. I 
play golf, tennis and bowling with my son.” 
“I like the competitive element of Wii games”. 
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3.2.3.5.2 Professional user group 
The healthcare professionals sometimes recommend use of the Wii 
for arm therapy in selected patients  
“It depends on the type of arm impairment and availability of the 
equipment. It can be engaging and can augment the intensity of arm 
therapy.”  
“Computer gaming exercise may be an adjunct to conventional 
treatments if chosen appropriately and based on individual clinical 
assessments”. 
3.2.3.6 IT skills and computer games 
3.2.3.6.1 End-user group 
All participants had either used computers in the past or currently use 
them on a regular basis. They described their IT skills as basic and used the 
computer for Internet browsing, shopping and emails. Seven participants had 
laptops, one had a desktop computer, and two had both a laptop and a 
desktop computer. One participant did not have a computer at home. Seven 
participants’ family members or carers had basic computer skills and could 
use computers for Internet browsing, shopping and email. 
Three participants have previously played computer games, such as 
card games, street game, formula one car racing games, darts and Chinese 
checkers with their families. 
 “I would like to play computer games based on golf, bowling and 
tennis.” 
“Games based on Soduku or shopping would be interesting.”  
“Games based on space (asteroids) or word building (scrabble) would 
be good”. 
3.2.3.6.2 Professional user group 
The healthcare professionals felt computer games might keep some 
patients interested. 
“Not all would find using a computer easy and interesting, especially 
the elderly patients and those with cognitive problems.”  
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“The nature of games that will engage patients will vary between 
individuals, depending on sex, vision problems, interests and previous 
experience”. 
3.2.3.7 Individual’s perceptions on the role of arm rehabilitation 
technology in the home setting 
3.2.3.7.1 End-user group 
All participants believed that using a home-based technology aimed at 
arm exercises would help them perform more arm exercises. They felt it 
would give them more independence in their rehabilitation program and 
motivate them to engage more in the exercise program. 
“It (rehabilitation technology device) can improve one’s concentration 
and thinking ability.” 
“It can improve hand-eye coordination and fine skills.” 
“It would have been ideal if it were available straightaway when I was 
discharged from hospital after my stroke.” 
“It might give me a purpose to get out of bed and use the device every 
day”.  
Seven of the participants preferred to use the technology on an 
individual basis at home. 
“I prefer using it on my own as feel I would become conscious of my 
problems when using such devices in front of other people.”  
“Competition is good but not with able-bodied people.” 
“I do not like stroke clubs and resource centres”. 
Two participants also preferred to use the technology in a multi-user 
setting with other individuals. They were interested in the idea of a 
collaborative approach where one could play with another individual remotely 
via an Internet connection. 
“Using such technology in hospital setting would benefit us (patients) 
early after stroke.” 
 
 
  
  
- 68 -  
 
3.2.3.7.2 Professional user group 
All healthcare professionals supported the idea of having technology 
that could help individuals perform arm exercises in their homes. 
“Such technology could improve thinking ability and cognition”. 
Most healthcare professionals (five) felt that patients would prefer 
using such technology both on an individual basis and in a multi-user 
approach in community centres and stroke clubs.  
“Patients are generally motivated in groups but some patients could 
become self-conscious and threatened in a group.” 
“Younger people like competition.” 
“ Elderly patients might not be keen on technology.” 
“There might be some potential difficulties installing the device in 
community centres, like with the maintenance of the device, the 
transport facilities for patients to get to the centres and the inability to 
access the device when facilities were closed”.  
3.2.3.8 Comparison of arm rehabilitation technology to conventional 
hands-on physiotherapy 
3.2.3.8.1 End-user group 
All participants stated that the technology would provide them with 
additional therapy to their physiotherapy and would benefit the eventual 
recovery of their arm function. They stated that home-based technology 
could increase their ability to perform arm exercises independently in their 
free time. 
“Home technology might save time going to hospitals and would help 
me undertake therapy when my child (2 yr old) is asleep.” 
“Using computer games could increase my concentration and thinking 
ability that has been affected by the stroke.” 
“I am unsure if playing computer games could be used to provide 
useful exercises for arm recovery.” 
“I would not know whether the correct exercises were being 
undertaken using the technology as they would not be supervised by 
professionals”. 
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3.2.3.8.2 Professional user group 
All healthcare professionals felt that technology can augment hands-
on physiotherapy after stroke.  
“It might provide intensity to the exercise program and encourage 
patients to perform exercises when not being supervised.”  
“It might empower the patient by increasing independence.”  
“It can increase engagement and have a positive impact on cognitive 
function.” 
“It might be cheaper, convenient and flexible (in terms of taking breaks 
within sessions when tired)”. 
Four healthcare professionals stated a major drawback would be the 
lack of ability to monitor the patient performance and quality of movements 
undertaken.  
“It might be difficult to correlate device movements to the functional 
relevant daily activity movements.”   
“One concern is the huge costs involved in developing such 
technology and whether it is cost-effective in the long run”. 
3.2.3.9 Expectations of the home-based arm rehabilitation device  
3.2.3.9.1 End-user group 
The participants (seven) wanted the device to be simple and easy to 
use with a footprint suitable for installation in a home setting.  
Participants wanted the device to be deployable in a living room (three 
participants) or kitchen (two participants) or bedroom (four participants). All 
these four participants’ bedrooms were first floor rooms with a staircase as 
the only route to the rooms. 
“It should be a tidy piece of equipment.” 
“It has to be easily moveable and portable.” 
“The device must be safe especially electrical faults.”  
“Hope there will be access to engineers to fix any technical issues that 
arise”.  
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3.2.3.9.2 Professional user group 
All healthcare professionals felt the device should be safe and easy to 
set-up and use. They suggested the device should be compact and easily 
installable in the home setting. 
Two healthcare professionals stated that the system should have 
options to individualise exercise programs depending on patient’ deficits and 
needs. 
“The technology must be simple, appealing and motivating for the 
patients.” 
“The computer tasks must be meaningful and functionally relevant 
based on the principles of motor relearning. The device should help 
maintain the range of movement and improve strength in the weak 
arm.” 
“I like the idea of ability of the device to provide assistance when the 
user is unable to complete the task with the affected arm.” 
“It would be difficult to engage some elderly people who are not used 
to computers and games.” 
“Hygiene issues must be considered while designing and delivering 
devices to people’s homes.” 
“Patients must have access to engineers and healthcare professionals 
who have knowledge about the technology”.  
3.2.4 Extracting interview concepts 
Meaningful concepts extracted from each interview topic questions 
and responses/discussions with end-users and healthcare professionals are 
listed in Table 7. In cases of duplication of concepts, they are listed only once 
in the table. 
3.2.5 Matching interview themes to the ICF Core Set for stroke 
 
Concepts linked to the most relevant ICF Core Set category(s) are shown in 
Table 8. Two concepts were assigned as related to “health condition”, 14 
concepts were assigned to “personal factor” and one concept was assigned 
“not covered”. 
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Table 7. Meaningful concepts extracted from the interviews 
Interview topic Concepts emerging from the discussions 
 
Demographic characteristics Age, gender, type/time of stroke, side of 
weakness, dominant side, speech and language 
skills, vision, stiffness, weakness, sensation, 
pain, cognitive problems, mood, employment  
Therapy and exercises Duration of exercises, intensity of exercises, 
walking, upper limb specific exercises, time since 
stroke, NHS resources, daily activities, quality of 
life, personal goals  
Home exercises Home setting, private therapy, fine hand skills, 
stretching exercises, strengthening exercises, 
endurance exercises, sensitisation exercises, 
balance, compliance, motivation, cognitive 
problems 
Functional activity goals Use of affected arm, writing, daily activities, 
combing hair, washing, dressing, cooking, eating, 
swimming, driving 
Home technology Playing games, engagement, intensity of therapy, 
personal choice, leisure interests 
IT skills and computer games Computer use, owning a computer, playing 
games, cognitive skills, gender, vision, interest, 
experience 
Individual perception Concentration, thinking, coordination, fine skills, 
time since stroke, purpose in life, competition, 
motivation, social life, age, community resources 
Comparison between 
technology and hands-on 
physiotherapy 
Therapy principles, cognitive skills, 
independence, supervision by professionals, 
cost, maintenance 
Expectations from home-based 
device 
External look of device, expectations of users/ 
professionals/friends/family carers, motivation, 
assistance, safety, hygiene, engagement, 
meaningful exercises 
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Table 8. Interview concepts and matched ICF Core Set categories 
Interview concept 
 
ICF Core Set category 
Type/time of stroke Health condition 
Side of weakness Health condition 
Dominant side Personal factor 
Speech and language problems b167, b330 
Weakness b730 
Stiffness b735 
Involuntary movements b755 
Sensory function problems b260, b265, b270 
Pain b280 
Vision problems b210 
Inattention b140 
Memory problems b144 
Cognition problems b164 
Mood problems b152 
Employment d850, d855 
Therapy/ exercises d210, d220, d230, e580 
Duration of exercises b455 
Walking d450 
Upper limb exercise d440, d445 
Daily activities d230, d430, d510, d520, d530, 
d540, d550 
National Health Service (NHS) services d580 
Quality of life Not definable 
Intensity of exercises b740 
Fine hand skills b440 
Home setting e210 
Private therapy e580 
Strengthening exercise b730 
Stretching exercise b710 
Sensitisation exercise b270 
Endurance b740 
Balance b770 
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Compliance Personal factor 
Motivation Personal factor 
Cognitive problems b110, b114, b117, b140, b144, 
b152, b156, b164, b167, b172, b176 
Usage of affected arm Not covered 
Washing d510, d530 
Dressing d540 
Cooking d630 
Eating d550 
Combing hair d520 
Writing d170 
Swimming d920 
Driving d475 
Playing games using technology d210, d220 
Engagement b140 
Intensity of therapy b740 
Personal choice  Personal factor 
Leisure interests d920 
Computer usage e115 
Owning a computer e165 
Gender Personal factor 
Interest Personal factor 
Experience Personal factor 
Concentration b140 
Thinking ability b164 
Coordination b755 
Purpose in life Personal factor 
Competition Personal factor 
Motivation Personal factor 
Social life e325 
Age Personal factor 
Community health resources e575, e580 
Independence Personal factor 
Supervision by professionals e355, e360 
Cost e165 
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Convenience Personal factor 
External look of device e150, e155, personal factor 
Expectations of friends, family, staff e410, e420, e425, e440, e450, e455 
Engagement Personal factor 
Assistance e115 
Hygiene e150, e155 
Safety e150, e155 
 
3.2.6 Interview results - prototype (design) feedback 
3.2.6.1 Hardware 
3.2.6.1.1 End-user group  
All participants liked the look of the prototype device and were 
satisfied with the likely final footprint of the hCAAR device and felt it would be 
deployable in their homes. They identified in their homes the exact rooms 
they would prefer the device to be installed if they were part of the feasibility 
clinical study. We realised that some participants would prefer to use the 
device in rooms on the first floor. We had to design the device in such a way 
that it could be dismantled sufficiently to enable it to be taken upstairs and 
assembled in the desired location. We had to make the computer screen and 
joystick height adjustable to accommodate the different heights and builds of 
participants. We realised the keyboard was occupying too much space and 
some participants found it cumbersome; it needed to be replaced with a 
smaller keypad.  
Two participants were using considerable trunk movements to move 
the joystick and had to be instructed to try to bring the desired movement 
more from the arm while keeping their trunk rested against the back of the 
chair. We incorporated this aspect of usage to be checked in the weekly 
telephone communication with the participants in the feasibility study. While 
observing patients use the device, we identified a need for separate design 
for right arm use and left arm use to enable participants to operate the safety 
button with the unaffected arm while using the joystick with the affected arm.  
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3.2.6.1.2 Professional user group  
Two therapists suggested the need to vary the joystick height and 
position depending on the handedness and height of the user. This 
suggestion was incorporated in the design modifications.  
“The system could have an adjustable screen and joystick, which 
could be moved up, so that the patient could perform tasks in a 
standing position. This would simulate some of the arm exercises that 
could be performed in a standing position. This can be challenging to 
the user and improve the individual’s balance as well”. 
The research team discussed this suggestion and it was felt that this 
modification would increase the size of the device and make it less appealing 
for the home setting. 
“The joystick handle could be set-up in a horizontal or semi-horizontal 
position to suit patients who have lost supination range at their 
forearm”.  
The research team felt that that the planned vertical handle design 
would encourage patients to regain the lost range of supination movement in 
the forearm and would more closely resemble the anatomical positions used 
in most daily tasks.  
“Could the handle incorporate pronation/supination and finger 
movements to work on distal muscles as well?” 
As part of their ongoing research in developing rehabilitation robotic 
systems for arm rehabilitation, the research team had already developed 
additional modules to promote distal movements of pronation/supination and 
hand movements. However, they felt that for this device (hCAAR), adding 
additional modules again increased the size of the device and would make it 
less acceptable to users in a home setting. 
Two therapists felt that a drawback of the device is that it facilitates 
movements in one plane only.  
“The device would be less appealing to those with mild weakness and 
those who can do more complex tasks.”  
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“I feel rotation movements in the shoulder while performing the joystick 
movements would encourage maintain range of movement at the 
shoulder joint.”  
The research team acknowledged that hCAAR would appeal most to 
those with moderate impairment or deficits after stroke. 
3.2.6.2 Software 
3.2.6.2.1 End-user group 
All participants liked the concept of therapy based on joystick 
movements. They appreciated the joystick assisting their arm movements 
and felt the movements were easier in the assistance mode. They liked the 
idea of scores being displayed on the screen after each game which gave 
them an indication of their performance. Two participants could not recognise 
from the display whether their performance was getting better or was the 
same, which prompted us to change the score display format.  
3.2.6.2.2 Professional user group  
The therapists liked the idea of being able to adjust the assistance to 
the system based on individual deficits and the ability of the device to help 
individuals complete tasks on the screen. They also appreciated the concept 
of the assistance adjusting automatically based on individual performance. 
This variation is important to keep robot assistance to the minimum and 
encourage the user to actively perform the movements. We changed the 
assistance algorithm based on this feedback.  
Two therapists were interested in knowing whether the system could 
track individual performance (in terms of movement kinematics) and give 
feedback to the user as the therapy progresses. We felt this was a good 
suggestion and planned to incorporate this in future versions of the device. 
For this study, we planned to get feedback on simple display of previous best 
scores and then make changes to feedback methods in future version. 
“It would be interesting to analyse the effect on tone (spasticity) after 
using the device.”  
“The long-term benefits of using the device must be analysed”. 
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3.2.6.3 Games 
3.2.6.3.1 End-user group  
All participants enjoyed the games on the prototype system and were 
interested in using the games in a clinical study. They were shown four game 
concepts: van, river, chase and puzzle. Two participants found the animation 
aspect of the game more suited for children than adults. This prompted us to 
include four more games with similar themes but without the animated 
characters. 
3.2.6.3.2 Professional user group 
The therapists agreed that the movements being generated by the 
system were functionally relevant, though restricted to one plane. Most of the 
functional daily activities involve reaching movements and the system was 
generating mainly reach and retrieve movements. One therapist suggested 
having a library of levels for the computer games, and have them set-up in an 
increasing order of difficulty. We adapted this suggestion to create a library of 
levels, with levels becoming progressively harder and involving a larger 
range of movement for the shoulder. 
“Different kind of games would suit different patients depending on 
extent of spasticity and motor weakness. One could use games (such 
as chase and puzzle) that enable range of movement if spasticity was 
the predominant problem and use games (such as river and van) that 
enable precision of movement when user has low tone and more 
weakness”.  
The research team used this suggestion to personalise therapy with 
hCAAR in the feasibility study. 
“Having a level of unpredictability in games adds to the cognitive 
demand on the patients”.  
 The levels of games were designed to introduce unpredictability and 
complexity as levels progressed. The researcher MS designed the levels of 
games and helped the researcher JG with writing the code for the levels of 
the games.  
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“Games based on planning a day, using the shopping trolley, 
managing accounts, doing puzzles, crosswords, Soduku, Scrabble or 
word formation, could be cognitively challenging to patients.”  
“Virtual games based on daily activities would be functionally 
relevant”. 
 Three therapists felt that playing games can become boring for some 
patients in the long run and felt that some patients may fatigue easily playing 
demanding computer games.  
The suggestions of creating more challenging games based on users’ 
leisure interests and creating virtual games based on daily tasks is 
challenging and would require extensive resources because the games, once 
created, need to be designed in a way that they have functional relevance to 
everyday tasks. They then need to be linked to the joystick movement and 
assistance algorithm of the device. These ideas will be considered when 
developing the future versions of the device. 
3.2.7 Description of final hCAAR system 
3.2.7.1 Hardware components 
The hardware components of the device consist of a Personal 
Computer (PC) allowing interaction between the user and the computer 
software (Figure 7). The interface equipment consists of a joystick handle 
linked to a chassis. The chassis allows the handle to move within a set 
workspace relative to the user, which is set to maximise the therapeutic 
exercise workspace. The exercise workspace can be adjusted if needed both 
physically or through software depending on the progress of the person. The 
motion of the device is limited to a two-dimensional plane at the central 
attachment point of the joystick.  
The interface device has a system of motors and pulleys that provides 
assistance to (or alternatively resistance to) the motion of the joystick handle. 
Sensors within the handle and chassis allow tracking of the handle position 
and the force applied. This creates a position control loop, which can be 
changed in real time to make the handle move to different positions in the 
exercise workspace. Within the chassis a controller, motor and gear system 
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enable force feedback from the software to guide the position of the handle. 
A system of sensors (potentiometers on the bearing joints) is used to track 
the position of the handle and any other inputs into the PC, such as the force 
applied to the handle and button switches. All of the above components are 
covered by purpose-built panels and set-up in a moveable trolley system.  
Figure 7. hCAAR device 
 
 
There is an additional handle switch connected to the computer that is 
meant to be operated by the good arm while playing the computer game 
(Figures 8 and 9). An emergency stop button in the system enables the user 
to disconnect the motor assistance to the joystick in case of emergency.  The 
device is purpose-built for use on one side only so that the joystick handle is 
operated by affected/impaired arm and the unaffected arm is able to operate 
the switch and keypad. The unaffected arm can be used to operate the 
emergency button if needed. The equipment was tested for reliability and 
physical and electrical safety by the School of Mechanical Engineering using 
University of Leeds standards. 
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Figure 8. A left-hand device being used 
 
 
Figure 9. The affected arm holds the joystick and the good arm operates the 
switch and emergency button (when needed) 
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3.2.7.2 Software components 
The computer program includes a base “software platform” for underlying 
functions and a set of activity-based tasks that will be used to direct and 
control the exercises. Software components include the following key points: 
 Data acquisition and interface device inputs. Inputs are important for 
moving elements of the activity relative to the handle position, also data 
acquisition is accurate enough to control the position of the handle in a 
safe way. 
 Multimedia including graphics and sound. Libraries within the software 
produce images on the PC monitor using the available graphics cards, 
and produce sound through the PC sound card operates the user 
interface. 
 Statistical data tracking. Storing measurements of the usage, assistance 
level, and other important data that can be used in the evaluation of the 
user’s performance. 
 Interactive software. The key feature is computer games/interactive 
activities that engage users in using the device.  
 Local Area Networking, Client/Server networking can be incorporated 
within a laboratory setting but this was not part of the clinical evaluation in 
this project. The aim in the future is to develop the software platform that 
will enable multi-user interactive exercises on a local network or through 
the internet.  
The system hosts a database storing user information including: 
a The times of login and duration of time used. 
b The duration of assessment exercises and game play. 
c The number of attempts at various games/exercises and the number of 
levels completed within each game. 
d The accuracy of the position of the handle during assessment and game 
play. 
e The improvement in a user’s performance improved over time. 
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The software also measures the number of hits in the assessment 
exercise. The assistance levels adjust according to the performance in the 
assessment exercise. As the user performance increases, the assistance 
levels decrease by the set algorithm of the software. The computer screen 
provides visual and auditory feedback of the target location and the 
movement of the joystick. The baseline clinical examination and computer 
assessment exercise allows the initial exercise parameters (duration, nature 
of games, game levels and assistance level) to be set.  
There are two operational modes for the device: 
 Active nonassist – the movement is performed completely by individual’s 
own effort with no assistance/resistance offered by the device. This mode 
is used for the assessment exercise prior to game play.  
 Active assisted bimanual mode – the individual initiates the movement 
and is aided by the device towards the goal. The joystick directed 
movement on the monitor can complete the task only when accompanied 
by the action of a switch device controlled by the unaffected arm. This 
mode is used during game play.  
3.2.7.3 Computer games  
There are eight computer games that were designed to provide arm 
exercises to the participant (Figure 10). Each game involves a series of linear 
movements within the monitor workspace to be performed by moving the 
joystick using the affected arm. The characters have to be moved to the 
target and the switch device pressed by the unaffected arm to complete each 
component task within the game. Four games have animated characters to 
provide more fun while performing tasks and four games do not have the 
animated characters. Each game is based on a series of movement steps on 
the screen.  
The river game and the wave game: In the river game, the user must 
guide the monkey image to follow the path of a river stream. The user 
collects bananas along the way by clicking the switch with the unaffected 
arm. The assistive force helps keep the monkey along the river path. The 
score is based on number of bananas collected. The wave game is similar to 
the river game without the animated figures of monkeys and bananas.  
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The van game and loop game: In the van game, the monkey has to 
move up and down and collect the bananas being fired by the van. The 
monkey also has to avoid flames coming from the back of the van to avoid 
losing points. The assistive force keeps the monkey image along the 
expected path. The loop game is similar to the van game without the 
animated figures of monkeys and bananas. 
Figure 10. hCAAR games menu 
 
The chase game and circuit chase game: In the chase game, the 
monkey has to follow the bridge paths between the islands and reach the 
target. The assistive force keeps the monkey image along the bridge path. 
The time taken to complete the task determines the score. The circuit chase 
game is similar to the chase game without the animated images.  
The puzzle game and circuit jump game: In the puzzle game, the user 
must press the switch to open the bridges, reach the target and release the 
caged monkey. If the image falls in the water, points are lost. The assistive 
force keeps the monkey image along the path. The circuit jump game is 
similar to the puzzle game without the animated images. 
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3.2.7.3.1 Game level generation 
In order to maintain engagement and promote progression of arm use, 
every game has different levels arranged in a hierarchical order of difficulty. 
The river game was based on a combination of sine waves. The earlier levels 
start with a simple design but in the higher levels, the sine waves become 
more frequent and taller. The chase and puzzle games were based on a 5 x 
4 grid of islands and connecting bridges. The series of steps in each level 
were created from a series of three numbers representing the position on the 
grid and the intended direction of movement. The first number represents the 
x-axis position, the second number is the y-axis position and the third number 
is the direction of movement in the grid. For example, the path in Figure 11 
could be created from the following sequence: 131, 123, 223, 325, 330. The 
direction of ‘0’ represents the end of the sequence. 
 
Figure 11. Example chase game level generation 
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Each game has 75 built-in levels designed to provide a hierarchical 
order of difficulty in terms of the number of movement steps and the extent of 
workspace used. For example level 1 of the chase game has a small 
workspace of approximately 4 x 2 inches on the screen whereas level 75 has 
a workspace of approximately 6 x 6 inches on the screen (Figure 12). The 
range of movement the shoulder and elbow go through while performing level 
75 is greater than the range used in level 1. This makes the levels 
progressively difficult and more challenging to the user. 
 
Figure 12. Chase game levels 
Chase game level 1                      Chase game level 73 
     
 
 
Level 1 in the above example involves 12 movements restricted to a 
4x2 inch space on the monitor that can be performed with a limited range of 
movement in the shoulder and elbow. Level 75 is more complex; it involves a 
total of 40 movements and is spread over a 6 x 6 inch space on the monitor 
and will need a greater range of movement in the shoulder and elbow. We 
roughly estimated the range of movements the shoulder and elbow go 
through in the sagittal plane while moving the character from bottom of 
screen to the top of screen (three upward movements) (Figure 13). The 
elbow angle changed from 110 to 135 degrees of extension and the shoulder 
angle changed from 3 to 30 degrees of flexion. 
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Figure 13. Shoulder and elbow ranges of movements in the sagittal plane 
during reaching movements 
     
                                                                                
     
 
3.2.7.4 System menus 
 Figure 14 shows the system menus and how the games are played. 
Interactions with the menu are through a push switch held in the unaffected 
hand of the user.  
 
Figure 14. System menus for playing games 
(a) Align the joystick   (b) Player confirmation 
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(c) Warm-up instructions    (d) Warm-up routine 
     
 
 
(e) Assessment instructions  (f) Assessment task 
     
 
 
(g) Assessment well done   (h) Games menu 
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After each level of game played, the performance score comes up on 
the screen with a comparison with the previous score on that level which 
gives an indication of the individual’s performance (Figure 15).  
 
Figure 15. Sample score display 
 
 
3.3 Discussion 
 
Three aspects of user-centred design have been undertaken in this 
study. Firstly, the users’ needs and expectations of a home-based robotic 
device were explored.   Secondly, the interview concepts were matched to 
the Comprehensive ICF Core Set categories and found that the 
Comprehensive ICF Core Set serves as a template for researchers to 
understand user needs and expectations in the concept stage of device 
development. The matching of interview concepts of other stages (design 
and testing) of device development to the Comprehensive ICF Core Set 
categories will be described in Chapter Six. Thirdly, we have successfully 
developed a definitive device ready to be tested in a clinical setting. 
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3.3.1 Concept stage of user-centred design 
Involving users early on in the technology development process will 
lead to improved technology design, which will lead to a greater likelihood of 
usability, adherence to treatment protocols both within clinical studies and in 
routine use, and the subsequent adoption of the technology by the health 
services. The interviews in this user-centred design study provided valuable 
insights into the problems faced by individuals after stroke and the current 
status of upper limb rehabilitation therapy. It is clear that different patients 
have different needs in their daily lives, and it is important for upper limb 
exercises to be based on functional needs and often patients require higher 
intensity than they are currently receiving. Unfortunately, long-term therapy in 
the NHS is limited and there is a lack of long-term continued motivating 
therapy in the home setting for patients after a stroke.  
The interviews highlighted two potential gaps in the therapy services 
provided in the period after discharge from hospital: the first gap occurs 
immediately after discharge from acute hospital treatment, while waiting for 
input from community rehabilitation services, and the second gap is after 
discharge from community rehabilitation services until long-term continuing 
outpatient therapy is organised. The second gap can vary widely in length as 
some users do not receive any long term continuing outpatient 
physiotherapy. These gaps in upper limb therapy services could potentially 
be covered by therapy delivered by technology to meet patients’ needs in the 
long run. Such therapy needs to be novel, intense and based on functional 
activities. 
Home technology has been welcomed with enthusiasm by both end-
users and therapists who feel it might augment hands-on conventional 
physiotherapy and increase the practice intensity. It might also motivate end-
users to engage in therapy and give them more independence and control in 
their rehabilitation programs. Technology can provide variety and feedback 
which are key principles of motor leaning after stroke [259]. The Wii video 
games console is currently being used in homes by some patients and is also 
being recommended by therapists for upper limb exercises after stroke. The 
Wii system is, however, limited by the lack of physical assistance to upper 
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limb movement, hence individuals who have significant weakness in their 
arms are unable to use this technology. It does not provide feedback specific 
to stroke survivors and it could exacerbate their conditions due to the 
unrestrained movement it allows.  
The perception of end-users and therapists is that any technology 
developed to aid recovery needs to be simple, easy to use and safe. End-
users preferred to use the arm rehabilitation device on their own in their 
homes, rather than using it with others in a centre. One drawback that has 
been highlighted by the end-users and therapists is how to monitor 
performance and movement patterns while using the device in the home 
setting.  
3.3.2 Matching of interview concepts and ICF Core Set categories 
The matching of the concept stage interview concepts with the ICF 
Core Set categories showed that most concepts were covered within these 
ICF Core Set categories. Some interview concepts related to the personal 
factors domain in ICF, but as yet there are no “personal factor” categories 
described yet in the Comprehensive ICF Core Set. The overlap of topics can 
be represented in a schematic diagram (Figure 16). 
Figure 16. Concepts in the user-centred design process in the concept stage 
of device development 
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This implies that researchers can use the ICF framework/Core Set for 
stroke as a tool to understand the critical problems/needs of individuals with 
stroke. This will help in the development of an inclusive technology that 
meets these needs and caters to the target population. Some examples from 
each ICF domain are discussed below. 
Some “body function” factors, such as the side affected by the stroke 
can be crucial in informing the design of the system. We considered this 
aspect in designing a home-based exercise technology that can be adjusted 
for right or left upper limb use to make it efficient in terms of usability and 
acceptability to the user. Also, visual inattention or neglect are common in 
left-sided stroke and language problems are common in right-sided stroke. 
Recognising the types of visual inattention and field defects these users 
could have, we designed an adjustable monitor screen to suit individuals with 
specific deficits. Keeping the display and user login instructions simple was 
most important to enable those with language and cognition impairments to 
use the technology. Stroke survivors can experience pain in the affected 
upper limb and assessing the impact this has on technology usage and vice-
versa, enabled us to advise participants on the device usage time and 
develop tailor-made or personalised therapy within the range of pain-free 
movements.  
Understanding the ICF “activity and participation” factors such as 
functional daily activities, will help us design games or tasks that replicate 
those desired activities and make the technology more meaningful and 
functionally relevant to the user. The ICF “environmental factors”, such as 
home environment, physical space available for device, appearance of 
device, carer support, perceptions and opinions of people (including 
professionals) around the individual has a major influence on the individual’s 
progress and usage of technology. We have ensured these needs are 
catered to with the hCAAR device. This is likely to increase the acceptability 
and usage of the device. 
Finally, the ICF “personal factors” are arguably the most important 
factors that can determine the success of any technology. These include the 
individual’s perception of the technology, self-efficacy and belief in the 
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therapy, computer skills, motivation, interest, experience and liking for the 
technology. These factors could determine how much the technology will 
appeal to or motivate the individual and will determine the extent of 
engagement of the individual. We aim to capture these aspects of device 
utility in the feasibility clinical study. 
3.3.3 The hCAAR device 
The hCAAR device is a simple low-cost end-effector planar robotic that 
helps to improve the range of movement at the shoulder and elbow with the 
hand moving in a single horizontal plane. The evidence base in the current 
literature is mainly around the complex exoskeleton (such as ARMin) and 
complex end-effector devices (such as MIT-Manus and MIME) with a paucity 
of clinical studies on simple low-cost end-effector robotic devices that can 
assist arm exercises. hCAAR has the potential to fill this void in the current 
literature. 
hCAAR is potentially deployable in the home setting and could be used 
by individuals with stroke in a minimally-supervised environment. The joystick 
handle is adjustable, and so is the computer screen to accommodate the 
different heights of users and their vision problems post-stroke. The device is 
purpose-built for one side use to allow the user the safety of being able to 
operate the emergency switch easily with the unaffected upper limb. The 
trolley has been designed in such a way that all hardware fits in a compact 
space and the footprint of the device is as small as possible; the device has a 
pleasing external look. The final dimensions of the device are approximately 
90cm by 60cm, which are similar to the dimensions of some common 
household equipment, such as fridges and washing machines. Panels cover 
most of the hardware and give it a look that is acceptable for all users to have 
the device in their homes.  
The inclusive design methodologies of the hCAAR ensure that a wide 
spectrum of individuals will be able to set-up and use the system. Individuals 
with impairments such as language deficits, speech problems, visual field 
defects or inattention, mild to moderate pain in the affected upper limb, 
varying degrees of upper limb weakness and stiffness and mild cognitive 
problems should be able to independently use the device. The nine 
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participants who were involved in the development process had a wide range 
of the above deficits and they were all able to set-up and use the device 
independently in the research laboratory.  
The hCAAR device provides reach and retrieve movements to the 
affected upper limb using the joystick. The predominant movements 
replicated by the games are shoulder flexion and extension, shoulder 
rotation, and elbow flexion and extension, which all are functionally relevant 
movements for daily activities. Reaching is the predominant movement 
required in most daily activities as reflected in the Barthel index where 
reaching is required in more than 50% of tasks in the outcome measure 
[260]. Reaching involves a complex interplay of shoulder flexion and elbow 
extension and is influenced by the residual power, stiffness and range of 
motion in these two major joints. The therapists were satisfied with these 
movements being replicated by the prototype device even though the 
movements were restricted to a single plane. There was concern that the 
computer games might not appeal to everyone equally, or that they would 
become less engaging in the long run. The computer games were designed 
to incorporate different levels that progressively become harder as the 
performance improves. The device has the facility to personalise the exercise 
program based on extent of weakness, range of movement and amount of 
stiffness (spasticity) in the affected upper limb. 
The assistance factor of the hCAAR device is an important feature that 
enables individuals to complete therapy tasks. The device also adjusts the 
assistance provided to upper limb movement based on individual 
performance so that the patient is encouraged to use more of their own effort 
to perform the movements, rather than depending on the assistance of the 
device. As the upper limb function and performance improves, the assistance 
drops accordingly to facilitate increased participation of the individual in the 
task. This matches the general approach adopted by therapists in 
conventional hands-on physiotherapy where the individual is initially helped 
by therapist to perform movement but as the individual improves, they are 
promoted to perform tasks independently. 
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The assistance feature differentiates the device from other technology-
based therapy devices such as the Wii. The assistance level of hCAAR can 
be adjusted to suit the residual power in the user’s upper limb. The 
assistance also auto-adjusts based on the user’s performance so that there 
is an element of challenge for the user while playing the games. This 
approach has been used to good effect in other robots such as MIT-Manus, 
MIME and GENTLE [52, 60, 80, 111]. These robotic systems can be 
operated in three different modes: active assist (assists user’s active 
movement), active non-assist (no assistance to user’s active movement) and 
passive (all movement done by the robot) [261]. In robot studies, the active-
assist therapy has been shown to be superior to the other modes [80, 86]. 
hCAAR can operate only in two modes: active assist and active non-assist. It 
cannot operate in passive mode as the actuators are not as powerful as the 
other lab-based robotic devices. This is the compromise that had to be made 
to keep the device simple and suitable for home installation and use. 
The hCAAR games generate uniplanar reach and retrieve movements 
and lack the three-dimensional aspects of functional tasks. The ADLER, 
RUPERT and ARMin devices are robotic devices that promote the upper limb 
to do real world tasks [70, 92, 262]. The ARMin robot can provide therapy in 
three modes: mobilisation (passive mode), games (active-assist) and training 
for ADL (active or active-assist) [70]. However these devices are too complex 
to be used in home settings and use of the device needs assistance from a 
helper or therapist. The levels of games can be individualised based on the 
available range of motion and ability of the user, similar to the approach used 
by other robots [74, 91].  
hCAAR incorporates the concept of bilateral therapy as the unaffected 
upper limb operates a switch to complete tasks in game play. The task of 
operating the switch is however a minor task and its contribution to overall 
motor recovery is debatable. The current literature is still inconclusive as to 
whether bilateral therapy is superior to unilateral therapy [113]. The 
involvement of the other upper limb predominantly for symmetric movements 
is promoted by the robot devices such as MIME, BdF and BFIAMT [60, 81, 
83]. However, the criticism of this approach has been that most daily 
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activities are asymmetrical in nature. Therefore hCAAR aims to provide 
asymmetrical bilateral therapy but whether operating a switch is adequate 
contribution to motor tasks is debatable.  
3.4 Limitations 
 
There are some limitations to this user-centred design study. Firstly, a 
relatively small sample of end-users and healthcare professionals were 
included for the interviews. There is, however, no established literature in 
user-centred design on what the minimum sample size should be involved in 
such a process. The aim in this sampling technique was to cover the main 
impacts stroke has on the individual and additional information would be 
obtained from the healthcare professionals.   
Secondly, regarding the ICF Core Set linkage, the meaningful concepts 
are ideally linked to the most precise third-level ICF categories as per the ICF 
linking rules [257], but we have linked them only to the second-level 
categories available in the Comprehensive ICF Core Set. The aim of this 
experiment was only to explore whether ICF provides a useful template for 
the user-feedback process and not to test the accuracy of the linking 
process. Hence the linking to the available categories is justified.  
Finally, the hCAAR device has its limitations. The device has the 
potential to provide exercises to only the proximal muscles of the upper limb. 
Current literature suggests that benefits from exercises to proximal muscles 
do not extend to distal muscles in the chronic stage of recovery. However 
any additional attachment/ module to carry out distal movement for the upper 
limb is likely to make the device bigger and more complex, defeating the 
concept of keeping it simple, compact and usable in home setting. 
3.5 Conclusions 
 
A user-centred design development process involving stroke survivors 
with upper limb weakness and healthcare professionals has resulted in the 
development of hCAAR. The Comprehensive ICF Core Set provides a useful 
template to structure content of user-feedback methods in the device 
development process. 
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Chapter 4: Methodology of the hCAAR feasibility study 
The aims of the home-based Computer Assisted Arm Rehabilitation 
(hCAAR) feasibility study were to a) To investigate whether the hCAAR 
device could be deployed and used independently in a home setting by 
individuals with upper limb weakness after stroke b) To investigate the impact 
of hCAAR on affected upper limb movement and usage using clinical and 
kinematic outcome measures and c) To capture feedback from participants 
and therapists on device deployment and usage during the study (the testing 
stage of the device development life cycle).  
The aims of this chapter are to describe the study design including the 
outcome measurements, statistical analysis and research governance. The 
results of the study will be described in Chapters 5 and 6. 
4.1 Study design 
This was a pilot open label cohort phase 2 clinical study as defined by 
the Medical Research Council (MRC) Guidelines on Complex Interventions 
[263] for a new restorative rehabilitation robotic device, hCAAR. The study 
involved 8 weeks of home upper limb exercise using hCAAR for stroke 
survivors with residual upper limb weakness. This was not a randomised 
control study, all consented participants received the hCAAR system to 
undertake home exercises in addition to their usual treatments. The usual 
treatment varied between individual participants and involved treatments 
such as NHS community physiotherapy, private physiotherapy or self-
exercise. 
The study plan is as shown in Figure 17. 
4.1.1 Sample population  
Stroke survivors who were admitted to stroke rehabilitation inpatient 
services or were attending outpatient clinics within the Leeds Teaching 
Hospital NHS Trust and the Leeds Primary Care Trust were screened for 
suitability for the study.  
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Figure 17. Feasibility study flow-diagram 
 
4.1.2 Inclusion and exclusion criteria 
The inclusion criteria for the feasibility study were: 
- Age more than 18 years.  
- Diagnosis of ischaemic or haemorrhagic stroke at least 1 month prior 
to inclusion and either discharged from acute hospital or being 
planned for discharge to community care. 
- Residual weakness of an upper limb. 
- Some voluntary upper limb movement to allow the participant to 
perform the hCAAR tasks. Participant in a sitting position must be able 
to actively move the affected hand, rested on table, by at least 15cm. 
The exclusion criteria were: 
- Significant pain in the affected upper limb.  
- Significant limitation in the range of motion of the affected upper limb.  
- Cognitive impairment affecting capacity to consent.  
- Sensory impairment affecting ability to use the hCAAR system. 
- Significant medical co-morbidities such as uncontrolled epilepsy. 
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4.1.3 Recruitment 
The clinicians delivering stroke rehabilitation within the Leeds Teaching 
Hospital NHS Trust and the Leeds Primary Care Trust assessed participants’ 
suitability and gave them information on the study. These clinicians also 
passed on details of potential participants to the researchers. The clinicians 
within the research team explained the study further to interested potential 
participants, gave them the study information sheet and consent form and 
allowed a cooling off period of at least 24 hours for them to make their 
decision on participation.  
4.1.4 Consent 
Potential participants interested in participating in the study were given 
a user meeting appointment at the Charterhouse Rehabilitation Technologies 
(CRT) laboratory at the University of Leeds. This facility is on the ground floor 
with full access for wheelchair users and easy access to the disabled toilet 
facilities. In the meeting, potential participants had the opportunity to see the 
device and ask the researchers further questions. If they were willing to 
proceed, written consent was recorded. If the participant was able to provide 
fully informed consent but was unable to sign or otherwise mark the consent 
form, provision for completion of the consent form by a family member was 
made. Every participant had the right to decline to take part in the study at 
any time without giving reasons and without prejudicing any further 
treatment.  
4.1.5 Sample size 
The feasibility study planned to recruit 20 participants (stroke survivors 
with residual upper limb weakness). A sample of this size was deemed 
sufficient to indicate the practical aspects of using the device and indicate the 
potential for the benefits of the device. This sample size is sufficient to 
indicate the trends in change in upper limb movement and function, if any, 
from use of the hCAAR. The study will also provide data to develop methods 
for a larger- scale phase 3 randomised control study in the future. 
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4.1.6 Intervention  
Five hCAAR devices were available for use in the study. Up to four 
devices could be used at a given time during the study period. The device 
was set-up in the participant’s home by the research team. Participants were 
asked to use the device as much as they wanted during the 8-week period. 
The general recommendation was for at least half an hour of exercise every 
day for at least five days every week. This was based on robotic therapy time 
recommended in other robot studies [118, 261]. The participant’s usual 
medical and rehabilitation treatment continued as part of their routine care 
and was not altered due to participation in the study. 
4.1.7 Device installation/ deinstallation 
Within the first week after the baseline assessment, members of the 
research team visited the participant’s home at a mutually convenient time to 
set-up hCAAR. The researchers explained the process of using the device 
with the participant (and family member or carer if available). A device user 
instruction booklet with the contact telephone numbers of the researchers 
was given to the participant. Participants could contact the research team at 
any time during the study period if they were concerned about any aspect of 
using the device. The researcher MS contacted the participant by telephone 
once every two weeks to check the participant’s progress and to discuss any 
queries the participant might have. At the end of week 8, members of the 
research team visited the participant’s home to retrieve the system. 
4.2 Outcomes 
The outcome measures selected for the feasibility study were based on 
the systematic approach proposed in Chapter 2. The outcome measures 
captured the different domains of the ICF framework (a) Body function 
measures: Optical tracking device kinematic measurements during standard 
reaching tasks, MRC, MAS and FM-UE (b) Activity and Participation 
measures:  ARAT, CAHAI and ABILHAND and (c) Contextual factors: 
Participant, family, carer and therapist impressions of the device during and 
after the 8-week home use of the device. 
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4.2.1 Measuring quality of voluntary upper limb movements 
Measurement of voluntary upper limb movement using kinematic 
analysis was undertaken while performing a standardised reaching task 
similar to that reported in the current literature [264]. A suite of Optotrak and 
Optokat systems installed in the CRT laboratory was used to record variables 
of upper limb movement characteristics such as movement time, path length 
and jerk.  
4.2.1.1 Optotrak system 
The Optotrak (Certus) system comprises of a position sensor/camera 
mounted on the roof and a system control unit connected to a computer. The 
ceiling-mounted position sensor/camera captures signals from the 
markers/diodes (Figure 18). These signals are sent to a system control unit 
that calculates the position of marker as 3 coordinates (x,y and z) and sends 
the 3D raw data of marker position to the host computer for further analysis.  
4.2.1.2 Optokat 
Optokat provides a method of standardising the performance task so 
that variables can be compared within assessments for the same participant 
and between all participants. It comprises a standard moveable frame with a 
chair and a start and end point for the tasks (Figure 19). The four corners of 
the frame, seat position, start and end point are attached with infrared radio 
emitting diodes. The participant sat in a standard position in front of the touch 
screen monitor so that they could reach towards the stimuli along a para-
sagittal plane (this reduced the number of joint-level degrees of freedom 
required during the movement to two: one at the shoulder and one at the 
elbow). Markers were attached to the upper limb either as a single marker 
(shoulder and elbow) or a group of markers known as rigid-body markers 
(wrist, mid-arm and trunk) (Figure 20). Rigid-body markers enables the 
system to detect a combination of three markers from the rigid body 
(Cartesian coordinate system) to detect the three-dimensional movement of 
the limb segment.  
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Figure 18. The position sensor of the Optotrak system mounted on the ceiling 
picks up the marker signals (research team member in picture) 
 
 
Figure 19. The frame, seat, start position and target of the Optokat system 
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Figure 20. Single markers for shoulder, elbow and stylus; rigid-body marker 
for mid-arm and wrist (research team member in picture) 
 
 
 
4.2.1.3 Standardised tasks 
The study began with the participant holding a handle with the stylus 
positioned at the start point (Figure 20). In start position, the elbow angle was 
at approximately 90 degrees, forearm in a midprone/neutral position and the 
wrist in a neutral position. An auditory signal (which corresponds to the 
initialisation of data collection) indicated that the participant should start the 
movement. The participant was instructed to aim towards the switch picture 
on the screen quickly and accurately, with the goal being to press the switch 
on the screen with the stylus.  On touching the target, there was a bulb image 
displayed and an auditory signal indicating the end of the task. 
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The first task was a calibration task where the participant had to hold 
the stylus at the start position for 10 seconds. The system recorded the 
reference position of the markers. The second task was reaching a near 
reach target 120mm away from the start position (Figure 21). Five trials were 
performed with the near reach target and the software checked that all the 
required variables had been recorded. The third task was a far reach task 
with the target moved 30mm further away so that the target distance was 
150mm away from the start position. Five repeated trials at this target were 
performed and the software checked that the data had been converted to the 
required variables.  
 
Figure 21. Near reach and far reach tasks 
 
 
 
       
4.2.1.4 Extracting kinematic variables 
Data were collected for 4000ms at 100Hz, then stored for subsequent 
offline analysis and filtered using a dual-pass Butterworth second order filter 
with a cut-off frequency of 16Hz (equivalent to a fourth order zero phase lag 
filter of 10Hz).  Following this operation, the tangential speeds of the infrared 
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radio emitting diodes were computed and the onset and offset of the 
movement was estimated using a standard algorithm (the threshold for 
movement onset and offset was 50mm/s). The software generated kinematic 
data in terms of (upper limb reaching) movement time, path length and 
normalised jerk. The definitions for these variables are as follows: 
4.2.1.4.1 Movement time (MT) 
This is the time taken to complete the task of reaching from the start 
position to the target on the screen. It is expressed in seconds (sec) [181]. It 
reflects the overall speed of a movement, as a faster movement would result 
in shorter movement time [81]. 
4.2.1.4.2 Pathlength (PL) 
This is the distance taken to reach the target on the screen from the 
start position. It is expressed in millimetres (mm). It gives an indication of the 
path taken for the near reach and far reach tasks that had standard distances 
(between start and end points) maintained across the assessments. A 
reduction of path length would indicate a straighter path taken for completion 
of the task and hence improvement. 
4.2.1.4.3 Normalised jerk (NJ) 
Jerk is the rate of change of acceleration during movement and is a 
measure of the smoothness and efficiency of the movement. A reduction in 
the jerk value indicates smoother and more efficient reaching movement 
[144, 265]. As jerk varies with movement time and distance travelled during 
the movement, normalising the quantity in time and distance gives the NJ 
value. NJ is a dimensionless number that allows movements of different 
durations and lengths to be compared [266]. 
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4.2.2 Measuring clinical/ functional outcomes 
The clinical outcome measures used were FM-UE, ARAT, MRC, MAS, 
CAHAI and ABILHAND.  
4.2.2.1 Fugl Meyer motor - Upper limb section (FM-UE) 
The FM-UE was used to measure the movement ability of the affected 
upper limb. It is a validated upper limb measure with score ranging from 0 – 
66 points [137]. Each of the 33 items are scored on a 3-point ordinal scale 
0=cannot perform, 1=performs partially, 2=performs fully. The kit used for 
scoring comprised a tendon reflex hammer, a rubber ball, a folded A4 size 
paper, a cylinder, a pencil and a stopwatch (Figure 22). The participant was 
asked to undertake a series of motor tasks such as lifting the upper limb up, 
gripping the cylinder, etc. Each movement was scored on the 3-point scale 
depending on participant’s ability. This test took approximately 20 minutes to 
complete.  
Figure 22. FM-UE kit 
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4.2.2.2 Action Research Arm Test (ARAT) 
The ARAT was used to measure grasp, grip, pinch and gross 
movements. It is a validated upper limb measure with 19 items scored on a 
4-point scale: 0=no movement to 3=normal movement. The kit used 
comprised a standard ARAT table 92cm x 45cm x 83cm high, with a shelf of 
93cm x 10cm, positioned 37cm above the main surface of the table; a chair 
(46cm seat height) with a back rest and no arm rests; wooden blocks of 2.5, 
5, 7.5 and 10cm³; a cricket ball 7.5cm in diameter; two alloy tubes: one 
2.25cm in diameter x 11.5cm long, the second one 1.0cm in diameter x 16cm 
long; a washer; two plastic glasses; a marble 1.5cm in diameter; a ball 
bearing 6mm in diameter; and a stopwatch (Figure 23). This test took 
approximately 10 minutes to complete.  
 
 
Figure 23. ARAT kit 
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4.2.2.3 Modified Ashworth Scale (MAS)  
The MAS was used to measure spasticity (muscle stiffness) in the 
paretic arm. Spasticity in the shoulder abductors/ adductors/ flexors/ 
extensors, elbow flexors/ extensors, wrist flexors/ extensors and finger 
flexors/extensors in particular was recorded. The 6-point ordinal scale 0-4 
was scored as: 0= No increase in muscle tone, 1= Slight increase in tone 
with minimal resistance at end of range, 1+= Slight increase in tone with 
minimal resistance through range, 2= More marked increase in tone through 
the range and passive movement easy, 3= Considerable increase in tone 
and passive movement difficult, 4= Affected part rigid [167, 267]. The MAS 
scores of all muscles were summated to get a total MAS score in order to 
compare scores before and after intervention. This test took approximately 5 
minutes to complete.  
4.2.2.4 Medical Research Council (MRC) scale 
The MRC scale was used to record muscle power in the different 
muscle groups of the paretic arm. The 0-5 ordinal measure of muscle power 
was scored as: 0= No movement, 1= Palpable contraction but no visible 
movement, 2= Movement but only with gravity eliminated, 3= Movement 
against gravity, 4= Movement against resistance but weaker than normal, 5= 
Normal power [268]. The MRC score of shoulder flexion/ 
extension/abduction, elbow flexion/ flexion, pronation/ supination, wrist 
flexion/ extension and finger flexion was recorded. The scores were added to 
give a total MRC scale that was used to compare scores before and after 
intervention. This method of adding scores to give a total motor power scale 
is described in the literature [55]. 
4.2.2.5 The Chedoke Arm and Hand Activity Inventory (CAHAI) 
The CAHAI version 13.0 was used to capture functional ability in daily 
activities. It has 13 real life functional tasks (Table 4) scored on a 7-point 
scale to give a score ranging between 13 and 91 [147]. The criteria used for 
scoring: 1 = Total assist (weak UL <25% of effort), 2 = Maximum assist 
(weak UL =25-49% of effort), 3 = Moderate assist (weak UL =50-74% of 
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effort), 4 = Minimal assist (weak UL >75% effort), 5 = Supervision, 6 = 
Modified independence and 7 = Complete independence.  
The equipment comprised of height adjustable table, chair/wheelchair 
without armrests, dycem, 200g jar of coffee, push-button telephone, 12 inch/ 
30cm ruler, A4 size paper, pencil, 2.3L plastic pitcher with lid filled with 1600 
ml water, 250 ml plastic cup, wash cloth, wash basin (24.5cm in diameter, 
height 8cm), pull-on vest with five buttons (one side male & one side female), 
buttons (1.5cm. in diameter, 7cm apart), bath towel (65cm x 100cm), 75ml 
toothpaste with screw lid, toothbrush, dinner plate (heavy plastic, 25cm in 
diameter), medium resistance putty, knife and fork, 27inch/67cm metal zipper 
in polar fleece poncho, eyeglasses, handkerchief, plastic 38L container (50 x 
37 x 27cm), plastic grocery bag holding 4lb/2kg weight (Figure 24). This test 
took approximately 20 minutes to complete. 
 
Figure 24. CAHAI kit 
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Item 13 of the measure involved carrying a carry bag with 2kg weight 
up stairs. This was performed on staircase adjacent to the CRT laboratory in 
University of Leeds. All participants were risk-assessed prior to performing 
this task. This item was not performed for participants who were not using the 
stairs independently at home.  
4.2.2.6 ABILHAND 
The ABILHAND was used to capture participant perception of 
performance in actual daily life activities. It is a self-reported questionnaire 
with 23 items (Table 4) that relate to daily life activities.  The participant is 
asked to estimate the difficulty in performing each activity using a 4-point 
scale : not applicable, 0= impossible, 1= any difficulty or 2= easy [151]. The 
scale has also been validated based on the Rasch model and gives an 
interval measure of manual ability. The responses were entered in to an 
online computer program (http://www.rehab-scales.org/abilhand-rasch-
analysis-chronic stroke.html) that gave the score in logits. This test took 
approximately 5 minutes to complete. 
4.2.2.7 Qualitative feedback  
MS gathered qualitative feedback on hCAAR from all participants (in the 
study) and a community physiotherapist involved with these participants 
using semi-structured interviews. The feedback from participants was 
gathered at the post-use assessment stage. A separate appointment was 
arranged with the community physiotherapist to gather feedback on the 
device. The details of topics covered in these interviews and responses are 
described in Chapter Six. 
4.2.2.8 Device data  
The hCAAR device recorded the total amount of usage at home. It 
recorded the time spent in the assessment exercise and the duration of each 
game played in each session. The data were retrieved from the hCAAR 
device at the end of the 8 weeks of home use.  
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4.2.3 Assessment schedule 
All baseline and follow-up assessments were undertaken in the CRT 
laboratory in Worsley Building, University of Leeds.  
4.2.3.1 Baseline assessment (A0) 
Baseline assessments were undertaken within one week of the home 
installation of the device (week 0). Demographic data recorded included age, 
sex, date and type of stroke, affected side and clinical signs and symptoms of 
stroke, past medical history and medications. Researchers MS and Justin 
Gallagher (JG) carried out the kinematic assessment. MS assessed the 
clinical outcome measures. The participant was shown how to use the device 
and allowed to independently set-up and use the device. The user 
instructions manual was given to the participant for reference. A complete 
baseline assessment typically lasted around 2.5 hours. This included comfort 
breaks and refreshments. 
4.2.3.2 Post-use assessment (A1) 
Assessment A1 was carried out just after completion of the 8-week 
usage period (week 8/9). MS captured the participant and carer impressions 
of the device in semi-structured interviews. MS and JG did the kinematic 
assessments. Sophie Makower (SM) (research physiotherapist) assessed 
the clinical outcome scores. On two occasions, when SM was unable to 
attend due to sickness or leave, MS did the clinical assessments. A complete 
A1 assessment took on average took 2.5 hrs to complete. This included 
comfort breaks and refreshments. 
4.2.3.3 Final follow-up assessment (A2) 
Assessment A2 was undertaken four weeks after assessment A1 
(week 12/13). This corresponded to 4 weeks after stopping use of the device. 
MS and JG did the kinematic assessment. SM assessed the clinical outcome 
scores. MS assessed the clinical outcomes on one occasion when SM was 
unable to attend the appointment due to leave. A2 assessments took on 
average took 2 hrs each to complete. This included comfort breaks and 
refreshments. 
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4.2.4 Assessor training and blinding  
SM is a neurophysiotherapist with extensive experience of working 
with stroke patients and outcome measures related to upper limb function 
after stroke. SM also has experience of using outcomes in research studies 
in stroke rehabilitation. SM and MS were involved in a critically appraisal of 
all the available outcomes used in robot studies (Chapter 2) [235]. For the 
hCAAR feasibility study, the research team selected outcomes based on this 
systematic review. SM and MS practised the selected outcome measures on 
each other and with healthy volunteers (research colleagues) for at least 6 
months prior to start of the study to ensure consistency of scoring between 
them.  
MS assessed the clinical scores in assessment A0. SM was not aware 
of the baseline assessment scores while assessing participants in A1 and 
A2. If doubts on scoring arose during testing, they discussed those items 
between themselves after completion of assessment (without disclosing 
participants number) and reached a consensus on the score to be given. SM 
assessed the clinical outcomes while MS conducted the user feedback 
interviews in the same appointment at A1. Such a blinding of assessments 
was planned to minimise the assessor bias of knowing the pre-use scores 
and being influenced by a participant’s impression of the intervention.  
4.3 Drop-outs  
If a participant had consented to the study but could not eventually 
proceed to use the device, for any reason such as inadequate power in the 
upper limb to use the device, lack of space at home to install the device, 
medical problems, such participants were recorded as drop-outs from the 
study. Every participant had the right to withdraw at any stage during the 
study. If a participant started using the hCAAR device and subsequently 
developed any medical problems or personal problems, either the participant 
or the research team could decide to withdraw hCAAR use temporarily on 
clinical grounds. If any participant failed to attend an appointment in the 
laboratory, a subsequent meeting was arranged. If they failed to attend the 
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subsequent appointment as well, it was counted as “DNA (did not attend)” 
and assessment data was recorded as “missing” or “not available”. 
4.4 Analysis 
4.4.1 hCAAR usage 
Total usage time for each participant time was recorded in terms of 
time spent on the warm-up exercise, assessment exercise, and the time 
spent in playing games.  
4.4.2 Kinematic variables 
The output of the Optotrak software was saved as an Excel file that 
was extracted to a master Excel file. The software provided data on 
movement time, peak speed, time to peak speed, path length, path length 
ratio, peak elbow angle and peak trunk angle. The best three trials for each 
task (near reach or far reach) were selected based on the shortest movement 
time (and selected by path length if the movement time was the same for any 
two trials). The selection of the three best trials enabled the minimising of the 
bias of variation in the individual initiating the movement on the start 
command and dealing with distractions during the command. The mean and 
median of these three trials were calculated to give the average variable 
value for that assessment. Percentage changes for A1-A0, A2-A0 and A2-A1 
were calculated. The minimal clinically important difference (MCID) values of 
the kinematic variables are not yet known in the current literature.  
4.4.3 Clinical/ Functional outcome measures 
FM-UE, ARAT, total MAS, total MRC, CAHAI and ABILHAND scores 
were calculated adding item values using Microsoft Excel. A1-A0, A2-A0 and 
A2-A1 changes were calculated. To determine clinical significance, MCID 
values of outcome measures were used if already described in the literature 
(Table 9). MCID is defined as the smallest difference in score in the domain 
of interest that patients perceive as beneficial or that would be clinically 
meaningful. For the ABILHAND score, whose MCID has not yet been 
validated, this was arbitrarily set as 10% as suggested in the literature [269, 
270].  
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Table 9. Clinically significant change values for clinical outcome measures 
Outcome score 
 
Total maximum 
score 
MCID value 
 
Reference 
 
FM-UE 66 7 [128, 164] 
ARAT 57 6 [164, 182] 
CAHAI 91 7 [209] 
ABILHAND 46 5 (10% rule) 
Total MAS 40 N/A  
Total MRC 50 N/A  
 
4.4.4 Statistical analysis 
All the statistical analyses were carried out in Microsoft Excel and IBM 
SPSS version 22 software packages. The calculations of mean, median, 
standar deviation (SD) and inter-quartile range (IQR) and drawing the chart 
figures were done in Microsoft Excel. The median and IQR were the 
preferred measurements for average values to analyse the results in this 
study. The mean and SD values were used to compare the results in this 
study with other studies in the literature that have reported only mean 
average values. Non-parametric tests for calculating data significance levels 
were done using SPSS. A non-parametric Friedman’s test was used to detect 
the significance of the three related samples A0, A1 and A2. If this test 
showed statistical significance, a Wilcoxon post-hoc analysis was used to 
test for significance between two related samples such as A0A1, A0A2 or 
A1A2. The significance levels for these tests were set at p = 0.05. SPSS was 
also used to do multiple regression analyses to test the relationships 
between independent variables such as baseline score, age, time since 
stroke and device usage; and the dependent variable, change in outcome 
measure. 
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4.5 Research governance 
4.5.1 Ethical approval 
The project (including feasibility study) had approval from the 
Research Ethics Committee (Ref 09/H1313/25) and the Research and 
Development (R&D) departments of Leeds Teaching Hospitals NHS Trust 
(LTHT) and Leeds Community Healthcare (NP/0058). The Medicines and 
Healthcare Products Regulatory Agency (MHRA) approved the use of the 
device in the feasibility study (Ref CI/2011/0026).  
4.5.2 Safety reporting 
The feasibility study adhered to the guidance provided by the Department 
of Health’s Research Governance Framework for Health and Social Care 
(Second edition, 2005). 
An adverse event was defined as any untoward medical occurrence in a 
participant which does not necessarily have a causal relationship with the 
device and can include any unintentional, unfavourable clinical sign or 
symptom and any new illness or disease or the deterioration of existing 
disease or illness. Potential hCAAR related adverse events were identified 
as:  
- Pain in the affected/unaffected upper limb while using the joystick. 
- Fall from chair while using the hCAAR system.  
- Worsening of upper limb impairment (muscle stiffness or loss of 
power). 
- Fatigue, tiredness. 
A serious adverse event was defined as “any untoward medical 
occurrence or effect that results in death or is life-threatening or requires 
inpatient hospitalisation or prolongation of existing hospitalisation or results in 
persistent or significant disability or incapacity and may require medical or 
surgical intervention to prevent one of the outcomes listed above”.  
Any medical problems encountered during the project were addressed by 
physicians MS and BB who have experience in dealing with stroke patients in 
a rehabilitation settings. An analysis of the possibility of recurrence of such 
an event was made and the decision on the safety of the patient to continue 
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in the study was made. MS was responsible for the maintenance of log of 
medical adverse events. The principal investigator (BB) had the coordinating 
responsibility for reporting serious adverse event to the MHRA, REC and the 
R&D departments. 
A device-related event was defined as technical problems with the device 
or events related to usage of the device needing intervention by the research 
team. The technical complications related to the device were documented 
and addressed by engineers in the research team JG and ML. MS and JG 
were responsible for maintenance of the log of device-related events. 
4.5.3 Data handling and storage 
Informed consent from participants was sought to record personal 
details including name, date of birth, postcode, address and telephone 
numbers to facilitate follow-up by the research team. All data collection forms 
were coded with a study number that included their initials as participant 
identifiers. In addition, all participants (a) consented for access to their 
medical records by the GMC registered medical researchers (BB, MS) or 
from the regulatory authorities, where it was relevant to study participation; 
(b) consented for the data collected in the study to be used to evaluate safety 
and develop new research. The original consent form was retained in the 
Investigator Site File, a copy of the form was given to the patient. Any new 
information when became available that was relevant to the safety or well-
being of the participant, was notified to the existing participants by the 
medical researchers (BB, MS) and detailed in an updated patient information 
booklet and consent documentation.  
At the end of the study, all de-identified research data was archived on 
a secure University server, and password protected with access by the 
principal investigator. Following authorisation from the Sponsor, 
arrangements for confidential destruction will be made in the future. All 
information collected during the course of the project has been kept strictly 
confidential. Information is held securely on paper and electronically at the 
CRT lab and the Academic Department of Rehabilitation Medicine (ADRM) 
and complies with the 1998 Data Protection Act. The documents contained, 
or which have been contained, in the study master file will be retained for 5 
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years from the conclusion of the project as per the Medicines for Human Use 
(Clinical Studies) Amendment Regulations 2006 - sections 18 and 28 [271]. 
4.5.4 Quality control/ assurance 
A project management group comprising research team members 
(BB, MS, ML, JG, RH, SM, RJOC) oversaw the running of the whole project. 
The project was conducted to MRC Good Clinical Practice Consolidated 
Standards of Reporting Studies (CONSORT), and the Mental Capacity Act 
2007 in England and Wales and Adults with Incapacity Act 2000 in Scotland. 
The University/NHS R&D departments had access to all the project 
documents stored in the ADRM through request to researcher BB. Sponsor 
representatives or regulatory authorities had to request permission from the 
Chief Investigator BB for monitoring of research data.  
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Chapter 5: Results of the hCAAR feasibility study 
This chapter aims to a) provide descriptive characteristics of the 
participants b) analyse aspects of the device installation and usage in the 
study c) summarise the results of kinematic and clinical outcomes d) perform 
grouping of participants to explore trends in the changes observed and e) 
look at the influence of the predictive variables on the outcomes.    
5.1 Descriptions of the participants and their device usage 
Nineteen participants were recruited to the study. After recruitment, two 
participants could not use the device in their homes and dropped out of the 
study. Seventeen participants completed 8 weeks of hCAAR home use.   
5.1.1 Drop-outs 
5.1.1.1 Participant ID number 12 
This participant liked the device and was able to use device 
independently in the research laboratory. All initial assessments (A1) were 
completed satisfactorily. On the day of the deployment, the participant had 
reassessed his home situation (in view of some relatives living in his house 
for holiday) and felt there was inadequate space in his house to 
accommodate the device for the period of the study. He requested 
postponing his participation by few months. This participant was considered 
as a drop-out from this study as the project had been completed by then.  
5.1.1.2 Participant ID number 15 
This participant was deemed to be eligible for participation during 
screening but after consent and clinical examination, was unable to move the 
joystick to complete tasks even using the full assistance mode of the device. 
Hence, this participant could not continue in the study. This participant’s 
details were passed on to other researchers working on a research centre-
based robot iPAM that can be used by individuals with severe weakness of 
the upper limb. 
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5.1.2 Demographics 
The demographic information for the 17 participants (who used device 
in homes) at the time of starting device use is shown in Table 10. 
Table 10. Participants’ demographics 
 
Baseline characteristics Participants (n=17) 
Mean age in years (SD) 56.4 (11.5) 
Sex  
   Male 
   Female 
 
14 
3 
Mean time since stroke in months (SD) 24.8 (17.8) 
Type of stroke 
   Infarction 
   Haemorrhage 
 
13 
4 
Side of weakness 
   Right dominant 
   Right non-dominant 
   Left non-dominant 
   Left dominant 
 
9 
0 
8 
0 
Other impairments 
   Expressive dysphasia 
   Pain in affected upper limb 
   Visual inattention 
 
6 
3 
1 
Employment 
   Not in employment before stroke 
   Gave up employment since stroke 
   Employed 
 
14 
3 
1 
 
The device usage descriptions, details of additional physiotherapy, 
device usage, clinical observations, adverse events and device-related 
events for these 17 participants are described in the below sections. 
5.1.3 Additional physiotherapy received during hCAAR use 
Twelve participants received no additional physiotherapy during the 8-
week period of the study. Three participants received community hands-on 
physiotherapy for 4 weeks during the study period. This therapy involved two 
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1-hour sessions per week for 4 weeks. Two participants went to the gym at 
least once a week and did a variety of aerobic, strengthening and endurance 
exercises.   
Four participants had received advice on some additional home 
exercises by the researcher MS during the course of the study. Three of 
them had received shoulder mobilisation exercises for shoulder pain (both 
related and unrelated to joystick use) and one of them was given advice on 
wrist mobilisation and strengthening exercises for wrist pain associated with 
use of the joystick.   
5.1.4 Device set-up and usage descriptions 
The device was installed in the participants’ homes in various different 
locations both on the ground floor or the first floor (Figure 25). Ten 
participants had the device in their living rooms, four in the bedroom (first 
floor), two in the dining room and one in the conservatory. The research team 
(MS, JG and ML) did not encounter any difficulties in installing the device in 
these locations. 
 
Figure 25. hCAAR installed in the bedroom of a participant 
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After installation and retraining on the user instructions, 13 participants 
did not experience any difficulty in logging in and using the device 
independently during the entire 8-week device-use period. Two participants 
required help from family members during the first one week to log in and 
initialise the joystick, but were able to play games independently once the 
joystick was initialised. These two participants became fully independent in 
using the device after one week. Two other participants required help from 
family members to log in and initialise the joystick for two weeks before 
becoming fully independent in the using the device.  
Participants’ generally preferred, or aimed, to use the device for three 
to four times a week for 15-20 minutes per session during the 8-week usage 
period. Three participants used the device during the weekend as well. One 
participant could not use the device for almost the entire study period 
because of personal problems (total usage 12 min). Three participants were 
unable to use device for more than two weeks during the 8-week period due 
to unexpected travel and illness. One participant had a 5-year old son who 
would not let the participant concentrate on game play when he was around. 
This participant could use the device only at times when the son was asleep 
and consequently the usage time was affected. 
5.1.5 Clinical observations and adverse events 
All clinical adverse events during the device-use period were managed 
by the clinicians in the research team (MS and BB). None of the clinical 
adverse events needed hospital admission or external clinician intervention.  
One participant had a fall (and sustained a neck of femur fracture) after 
completing the home use and the device had been retrieved from the home. 
This adverse event was deemed to be unrelated to the study. This participant 
needed hospital admission to manage her hip fracture and could not attend 
her final assessment (A2) in the research laboratory.  Other clinical 
observations and clinical adverse events that occurred during the device-use 
period are listed in Table 11.  
 
  
   
 
  Table 11. Clinical observations and adverse events 
Number of 
participants 
Clinical observations/ Clinical adverse events 
 
Actions taken Result 
One Wrist pain when uses joystick for more than 10 
min particularly while playing higher-level games 
Advised to play lower level games, reduce 
duration of session, use a wrist splint and do 
wrist stabilising and strengthening exercises. 
Reduction in wrist pain 
Three Shoulder pain. Two participants reported an 
increase in shoulder pain with device usage. One 
of them was noted to be sitting with back 
unsupported in the chair and had excessive wrist 
flexion while holding the joystick. The third 
participant had long-standing shoulder pain 
unrelated to device usage. 
All three participants had shoulder 
impingement syndrome on clinical 
examination. They were advised on shoulder 
strengthening and range of motion exercises. 
One participant was advised on sitting back 
against the chair and holding joystick handle 
with the wrist in a neutral position during 
game play. 
Shoulder pain improved 
with exercises 
One Injured finger with bruising while trying to stretch 
fingers to hold the handle of the joystick 
Advised on slow stretching of fingers prior to 
holding handle. Also received botulinum toxin 
injection to finger flexors as routine planned 
treatment unrelated to this study. 
 
No further injury while 
gripping joystick 
  
   
Number of 
participants 
Clinical observations/ Clinical adverse events 
 
Actions taken Result 
One Reported scapula becoming more prominent in 
affected upper limb (has had the prominence 
since stroke) 
Reassured and advised on scapular 
stabilisation exercises. 
No further worsening of 
prominence 
Four Could not use device as expected due to personal 
problems or medical problems (such as chest 
infections) unrelated to device usage 
None. Research team not made aware of 
personal problems by the participants during 
the study period. 
Usage improved once 
medical problems were 
resolved 
Two Low mood. One participant due to chronic ill 
health and other participant due to family member 
being unwell. 
Reassurance. 
 
n/a 
One Painful thumb and index finger in the affected 
hand, reported to be not related to device usage. 
Found to have osteoarthritis of small joints in 
these fingers. Advised to use topical 
analgesia. 
Good relief of symptoms 
with topical analgesia  
One Episodes of dizziness during study period, 
reported to be unrelated to device use. Lacked 
motivation to use device. 
Dizziness symptoms resolved with 
adjustment of his regular medications. 
Needed lot of encouragement from 
participant’s wife to use the device. 
Needed encouragement 
from wife throughout 
study period 
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5.1.6 Device-related events 
All device-related events were managed by the research engineers in 
the research team (JG and ML) and did not need any external professional 
engineering input. Two joysticks needed to be changed as they became 
noisy and jerky in movement. Six participants encountered joystick 
calibration/initialising problems that led to them losing track of the joystick 
position on the screen while starting game play. This was resolved with a 
home visit by the engineer JG and additional training on initialising the 
joystick; the participants picked this up easily after one training session at 
home.  
5.1.7 Device usage time 
The mean device usage time during the 8-week study was 520 min 
(range 12 min – 1468 min, SD 381 min). The median usage time was 433 
minutes (IQR 250 – 791 min). One participant could not use the device 
beyond 12 min due to personal problems. 
5.1.8 Outcome measure assessments 
The clinical and kinematic measurements were successfully 
undertaken in the research laboratory at the A0, A1 and A2 assessment 
points as described earlier. The A1 assessments could not be done on one 
participant (ID number 07) and A2 assessments could not be done on 
another participant (ID number 05) as they did not attend their appointments. 
A complete set of assessments at all three assessments points, A0, A1 and 
A2, for kinematic, FM-UE, ARAT, CAHAI and ABILHAND was available for 
15 participants in total.  
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5.2 Summary of kinematic and clinical outcome scores 
Data were available for 17 participants who completed 8 weeks of 
device use. A summary of kinematic and clinical outcome scores for each 
participant is described in Appendix D. The data from two participants (ID 
numbers 05 and 07) were not included in the analysis as there were no 
assessments done at one of the assessments points for each of them. The 
descriptive statistics for the remaining 15 participants are shown in Tables 
12-17.  
The kinematic scores at A1 in the far reach task showed statistically 
significant changes in movement time and path length (p<0.05) (Table 14). 
The percentage improvement in the median movement time at A1 was by 
19%, path length improved by 15% and jerk improved by 19% (Table 13). 
The improvements (except path length) were maintained at the final 
assessment (A2) suggesting that the improvements were retained one month 
after using the device (Table 13).  
All the clinical score improvements at A1 were statistically significant 
when compared to baseline scores (p<0.05) (Table 17). The average FM-UE 
score in this study showed a median improvement of one point at A1 (post-
use assessment). The median gain in other clinical scores at A1 were 3 
points in the ARAT score, 5.5 points in CAHAI, 3 points in ABILHAND, 1.5 
points in the total MAS score and 2 points in the total MRC (Table 16). All the 
improvements were maintained at the final assessment (A2) suggesting the 
gains were retained at one-month follow-up. 
 
 
  
  
  
 
 
Table 12. Kinematic variable scores at three assessment points and percentage change in scores (mean and standard deviation)  
Kinematic 
variable 
Baseline A0 
Mean  
(SD) 
Post-use A1 
Mean  
(SD) 
Final A2 
Mean  
(SD) 
A1 – A0  
% change 
Mean (SD) 
A2 – A0  
% change 
Mean (SD) 
A2 – A1  
% change 
Mean (SD) 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
 
Movement 
time 
 
0.48 
(0.20) 
0.66 
(0.33) 
0.42 
(0.16) 
0.48 
(0.17) 
0.37 
(0.11) 
0.46 
(0.11) 
- 5 
(37.3) 
- 19 
(33.8) 
- 16 
(29.9) 
- 21 
(27.2) 
- 7 
(29.1) 
 2 
(20.3) 
 
Path  
Length 
 
154.00 
(51.42) 
188.53 
(49.5) 
141.31 
(39.45) 
164.70 
(38.35) 
126.01 
(18.28) 
161.05 
(20.75) 
- 5 
(22.2) 
- 9 
(24.9) 
- 11 
(28.0) 
- 11 
(17.1) 
- 6 
(24.9) 
0 
(14.3) 
 
Normalised 
Jerk 
 
393.20 
(173.01) 
453.83 
(179.15) 
276.79 
(114.59) 
385.62 
(149.56) 
282.35 
(144.82) 
349.68 
(93.06) 
- 17 
(50.1) 
- 4 
(59.0) 
- 20 
(43.6) 
- 14 
(43.2) 
16 
(64.5) 
- 1 
(33) 
 
  Movement time – in sec 
  Path Length – in mm 
  Normalised Jerk – no units 
  n/a – not applicable 
  
  
  
 
 
Table 13. Kinematic variable scores at three assessment points and percentage change in scores (median and Inter-quartile range) 
Kinematic 
variable 
Baseline A0 
Median 
(IQR) 
Post-use A1 
Median 
(IQR) 
Final A2 
Median 
(IQR) 
A1 – A0 
% change 
Median (IQR) 
A2 – A0 
% change 
Median (IQR) 
A2 – A1 
% change 
Median (IQR) 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Movement 
time 
0.43 
(0.38 – 
0.51) 
0.53 
(0.48 – 
0.63) 
0.41 
(0.32 – 
0.49) 
0.44 
(0.37 – 
0.55) 
0.33 
(0.29 – 
0.43) 
0.44 
(0.42 – 
0.55) 
-10 
(-30.5 –  
3.5) 
-19 
(-39.5 –  
-11) 
-9 
(-37.5 – 
0.5) 
 
-20 
(-42.5 –  
-8.5) 
 
-8 
(-26 – 
12.5) 
 
2 
(-11 –  
9.5) 
 
Path Length 
132.85 
(122.18 – 
172.03) 
187.12 
(148.89 – 
212.35) 
127.80 
(112.83 – 
154.22) 
155.95 
(140.40 – 
180.41) 
125.66 
(111.56 – 
135.50) 
165.94 
(140.23 – 
179.23) 
-4 
(-15 – 
 -1) 
-15 
(-19.5 – 
 -4.5) 
-7  
(-21 – 
 -3.5) 
 
-11  
(-23 –  
-4.5) 
 
-3 
(-16 – 
 2.5) 
 
4  
(-4.5 –  
5) 
 
Normalised 
Jerk 
 
370.38 
(301.71 – 
405.46) 
 
447.75 
(350.22 – 
488.43) 
258.17 
(227.38 – 
283.43) 
388.65 
(289.28 – 
468.57) 
233.26 
(193.63 – 
308.34) 
363.64 
 (307.53 – 
391.89) 
-23 
(-55.5 – 
1) 
-19 
(-29 – 
4.5) 
-34  
(-44.5 – 
-21.5) 
 
-20  
(-42 – 
-1) 
 
-7 
(-31 – 
-48.5) 
 
-7  
(-23.5 – 
13) 
 
 
Movement time – in sec  
Path Length – in mm  
Normalised Jerk – no units 
 
  
  
  
 
 
 
 
Table 14. Statistical significance values for the kinematic variables 
Kinematic 
variable 
Significance 
A0A1A2 
Significance 
A0A1 
Significance 
A0A2 
Significance 
A1A2 
Near reach Far reach Near reach Far reach Near reach Far reach Near reach 
 
Far reach 
 
 
Movement time 
 
0.105 0.006 n/a 0.036 n/a 0.008 n/a 0.460 
 
Path Length 
 
0.011 0.015 0.112 0.061 0.011 0.027 0.140 0.650 
 
Normalised Jerk 
 
0.038 0.091 0.069 n/a 0.023 n/a 1.000 n/a 
 
 
 
 
 
 
 
 
 
  
  
  
 
 
      Table 15. Clinical outcome scores at three assessment points and change in scores (mean and standard deviation) 
Outcome 
measure 
Baseline A0 
Mean  
(SD) 
Post-use A1 
Mean  
(SD) 
Final A2 
Mean  
(SD) 
A1 – A0 
Mean  
(SD) 
A2 – A0 
Mean  
(SD) 
A2 – A1 
Mean  
(SD) 
 
FM-UE 
 
28.5 
(9.8) 
31.1 
(8.9) 
31.2 
(8.7) 
2.5 
(3.4) 
2.6 
(5.0) 
0.1 
(2.9) 
 
ARAT 
 
26.4 
(19.9) 
30.2 
(18.9) 
31.1 
(20.1) 
3.8 
(3.9) 
4.7 
(6.1) 
0.9 
(3.9) 
 
CAHAI 
 
48.8 
(21.7) 
55.3 
(20.1) 
58.8 
(18.8) 
6.6 
(4.7) 
10 
(9.5) 
3.4 
(5.8) 
 
ABILHAND 
 
18.2 
(9.3) 
22.5 
(10.1) 
23.8 
(8.9) 
4.3 
(5.5) 
5.6 
(5.3) 
1.3 
(3.2) 
 
Total MAS 
 
11.0 
(5.0) 
9.1 
(4.7) 
8.5 
(4.5) 
- 1.9 
(1.5) 
- 2.5 
(2.6) 
- 0.6 
(2.1) 
 
Total MRC 
 
36.2 
(4.6) 
39.1 
(1.3) 
39.6 
(1.5) 
2.9 
(4.2) 
3.4 
(4.4) 
0.5 
(1.2) 
 
 
 
  
  
  
 
     Table 16. Clinical outcome scores at three assessment points and change in scores (median and inter-quartile range) 
Outcome 
measure 
Baseline A0 
Median 
(IQR) 
Post-use A1 
Median 
(IQR) 
Final A2 
Median 
(IQR) 
A1 – A0 
Median 
(IQR) 
A2 – A0 
Median 
(IQR) 
A2 – A1 
Median 
(IQR) 
FM-UE 29 
(19.5 – 36.5) 
32 
(28.5 – 35.5) 
30 
(28 - 36) 
1 
(1.0 – 4.0) 
 
1 
(-1.0 – 4.5) 
 
 
0 
(-1.0 – 4.5) 
 
ARAT 23 
(9.5 – 44.5) 
31 
(16 – 46.5) 
33 
(11.5 - 49) 
3 
(1.0 – 4.0) 
 
4 
(1.0 – 5.5) 
 
 
0 
(-2.0 – 2.0) 
 
CAHAI 47.5 
(33.3 – 65.8) 
55 
(42.5 – 71.8) 
62 
(48.5 – 68.8) 
5.5 
(4.3 – 8.5) 
 
10 
(2.3 – 13.5) 
 
 
3 
(0 – 6.75) 
 
ABILHAND 17 
(11.5 – 24.5) 
24 
(16.5 - 31) 
22 
(18 – 31.5) 
3 
(1 - 5) 
 
5 
(1.0 – 8.5) 
 
 
0 
(-0.5 – 4.0) 
 
Total MAS 12 
(7.5 – 14.5) 
9.5 
(5.5 – 12.5) 
7.5 
(5.5 - 11) 
-1.5 
(-2.5 – -0.5) 
 
-2 
(-3.5 – -1) 
 
 
-1 
(-2.0 – -1.0) 
 
Total MRC 38 
(34.5 – 39.3) 
40 
(38.5 - 40) 
40 
(40 - 40) 
2 
(0 – 3.25) 
 
2 
(1.0 - 4) 
 
 
0 
(0 – 1.0) 
 
 
 
  
  
  
 
 
      Table 17. Statistical significance values for the clinical outcome measures 
 
Outcome 
measure 
 
Significance 
A0A1A2 
Significance 
A0A1 
Significance 
A0A2 
Significance 
A1A2 
 
FM-UE 
 
0.028 0.009 0.094 0.964 
 
ARAT 
 
0.000 0.001 0.007 0.306 
 
CAHAI 
 
0.000 0.001 0.002 0.050 
 
ABILHAND 
 
0.000 0.004 0.001 0.154 
 
Total MAS 
 
0.000 0.001 0.004 0.344 
 
Total MRC 
 
0.000 0.011 0.005 0.202 
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5.3 Grouping of participants 
The inter-quartile ranges for the kinematic and clinical scores suggest 
a wide distribution of values. Therefore to perform further analysis of the 
data, the participants were divided into three groups based on the magnitude 
of the observed changes in relation to the Minimal Clinically Important 
Difference (MCID) values of the clinical measures and the uniformity of the 
changes across the different clinical measures. The criteria used to 
categorise the participants are shown below in Table 18 (MCID values FM 7; 
ARAT 6; CAHAI 7 and ABILHAND 5). Kinematic variables were not 
considered for the categorisation, as the MCID values for kinematic variables 
are not yet established.  
 
Table 18. Categorisation of participants based on changes in scores 
Group 
 
Criteria Participant ID number (n) 
I MCID changes in all clinical 
measures FM, ARAT, CAHAI 
and ABILHAND 
8,10 and 13 
 
3 
II MCID change in at least one of 
the clinical measures FM, 
ARAT, CAHAI or ABILHAND 
1, 2, 3, 9, 11, 14, 18 and 19 
 
8 
III MCID change in none of the 
clinical measures FM, ARAT, 
CAHAI or ABILHAND 
4, 6, 16 and 17 
 
4 
 
 
The rationale for grouping of participants was three-fold: one, to 
identify the participants (Group I) about whom one could be reasonably 
confident that they had improved clinically in functional ability; two, to analyse 
whether the kinematic variables follow the same trends as observed with 
clinical outcomes within these three groups i.e., best improvement in Group I, 
moderate improvement in Group II and mild or no improvement in Group III; 
and three, whether there are any trends within the four individual clinical 
outcomes in terms of their responsiveness.  
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5.3.1 Kinematic variables 
5.3.1.1 Movement time 
The median movement time at A1 decreased more in Group I as 
compared to Group II, whereas it was increased in Group III (Table 19 and 
Figure 26).  
 
Table 19. Movement time scores (median and IQR) in each group 
Mov. Time  
(Far reach) 
(sec) 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 0.79 0.67 - 1.18 0.5 0.48 - 0.54 0.45 0.43 - 0.52 
Group II 0.5 0.49 - 0.55 0.38 0.35 - 0.42 0.42 0.38 - 0.46 
Group III 0.49 0.45 - 0.56 0.57 0.42 - 0.76 0.54 0.44 - 0.63 
 
  
Figure 26. Movement time scores (median and IQR) in each group 
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5.3.1.2 Path length  
The path length had decreased in both Groups I and II by a similar 
extent, whereas it had increased in Group III (Table 20 and Figure 27).  
 
Table 20. Path length scores (median and IQR) in each group 
Path length  
(Far reach) 
(mm) 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 190 
169.0- 
255.8 155.95 
154.5- 
170.3 165.95 
157.8- 
178.8 
Group II 184 
150.1- 
218.4 141.03 
131.2- 
169.5 152.67 
137.0-  
180.9 
Group III 166.2 
143.6- 
192.0 186.59 
168.2- 
 216.0 170.91 
157.9- 
176.3 
 
Figure 27. Path length scores (median and IQR) in each group 
 
 
 
  
 
- 134 -    
5.3.1.3 Normalised Jerk 
The median jerk had decreased most in Group I followed by Group II 
and there was slight increase in Group III, keeping with the trend observed in 
movement time and path length  (Table 21 and Figure 28).  
 
Table 21. Jerk scores (median and IQR) in each group 
Jerk  
Far reach 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 601.58 
490.3 - 
770.5 391.79 
385.4 - 
421.3 391.3 
377.5 - 
391.9 
Group II 350.21 
310.0 - 
398 297.75 
284.1 - 
399.8 364.84 
260.3 - 
396.5 
Group III 488.43 
486.8 - 
528.8 499.28 
412.1 - 
563.1 335.84 
320.0 - 
383.9 
 
 
Figure 28. Jerk scores (median and IQR) in each group 
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5.3.2 Clinical outcome measurements 
5.3.2.1 Fugl Meyer – Upper Extremity (motor)  
The median and inter-quartile range of the FM - UE (motor) score for 
each group at the A0, A1 and A2 assessments is shown in Table 22 and 
Figure 29. Group I showed an improvement of 9 points at A1 and further 
improvement by 3 points between A1 and A2. Groups II and III showed only 
marginal increase of 1.5 points at A1.  
 
Table 22. FM-UE scores (median and IQR) in each group 
FM - UE 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 19 18.5 - 19.5 28 26.0 - 28.5 31 29.5 - 31.5 
Group II 31 25.5 - 36.2 32.5 26.7 - 35.2 30 26.0 - 34.5 
Group III 33.5 29.5 - 38.5 35 31.2 - 39.5 35 28.7 - 41.7 
 
Figure 29. FM-UE scores (median and IQR) in each group 
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5.3.2.2 Action Research Arm Test  
The median ARAT score for Group I showed an improvement of 10 
points at A1 and further improvement of 8 points between A1 and A2 (Table 
23 and Figure 30). The improvements in Groups II and III at A1 were only 3 
and 2 points, respectively, and were similar to the trends seen with the FM-
UE scores. 
 
Table 23. ARAT scores (median and IQR) in each group 
ARAT 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 9 7.0 – 16.0 19 13.5 – 28.0 27 19.5 - 33.5 
Group II 33 8.0 - 48.2 36 14.7 - 51.5 40 9.5 - 51.7 
Group III 31 18.0 - 45.2 33 21.5 - 45.5 34 20.0 - 46.7 
 
 
Figure 30. ARAT scores (median and IQR) in each group 
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5.3.2.3 Chedoke Arm and Hand Activity Inventory 
The median CAHAI score for Group I showed an improvement of 12 
points at A1 and further improvement of 10 points between A1 and A2  
(Table 24 and Figure 31). Group II score improved by 7 points at A1 and a 
further 7 points between A1 and A2. This trend for Group II was not observed 
with FM-UE and ARAT scores. This suggests the higher responsiveness of 
CAHAI when compared to FM-UE and ARAT in this study. Group III showed 
an improvement of 5 points at A1 and a drop of 5 points between A1 and A2. 
This trend is similar to the trends seen in kinematic variables (movement 
time, path length and jerk) for Group III. This suggests the CAHAI score 
matches the trend seen in kinematic measurements better than FM-UE and 
ARAT.  
Table 24. CAHAI scores (median and IQR) in each group 
CAHAI 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 32.0 28 - 38 44.0 43 - 47.5 54.0 53.5 - 56.5 
Group II 52.5 39.2 - 61.7 59.5 45.5 - 69 66.5 46.7 - 71.2 
Group III 69.0 46 - 73.5 74.0 51 - 76.5 69.0 46 - 74 
 
Figure 31. CAHAI scores (median and IQR) in each group 
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5.3.2.4 ABILHAND 
The median ABILHAND score for Group I showed an improvement of 
11 points at A1 (Table 25 and Figure 32). Group II also showed a 
considerable improvement of 5 points at A1. This trend is similar to CAHAI 
and unlike the trends with FM-UE and ARAT scores. The improvement in 
Group III was only a marginal 2 points at A1. This suggested ABILHAND 
behaved similar to CAHAI in changes between A0 and A1. The two scores 
ABILHAND and CAHAI however showed divergent trends in changes 
between A1 and A2.  
Table 25. ABILHAND scores (median and IQR) in each group 
ABILH 
AND 
A0 A1 A2 
Median IQR Median IQR Median IQR 
Group I 13.0 
12.0 –  
15.0 24.0 
19.5 - 
28.5 22.0 
21.0 –  
27.5 
Group II 16.5 
7.0 - 
23.0 21.5 
11.25 – 
28.0 22.0 
12.75 - 
31.0 
Group III 26.0 
19.5 – 
32.0 28.0 
21.25 - 
34.5 26.5 
21.0 –  
32.0 
 
Figure 32. ABILHAND scores (Median and IQR) in each group 
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5.4 Relationships between variables and outcomes 
The multiple regression analysis, using the independent variables of 
age, time since stroke, device usage time and baseline scores, and 
dependent variable of change in scores, revealed no significant predictive 
relationships for age, time since stroke and device usage time. The baseline 
clinical scores (ABILHAND logit scores), particularly the A0 scores for far 
reach task, seem to be the only variable which approached significance 
levels for predictive relationship with change in scores (Pearson coefficient 
exceeding 0.50 and significance value of 0.058). The output of regression 
analysis is summarised in Table 26. 
 
Table 26. Regression analysis between variables and outcomes 
 Pearson correlations 
Multiple regression 
coefficients - Significance 
 
A1 
MT-near 
change 
A1 
MT-far 
change 
A1 
ABILH. 
change 
A1 
MT-near 
change 
A1 
MT-far 
change 
A1 
ABILH. 
change 
Age 
 
0.30 0.01 0.36 0.13 0.62 0.62 
Time since 
stroke 
0.37 0.25 0.27 0.24 0.81 0.55 
Device usage 
 
- 0.11 - 0.03 0.46 0.47 0.34 0.98 
A0 MT-near 
 
- 0.43 n/a n/a 0.19 n/a n/a 
A0 MT-far 
 
n/a 0.36 n/a n/a 0.82 n/a 
A0 ABILH. 
 
n/a n/a - 0.50 n/a n/a 0.06 
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5.5 Discussion 
The feasibility study recruited 19 participants, of which 17 participants 
completed the 8 weeks of hCAAR home use. Two participants could not use 
the device and dropped out of the study: one of them did not have the 
minimal active movement required to move the joystick: and the other 
participant could not accommodate the device at home. This highlights that 
the most important prerequisites to use hCAAR are having a minimum 
voluntary movement in the upper limb and having a home environment 
suitable for device installation.  
The FM-UE score can be used to predict the participant’s ability to use 
hCAAR. The participant with an FM-UE score of 6/66 could not complete the 
computer tasks even with full assistance and hence had to drop out of the 
study. The range of FM-UE scores for the seventeen participants who 
completed the home use of hCAAR was 12 – 43. The participant with lowest 
FM-UE score in this group (12/66) was able to use the device. A FM-UE 
score of 12 could, therefore, be reasonably considered as the minimum score 
to be able to use hCAAR. This, however, cannot be considered as the 
definite minimum score for usability as there were no participants with a 
baseline FM-UE score between 6/66 and 12/66 in this study. The participant 
with FM-UE score of 6/66 had an ARAT score of 0 and CAHAI score of 16. 
The ARAT score of 0 emphasises the floor effect of this outcome measure 
and indicates that it cannot be used to screen participants for hCAAR use. 
There were no serious adverse events during the study. One participant 
injured a finger of his unaffected hand while trying to open his spastic fingers 
to hold the joystick handle. Training on gradual hand opening and spasticity 
management (a botulinum injection) enabled this participant to successfully 
use the device. Two participants developed shoulder pain, and another wrist 
pain that were deemed to be related to device usage. The rest of the clinical 
events listed in Table 11 are unrelated to device usage. Rest, avoiding the 
painful range of movement and optimising the position of the trunk and upper 
limb proved to be successful approaches to manage these symptoms. These 
events suggest the need for periodic clinical review during hCAAR use. 
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The changes in outcome scores seen in this study are comparable to 
those seen in previous robot studies. The mean improvement in FM-UE 
score in this study was 2.5 points; this change is similar to changes ranging 
from 2.8 to 5.3 that have been reported in previous robot studies [56, 59, 66, 
77, 81, 272]. The median improvement in ARAT score in the hCAAR study 
was 3 points; this is less when compared to a 9 point change in median 
improvement reported in one previous HapticMaster robot study [88]. The 
mean ABILHAND logit score improved by 0.56 in the hCAAR study, that is 
higher when compared to the observed change of 0.25 logits in one robot 
study involving Bi-Manu-Track device [66]. There was a 19% reduction in 
mean movement time in the hCAAR study whereas a 35% reduction in mean 
movement time was observed in a group of participants with chronic stroke in 
a BFIAMT robot study [81].  
The changes in spasticity and strength are also similar to other robot 
studies. The median total MAS scored showed a reduction of 1.5 points at 
post-use assessment A1. Similar reductions in spasticity scores has been 
observed in previous Bi-Manu-Track and BFIAMT robot studies [64, 81]. 
Whether the reduction of spasticity helps in improving movement and 
functional ability is unknown and cannot be inferred from these studies. 
Muscle strength measured using the total MRC showed a 2-point increase in 
median score A1 that was maintained at A2. A previous study using MIT-
Manus showed an increase of 5 points in total MRC score and a study with 
Bi-Manu-Track showed an improvement by 20 points [56, 64]. However, 
these studies however involved subjects in the subacute recovery stage. The 
only study involving chronic subjects showed an average change of 0.4 
points per muscle group [66]. Some authors have observed that the 
improvement in muscle strength with robot therapy does not necessarily 
correlate to gains in functional ability [70, 273]. 
There was a statistically significant (p<0.05) improvement in the mean 
clinical outcome scores at A1 and this improvement was retained at final 
assessment A2, one month after using the device. The improvements, 
however, did not reach clinical significance (observed gains at A1 were below 
the MCID values for the outcomes: 1 point in FM-UE; 3 points in ARAT; 5.5 
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points in CAHAI; and 3 points in ABILHAND). This was not the case when 
individual participant results were analysed. Some participants did show 
clinically significant improvements in their scores. This prompted a grouping 
of the participants based on change in scores in relation to MCID values of 
the clinical outcomes.  
Participants were considered in three groups. A group of three 
participants (Group I) had achieved clinically significant improvement in all 
the four clinical scores FM-UE, ARAT, CAHAI and ABILHAND. This suggests 
that these three participants had a level of improved upper limb function that 
was noticeable to them. This was confirmed in the qualitative interviews 
described in the next Chapter (Chapter 6). In another group of eight 
participants (Group II), the improvements reached clinical significance in 
some but not all four clinical outcomes. The disparity in the changes in the 
outcomes can be due to two reasons: the outcome measures have different 
psychometric properties (particularly responsiveness); and they represent 
different ICF domains. The chances that all nine of these participants would 
have noticeable improvements in function is less likely than for group I 
participants. The third group of four participants (Group III) did not 
demonstrate clinically significant improvements in any of the outcomes. One 
would assume that none of these four participants would have noticeable 
change in upper limb function. This was confirmed in the user qualitative 
interviews described in the next Chapter (Chapter 6).  
Previous studies have also demonstrated that not all participants in 
any robot study experience similar responses to the intervention [60, 80]. In 
the GENTLE robot study, a group of seven out of the 20 chronic stroke 
participants showed clinically significant improvement across all outcome 
measures [80]. The reason for using MCID values to categorise participants 
in the hCAAR study was to be certain about the interpretation of the clinical 
improvements. Interestingly, the group of three participants in this (hCAAR) 
study who showed clinically significant improvements in the four clinical 
outcomes, FM-UE, ARAT, CAHAI and ABILHAND, also reported significant 
changes in their upper limb function in the user-feedback interviews. 
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The kinematic scores also showed statistically significant improvement 
in movement time and path length scores at A1 (p<0.05). When kinematic 
measurements at the three assessment points for the three groups were 
plotted, the following was observed:  Group I had steep upward slopes 
indicating larger improvement; Group II had less steep upward slopes 
suggesting smaller improvement; and Group III showed flat or downward 
slopes suggesting no improvement or deterioration respectively. This suggest 
the kinematic measurements responded in similar fashion to clinical outcome 
measures in this study. 
The device seemed to be most suitable for individuals with moderate 
arm weakness. This median baseline FM-UE score of participants was 29 
(range 12-43). The individuals with severe weakness might not be best suited 
to use the device as suggested by the one drop-out from the study (with an 
FM-UE of 6/66). Participants with mild weakness might not find the device 
useful as they need to practice complex three-dimensional functional 
movements, which hCAAR is unable to provide.  
Among the participants with moderate weakness, the ones with lower 
baselines scores seem to have better gains from device use. The median 
baseline FM-UE score was lowest in group I (19 points) and this group 
showed better gains than other two groups II (baseline FM-UE 31 points) and 
III (baseline FM-UE 33.5 points). This trend was also observed with ARAT, 
CAHAI, ABILHAND and kinematic measurements. This is also supported by 
the regression analysis that showed that A0 baseline ABILHAND logit score 
was the only variable to approach predictive significant relationship (p = 0.06) 
with change in score value (A1-A0). This finding is supported by some other 
robot trials where individuals with moderate impairments (score of 15 – 40 on 
FM-UE score) improved more than those with severe weakness of the upper 
limb [52, 60, 80, 111, 261, 272, 274].  
There was a lack of a significant predictive relationship between time 
since stroke and the improvement in outcomes. The mean time since stroke 
for Group I participants (who had the greatest clinical improvement) was 11.8 
months. It is an encouraging finding that hCAAR therapy can lead to clinically 
significant improvements in individuals in the chronic stages after stroke. It 
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was difficult to compare the effect of hCAAR between subacute and chronic 
stages after stroke as most of the participants in the study were in the chronic 
stage. There were only four participants who were in the sub-acute stage 
(within 6 months post-stroke) and their outcome varied: only one was in 
Group I (best clinical improvement); two were in Group II (some clinical 
improvement); and one in Group III (no clinical improvement). A similar 
finding has also been observed in a larger study involving 38 chronic stroke 
participants who used the ARMin robot for 8 weeks [70]. The authors of the 
ARMin trial performed a post-hoc analysis stratified by age, hand dominance 
and time since stroke and did not find any significant relationships between 
these variables and the gains.  
The hCAAR study did not reveal the expected dose-response 
relationship. There was no significant correlation between device usage time 
and the gains observed. None of the previous robot studies was able to 
stratify data based on device usage as all the studies were based in hospitals 
or research centres with all participants receiving the same duration of robot 
therapy. This dose-response relationship needs to be explored in future 
studies. It is difficult to standardise the usage in a minimally supervised home 
environment, where the user is in charge of the usage time. However a 
minimum usage time can be recommended in future studies. 
The usage time in the hCAAR study was considerably lower than that 
of most previous robot studies. The mean usage of hCAAR in this study was 
520 min (range 12 min – 1468 min) during the 8-week period. This is lower 
than the usage time reported in other studies, which involved usage time of 
900 to 2160 min spread over 4 – 12 weeks [53, 70, 74, 79, 81]. It can be 
argued that hCAAR usage time might have been sub-therapeutic and that 
could explain why no dose-response relationship was seen. Previous robot 
studies have also identified that there is no advantage of robotic therapy at a 
low utilisation [80, 82, 118, 275]. One trial comprising 9 hours [540 min] of 
conventional functional retraining did not show any benefit in chronic stroke 
subjects with moderate upper limb impairment [275]. The study by Higgins et 
al. however, does not report whether a subgroup of participants showed 
improvement in upper limb function.  
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The improvements seen at A1 in this study are sustained at the 1-
month follow-up at A2. Previous robot studies suggest that improvement in 
chronic subjects is maintained for up to 3 months [64, 93, 276]. Robotic 
therapy in chronic stroke shows faster gains when compared to intensive 
conventional physiotherapy, but only while using the device and the gains 
become similar to intensive conventional physiotherapy in the long term (6 
months) [53, 70]. It is encouraging to find that the short- and long-term effects 
of robot therapy are similar to intensive conventional physiotherapy. The 
long-term retention effects of robot therapy beyond 6 months need to be 
further researched.  
5.6 Limitations 
There are some limitations to this feasibility study. Firstly, the small 
sample of participants limits the generalisation of the results on efficacy. The 
aim of the feasibility study was primarily to test whether the robot device 
could be used safely in a minimally supervised home setting. The efficacy 
data shows the potential for therapeutic effect in some participants and this 
needs to be explored in future hCAAR studies. 
All the participants were independently mobile with or without the use of 
walking aids. None of the participants was dependent on a wheelchair for 
mobility. None of them needed assistance with transferring to and sitting in 
the chair. It is difficult to predict whether participants needing assistance for 
chair transfers would use and accept hCAAR in their home setting unless this 
was tested in future studies.  
This study had a greater number of male than female participants (14:3) 
and greater number of middle aged than elderly participants. Only three 
participants were above 65 years of age and only one participant was above 
70 years of age. This limits the assumptions we could make on whether 
hCAAR would be equally usable by females and elderly people. However, 
this study included one female participant who was 81 years of age and who 
had never used a computer in her life before. She needed some supervision 
from family members to use hCAAR at first but became independent 
thereafter and completed the study with reasonable usage time in the 8-week 
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period (461 min). She became interested in computers during the course of 
the study and her family were considering getting her a computer for use in 
future. This example suggested that the device has the potential for use by 
elderly patients. 
This study lacked multiple baseline assessments to estimate ongoing 
natural recovery. From the spontaneous recovery studies reported by 
Duncan et al., we know that the recovery pattern tends to plateau after 3 or 6 
months, depending on the severity of the stroke [277].  In this study, most of 
the patients were in the chronic phase of recovery (mean time since stroke 
24.8 months; median 26 months) and there was a definite improvement in 
outcomes scores at A1 followed by a plateau or slight dip in improvement at 
A2. This improvement pattern suggests that the observed changes are due to 
hCAAR use in the intervention period and also suggests that with the aid of 
rehabilitation treatments, motor improvements can occur beyond the 6 
months post-stroke period.  
5.7 Conclusions 
The feasibility study has demonstrated that individuals with moderate 
upper limb weakness after stroke can safely use hCAAR in a home setting. 
The use of the device led to statistically significant improvements in kinematic 
and clinical outcomes. Three participants showed clinically significant 
improvements in all the four clinical outcomes FM-UE, ARAT, CAHAI and 
ABILHAND.  
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Chapter 6: User feedback from the hCAAR feasibility study 
6.1 Introduction 
The restorative rehabilitation assistive technology development process 
can be considered in four stages: Concept, Design, Testing and Deployment 
[246]. The concept stage starts with idea generation and includes technical, 
financial and commercial assessment [101] [246]. The design stage involves 
product development from (re) design to prototype development. The testing 
stage starts with prototype testing in house and includes studies in the real 
field. The deployment stage includes product marketing, launch and use in 
the real field [101] [246]. The concept and design stages of hCAAR were 
considered in Chapter 3. This chapter deals with the testing stage of hCAAR. 
A brief summary of the user involvement methods already described in detail 
in Chapter 3 is summarised in this section. 
There are a variety of direct and indirect methods used to involve 
users throughout the device development process. The methods, which can 
particularly be used in the testing stage are user discussion, interviews and 
usability tests [246]. There are no sufficiently detailed models so far 
described in user-centred design literature that describe which aspects of 
user requirement need to be covered in these user involvement methods.   
One framework that is commonly used in health sciences to 
understand and more fully capture the different aspects of any health 
condition is the World Health Organization’s ICF. The ICF classifies health 
condition into domains of body structure/functions, activities, participation, 
personal and environmental factors related to the individual [11]. This 
framework is internationally accepted and used extensively in research. 
Researchers have developed disease-specific ICF Core Sets for specific 
health conditions such as rheumatoid arthritis, multiple sclerosis and stroke. 
The Comprehensive ICF Core Set categories for stroke put forward by an 
international consensus group is widely used in stroke related research [252].  
This chapter will describe the user feedback from testing stage of 
hCAAR i.e, the feasibility study in the home setting. We have also 
investigated the usefulness of the stroke-specific Comprehensive ICF Core 
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Set to guide researchers in capture user feedback in the testing stage of 
device development.  
The aims of the hCAAR user-centred design process in the feasibility 
study (testing stage of device development) described in this chapter are: 
1) To obtain feedback on hCAAR usability and efficacy from end-users 
involved in the feasibility study and healthcare professionals  
2) To investigate whether the ICF framework can be used as a template to 
obtain user feedback in the testing stage of technology development.  
6.2 Methods  
6.2.1 Sample  
Seventeen participants from the feasibility study (end-users) provided 
feedback on hCAAR. The two participants who did not complete the home 
use of the device were not included in the feedback process. One of them 
had inadequate voluntary movement in her upper limb and the other felt there 
was no adequate space at home for the device. These two participants chose 
to drop out from the study. 
One neuro-physiotherapist (professional user) from the community 
stroke rehabilitation team agreed to provide feedback. This was the only 
therapist involved in providing treatment (usual treatment) to three 
participants enrolled in the study. Therefore only one therapist could be 
involved in the feedback process. The recruitment and consent process is as 
described in chapter 3.   
6.2.2 Stage I. Interview process 
All participants were offered a mutually convenient time to attend for 
face-to-face interviews with the researcher MS. The aim of interviews was to 
understand users’ experience of using or observing the usage of hCAAR, 
and obtain users’ perspectives and suggestions on the future development of 
the technology. The research team initially identified the broad interview 
topics by brainstorming ideas and discussion in research team meetings. The 
topics were based on previous experiences of the user-centred design 
process [103, 253] and existing literature on the development of assistive 
  
 
- 149 -    
technology for upper limb rehabilitation [254, 255]. The interviews comprised 
of predominantly open-ended questions based on the checklist of topics 
prepared by the research team. The interviews allowed the discussion to 
deviate from these topics to those that were identified by users based on 
their experience of using the technology. The interviews were recorded in 
writing by the researcher MS.  
The checklists used in the end-user group interviews and the 
professional user interview are described in Appendix E and Appendix F. The 
topics covered included device hardware, device software, exercises, effects 
on upper limb movement and activities, personal views and views of family 
members and professionals involved in the participants’ care. The researcher 
MS was blinded to the changes in clinical outcome measures while 
conducting these interviews at the A1 assessment. Researcher SM was 
performing the clinical outcome measures during the same appointment.  
6.2.3 Stage II. Extracting interview concepts 
 
The identification of meaningful concepts within outcome measure 
items and their responses, and the linking of the concepts to most precise 
ICF categories were initially published in 2002 [256] and later updated in 
2005 [257]. Meaningful “concepts” are those that describe the health 
condition, person, functional activity or any of the personal or environmental 
factors. For example, consider the statement/item “Pain doesn’t prevent me 
from walking any distance”. Two different meaningful concepts can be 
identified in this statement, “pain” and “walking”.  
Meaningful concepts referring to “quality of life” are assigned “Not 
definable - quality of life”. If a meaningful concept is not contained in the ICF 
and is clearly a personal factor, it is assigned “personal factor”. If a 
meaningful concept is not contained in ICF and is not a personal factor, it is 
assigned “not covered”. If the meaningful concept refers to a diagnosis or a 
health condition, it is assigned “health condition” [257].  
Meaningful concepts were extracted from the hCCAR testing stage 
interview topic questions and responses based on the above ICF linking 
rules. 
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6.2.4 Stage III. Matching interview concepts to ICF Core Set  
The meaningful concepts extracted from the semi-structured 
interviews were matched to the categories within the Comprehensive ICF  
Core Set for stroke [252]. The Core Set has 130 categories in total, which 
comprise of 46 categories from the body function and structure domain, 51 
categories from activities and participation domain and 33 from the 
environmental factors domain [252]. The personal factors domain has no 
categories as yet. 
The process of extracting interview concepts and matching them to 
ICF categories can be illustrated with the following example from our 
interviews. 
a) The participants were asked “Comment on the arm exercises or 
therapy delivered by the device” One meaningful concept that can be 
extracted from the question – “arm exercises”. 
b) A sample end-user response was “The hand was closed while 
performing reaching movements which is not in keeping with exercises 
suggested by the physiotherapists”. A sample professional user response 
was “The device has the ability to provide repetitive movement, engage 
person and motivate”. The meaningful concepts that can be extracted from 
the above two responses are – “hand movements”, “reaching movements”, 
“physiotherapist suggestion”, “repetition”, “engagement” and “motivation”. 
c) The extracted concepts are linked to one or more of the 
Comprehensive ICF Core Set categories, which convey the same meaning: 
Arm exercises – d210, d220 (Undertaking simple/ multiple tasks)  
Hand movements – d440, d445 (Fine hand use, hand and arm use) 
Reaching movement – d210 (Undertaking simple task) 
Physiotherapist suggestion – e455 (views of professionals) 
Repetition/ Practice – Not covered  
Engagement – b140 (Attention function) 
Motivation – Personal factor  
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6.2.5 Stage IV. Comparing participant feedback with outcome 
measure changes 
The user perspectives of the impact of intervention were subsequently 
matched to the clinical outcome measures to observe for any relationship 
between them.  
6.3 Results 
6.3.1 Stage I. Interview results 
The interview topic results were grouped as comments made by the 
end-user group and those made by the healthcare professional. Similar 
comments made by more than one individual are reported in the third person 
in this Chapter. Individual comments are reported as direct quotes (using 
quotation marks and italics).  
6.3.1.1 Hardware 
6.3.1.1.1 End-user group 
Sixteen participants were satisfied with the footprint and 
transportability of the device and felt it did not take up too much space in their 
homes. One participant felt the device took up too much space at home. 
“If the device was smaller it could be easily moved from one room to 
another within the house” 
“The device took up considerable space in our small kitchen and 
needs to be smaller than its current size” 
All participants were satisfied with the external look and manufacture 
of the device. 
“My three dogs have chewed away cables of devices in the past, but 
this device was placed in the corner and there were no exposed 
cables, so there were no particular problems.”  
Ten participants had the device installed in their living room, four in the 
bedroom (first floor), two in the dining room and one in the conservatory. 
Thirteen participants used their dining chairs to sit on while using 
hCAAR. Four participants did not have suitable chairs in their homes and 
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were provided with standard straight-back chairs from our research 
laboratory along with the device. 
“I used a dinner chair to start with but was not comfortable and 
changed it to a bar chair and found it better.” 
“I kept leaning forwards while using the device. Could there be an 
option of having a “seat belt” to minimise trunk movement?”  
“The position and angle of the arm should be similar each time the 
device is used and hence the chair could be made part of the system. 
The chair could be set-up in a standard position each time its used.” 
Fourteen participants did not experience any difficulties with the 
device joystick. Two participants had problems with noisy joysticks that 
needed to be replaced during the study. 
“My hand kept slipping from the joystick. May be having a strap to hold 
the hand in place while holding the joystick could be tried?” 
6.3.1.1.2 Professional user 
“I am impressed with this device. I am not sure whether the device 
could be made smaller, as one of the users found the device took up 
considerable space in his kitchen. This participant was also leaning 
forward while using the joystick. He needed constant reminding to sit 
in the recommended position while using the device. There must be 
clear instructions for users that the individual needs to sit with the back 
against the backrest of the chair and the arm should be in the normal 
resting position by the side of the body” 
6.3.1.2 Software 
6.3.1.2.1 End-user group 
Fourteen participants were satisfied with the assistance levels set for 
the hCAAR joystick. Of these, three participants felt the assistance provided 
by the joystick was not noticeable and felt their arms were actively performing 
most of the movements on their own while playing the games. Three 
participants felt the assistance was insufficient for their abilities and arm 
power. 
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“The assistance is the key concept of the device to help people with 
greater disability”  
Twelve participants liked the score display idea and felt the display of 
scores after each game helped them keep track of their previous scores and 
motivated them to try to better their previous scores. Five participants 
reported they did not pay much attention to their previous performance 
scores. 
“I wonder whether the device could display graphs to show my 
performance over a time period.”  
Twelve participants felt some of the games became repetitive and less 
interesting after a while. They felt their usage would have been better if the 
device had more interesting games. Three participants liked the concept of 
the levels becoming progressively harder as that kept them interested in 
using the device. Three participants suggested developing games based on 
sport such as football or golf.  
“I liked the puzzle and chase game in particular as the higher levels 
were interesting and complex.” 
“I liked the concept of the levels progressively becoming harder.” 
“The current games are pretty mind numbing. They need to be 
developed further.”  
“The graphics in the van game were all right but rest of the games 
were very basic.”  
“I would suggest games based on tennis and space invaders could be 
tried.”  
“Games based on shopping baskets and crossword puzzles would be 
nice.”  
“I did not like the river game and the loop game. The chase and puzzle 
games were okay.” 
“I liked the chase and puzzle games as they had graphics (crocodile, 
monkey) and interesting levels. I did not like other games as they 
lacked speed and challenge.” 
“The van game was complex and I found releasing the banana (and 
avoiding the flame at the same time) difficult.” 
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“A game based on crosswords would be good.” 
Six participants had problems with joystick calibration/initialising and 
required additional training by the research team.  
6.3.1.2.2 Professional user 
“The concept of telerehabilitation could be developed which would 
help communication with the user, monitor progress and make users 
aware of their progress. This could also enable remote monitoring of 
the user’s position while using the device. Unsupervised exercise in 
some individuals might lead to unhelpful patterns.” 
6.3.1.3 Therapy/Exercises 
6.3.1.3.1 End-user group 
All participants liked the concept of therapy based on computer 
games. Four participants had suggestions for future versions of the device. 
“The joystick promotes arm movement only in few directions. I wonder 
whether there could be more movements, like the arm going round”  
“The movements generated are restricted to a single plane. The hand 
is closed while performing reaching movements, this is not in keeping 
with the exercises suggested by the physiotherapists. They teach that 
the hand needs to be open while reaching the target.” 
“Good for certain movements like moving sideways and forwards. 
Could further developments include the joystick moving in other 
directions, and could hand and finger movement could be included?”  
“I wondered whether the arm activity would stimulate brain areas 
controlling speech”  
6.3.1.3.2 Professional user 
“The device has the ability to provide repetitive movements, engage 
the user, motivate the user and measure performance which is good. 
It does not replicate all required movements. Ideally, one would expect 
to work on hand opening and closing while performing reaching 
movements. The concept of bimanual involvement is good to see.”  
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6.3.1.4 Impact on arm movement and function 
6.3.1.4.1 End-user group 
As a result of using the device during the 8-week study period, five 
participants felt there was an improvement in power and movement ability in 
their affected arms. The remaining 12 participants did not notice any 
improvement in arm power and ability. 
“My hand is opening more and gripping things better.” 
“I feel more confident in moving the affected arm.” 
“I am generally more aware of my weak arm now.” 
All five participants who noticed improved power in their arms reported 
that they were using the affected arm more in daily activities and there was 
an improvement in functional ability in everyday tasks 
“I am zipping up my coat using both hands, which I could not do 
before.”  
“I am using the weak arm more in daily activities including washing up, 
peeling potatoes, carrying things, squeezing toothpaste, etc.”  
Four participants felt their affected arm was less stiff since using 
hCAAR.  
Two participants reported improvements in mood since they started 
using the device.  
“The device gave me a sense of purpose in life, something I looked 
forward to every day when I got up.”  
6.3.1.4.2 Professional user 
“I was involved with three patients using the device but our 
(community stroke team) follow-up finished before the end of the 
hCAAR pilot study, so I never got to formally assess the response 
specific to the hCAAR therapy. I know one participant was definitely 
getting better and benefited from having the device at home.” 
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6.3.1.5 Individual perception 
6.3.1.5.1 End-user group 
All participants liked the concept and purpose of the device.  
“This is a very good device.” 
“I would have benefited more if I had used it more frequently and my 
shoulder pain had not restricted usage of the device.” 
“Multi-player modes would be more engaging to people.”  
“It (the device) is interesting and motivates me to do more exercises at 
home.” 
“I had some initial problems with understanding the technology but 
once I got into routine use (of the device), it became easy to use.”  
“I got bored using the device. Going to the gym suits me more as I 
meet other friends and do a variety of exercises.” 
“I am motivated as a result of using this device to do more exercises.”  
“This is a good idea to encourage (arm) movement.” 
Twelve participants felt the games need to be made more interesting 
and challenging to increase the device usage. Three participants suggested 
the device was more suited for individuals with greater weakness in their 
arms than theirs. Two participants commented they were motivated to use 
the device as they were participating in a research study.  
“Please put my name down for future studies involving such devices.”   
“I appreciate the efforts put in by you all (researchers) in designing the 
device.”  
Three participants suggested the device should be used in the early 
period after stroke. Two participants felt the device motivated them to do 
more exercises at home. Two participants felt they could not use the device 
as much as they wanted due to various reasons (such as illness and 
personal problems). These participants felt they would have derived greater 
benefit had they used the device more. Two participants were interested in 
buying the device if it were available commercially. Three participants 
commented that they would be interested in buying the device provided the 
games were improved.   
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Four participants felt the device could be used in stroke centres. Two 
participants would like to use the device in multi-player settings in community 
centres whereas all other 15 participants preferred to use the device on their 
own in a home setting. Two participants commented they would be more 
comfortable using it with people who had similar disabilities rather than 
playing in front of non-disabled people.  
6.3.1.5.2 Professional user 
“The device provides independence to the individual to engage in 
therapy and can be used in addition to hands-on therapy from a 
therapist. For the future research study, there could be two arms of a 
controlled study - hCAAR + standard physiotherapy versus standard 
physiotherapy in a larger sample of users with appropriate outcome 
measures.” 
6.3.1.6 Family and therapist perception 
Family members (wives/partners/sons/daughters) of seven 
participants expressed their satisfaction with the device and felt the device 
had been very useful to the participants.  
“It is a brilliant concept for arm exercises.”  
“The device could improve thinking as well.”  
“It is a good concept for encouraging arm movement.” 
“Such devices should be available early after stroke.” 
“His arm movement has improved and he uses the arm more in 
everyday activities. The device has given him hope and kept him 
occupied at home. He used to get easily get frustrated with the lack of 
therapy particularly lack of speech and language therapy. The device 
might be good for his brain activity as well.”  
“I liked the idea of this device.  He is moving his arm better than 
before. We are interested in buying such a device if available on the 
market.” 
“His arm feels less tight now since using the device. I massage the 
arm on a regular basis and can tell the difference. I feel the device 
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increases ones independence and is good for brain function and 
thinking ability.” 
“The device has helped improve his arm movement and has kept him 
occupied. The device provides the option of doing exercise at home 
whenever he wants to do exercise. He doesn’t need to depend on a 
therapist.” 
“I am impressed with the device and feel the device could have had a 
better effect on his arm movement if he had used it more often. The 
device should be part of the physiotherapy program, particularly early 
after stroke. The warm-up and assessment exercises could be quicker 
or bypassed so that one could start using the games straight after 
logging in to the device. I would suggest improving the games in future 
like: car around a track, electric loop buzzer game, horse racing with 
jumping (grand national), hurdle racing, archery target, basketball 
shooting, demolition game (blow things up, crane with ball), paintball 
game (good for colours), fox hunt (chasing through woods, etc), boats 
on water, battleships.” 
“The login procedure needs to be made simple so that the person can 
go straight to games after switching on the computer. Games could be 
based on word formation from letters.” 
“The device has good potential and would have made a big difference 
to him if it had been available early after stroke. Our close friends have 
liked the device and the concept.”  
“We have noticed him using the arm more towards the end of the 
study period.” 
“My private therapist was satisfied with the movements being 
performed while using the device and encouraged me to use the 
device as much as possible. He suggested that any movement is good 
movement after a stroke.” 
“The device took up significant space in the kitchen and we would not 
wish to have such a device at home in the future.”  
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6.3.2 Stage II. Extracting interview concepts 
Meaningful concepts extracted from each interview topic questions 
and responses/discussions with the end-users and the healthcare 
professional are listed in Table 27. Where there are duplication of concepts, 
they are listed only once in the table. 
 
Table 27. Meaningful concepts extracted from the interviews 
 
Interview topic Concepts emerging from discussions 
Hardware  Home setting, space, technology, computer use, 
personal view, assistance at home, comfort, hand 
grip 
Software Playing games, computer game, personal choice, 
engagement, motivation, telerehabiltation 
Exercises/ Therapy Upper limb exercises, duration and intensity of 
exercises, tolerance, reaching movement, hand 
grip/ movements, compliance, health service, 
sport 
Impact Arm movement, sensation, power, tone, spasticity, 
pain, functional activity, daily activities, cognition, 
mood, speech, language, performance at work, 
leisure interests, quality of life, personal goals, 
confidence, purpose in life  
Individual perception Knowledge, time after stroke, social skills, cost 
Family and therapist views Views of family members, views of professionals, 
Independence, frustration, effort 
 
6.3.3 Stage III. Matching interview concepts to the ICF Core Set 
for stroke 
Table 28 shows the concepts linked to the most relevant ICF Core Set 
category or categories. Eleven concepts were assigned to “personal factor”, 
one concept as “not covered” and one concept was assigned “not definable”. 
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Table 28. Interview concepts and matched ICF Core Set categories 
 
Interview concept ICF Core Set category 
Personal view Personal factor 
Geography e210 
Technology e115 
Comfort Personal factor 
Computer use e115 
Handgrip/hand movements d440, d445 
Assistance e340 
Body position d410 
Playing game d920 
Engagement b140 
Motivation Personal factor 
Telerehabilitation /health services e580 
Training/ practice Not covered 
Upper limb exercises  d210, d220 
Duration of exercises b180 
Intensity of exercises b740 
Tolerance Personal factor 
Reaching movement d210 
Compliance Personal factor 
Sport d920 
Arm movement  d210, d220 
Sensation b265, b270 
Power b730 
Tone/spasticity b735 
Pain b280 
Functional activity d210, d220 
Daily activity d230, d420, d430, d475, d510, d530, 
d540, d550, d630, d640 
Cognition b140, b144, b164 
Mood b152 
Speech b330 
Language b167 
Work/employment d845 
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Leisure interests d920 
Quality of life Not definable 
Personal goals Personal factor 
Confidence Personal factor 
Purpose in life Personal factor 
Knowledge b126 
Social relationships d750 
Views of family members e410 
Views of professionals e455 
Independence Personal factor 
Frustration Personal factor 
Effort Personal factor 
Cost/affordability e165 
 
6.3.4 Stage IV. Comparing participant feedback with objective 
outcome measure changes 
The changes in clinical outcome scores (reported in Chapter 5) for the 
five participants who reported significant change in their arm movement in 
their interviews were analysed. Three of these five participants belonged to 
Group I (clinically significant changes in all the four outcomes FM-UE, ARAT, 
CAHAI and ABILHAND). The other two participants belonged to Group II 
where some clinical outcomes improved by clinically significant levels. The 
other six participants of Group II (who had clinically significant improvement 
in some outcomes) did not report improvement in the user feedback 
interviews. The four participants of Group III (who did not have clinically 
significant improvement in any of the clinical outcomes) did not report any 
improvement in the feedback interviews. 
In their interviews, four participants had reported a reduction in arm 
stiffness after using the device. The total MAS score in each of these four 
participants showed a reduction by at least 2.5 points at A1. Conversely, 
there were two participants who showed considerable reduction in their total 
MAS score (2.5 points in one participant and 3.5 points in the other) but 
neither of them reported any noticeable reduction in arm stiffness in their 
interviews.  
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The two participants who reported improved mood while using the 
device were among the four participants who had used the device most 
during the feasibility study. One of these two participants did not show 
clinically significant improvement in any of the clinical outcomes and was 
categorised in to Group III (clinical significant change in none of the clinical 
outcomes). The other participant belonged to Group II and showed clinically 
significant changes in CAHAI and ABILHAND.  
Family members of seven participants reported an improvement in 
either the arm range of motion, power, stiffness, involvement in daily 
activities or functional ability. These participants included the five participants 
who had themselves reported improved arm movements in the interviews. 
The two remaining participants belonged to Group II where there was 
clinically significant improvement in some outcome measures.  
6.4 Discussion 
6.4.1 The hCAAR device feedback (testing stage) 
Only a few robot studies in the current literature report on patient and 
therapist impressions of the device in the study. This could be related to 
either restrictions on length of the publication or lack of user-centred design 
approach or separate publication on user feedback on the device. The 
reported measures in some studies are user satisfaction of device [74, 96, 
117], compliance [74], content of therapy [73, 117], functional impact [73, 87, 
96, 117] and therapist views [89]. The ACRE robot study reports on the 
actual design modifications made in the device based on user feedback from 
patients and therapists [89].  
hCAAR was generally well accepted by users and their families or 
carers in their home environment in this study. Out of the recruited 19 
participants, 17 participants were able to use the device on their own in their 
homes. Out of these 17 participants, two participants with greater disability in 
certain aspects (one with severe spasticity and other with severe dysphasia) 
needed some additional help and training from family members for two 
weeks prior to becoming independent. The usability of hCAAR by people with 
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greater physical, language and cognitive ability needs to be explored in future 
studies. 
The transportability, footprint and external look of the device were found 
to be satisfactory and appreciated by users and carers. hCAAR has been 
successfully transported and installed in various locations (in both the ground 
floor and the first floor) in homes. The members of the research team did not 
encounter any difficulties in installing and retrieving the devices at these 
locations. Some of the participants’ suggestions and the resulting discussions 
in the research team and their outcome is summarised in Table 29. 
The levels in the hCAAR games were designed to provide a hierarchical 
order of difficultly to the user. The range of motion of the shoulder and elbow 
increases with the higher levels of each game. This approach allowed 
hCAAR to be used by a wide range of users. However some users with mild 
upper limb weakness did not find the games challenging enough for their 
level of ability (even at the advanced levels of the game). This highlights that 
the current planar hCAAR device is more suitable for those with moderate to 
severe weakness.  
The hCAAR device can deliver active assist and active non-assist 
modes of therapy. The clinician can adjust the assistance based on the 
available power in the user’s upper limb. All the participants in the feasibility 
study were on active assist mode and the device could alter the assistance 
level based on the performance of the user. None of the participants reached 
a zero assistance level during the study period, despite three participants 
feeling that they received no assistance from the device; this suggests all the 
participants needed some assistance to complete the tasks in the games. 
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Table 29. Participants' suggestions and research team discussions 
 
Number of 
participants 
Suggestion Discussion by research team Action 
One Device taking up considerable 
space in the kitchen 
Further reduction is challenging to achieve; in 
fact, if target population were to include 
people with severe upper limb weakness, 
device likely to be bigger to accommodate 
attachments 
None 
One Having a standard chair. And 
standard instructions on sitting 
position and position of arm while 
using device 
Standard user instructions already mention 
these aspects of usage 
User instructions to be made more 
clear in future instructions guide. 
Standard chair to be made integral 
part of device in future  
One Web-based camera to enable 
monitoring of therapy 
Would enable tele-rehabilitation and monitor 
usage and progress 
To be considered for future version 
of the device 
One Additional attachments like straps 
to hold hand on the joystick 
Optional attachment to secure hand on to 
joystick would be useful when users have 
minimal voluntary hand control 
To be considered for future version 
of the device 
Six Problems with joystick 
initialisation and double-clicking 
of switch 
Joystick position when initializing needs to be 
clarified in the user instructions. Use of 
keypad instead of the switch to initialise might 
simplify the process 
To be considered for future version 
of the device 
Twelve Games need to be made more 
interesting and challenging. 
Games based on functional 
activities and games suggested 
Games design was restricted by available 
resources and expertise in designing hCAAR 
specific games that could be linked to the 
joystick movement 
Games need to be further developed 
with including experts in this area 
and explore possible link up with 
commercial gaming. 
One Device could display 
performance over a period of 
time 
Results and performance over a period of 
time need to included in the device feedback  
Software update in the future version 
of the device 
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The professionals involved in the design and testing stage feedback 
interviews have appreciated the bimanual aspect of hCAAR therapy. The key 
underlying principle of bilateral therapy is to stimulate the motor area of the 
unaffected upper limb that is believed to have a modulating effect on the 
affected side motor cortical area. This was the basis for introducing the 
switch button in hCAAR for the unaffected upper limb. It is difficult to evaluate 
whether the activity of the unaffected upper limb in the hCAAR device was 
adequate to contribute to the functional gains seen in this study. This will 
need to be explored in future studies. 
he need to remotely monitor the user during hCAAR therapy has been 
highlighted in the interviews. The remote therapist would have the advantage 
of being able to collect data without travelling and minimising the time used 
for each user, which can be substantial when home visits need to be done 
across a large geographic area. This is an aspect that needs to be the focus 
of future research.  
In this study, the concept of the hCAAR has appealed to users and 
there were no drop-outs once users started using the device (there were two 
drop-outs prior to home use). When asked whether users preferred to use 
hCAAR at home or in a public place, most (15) participants preferred to use 
the device on their own in their homes. Two individuals expressed views that 
they became self-conscious when using the device in the presence of non-
disabled or more-able individuals in a group. This suggests hCAAR should 
continue to be tested in home settings in future trials.  
hCAAR gave the participants control and independence in their therapy 
needs, which two participants highlighted in the interviews. The user has the 
advantage of using the device when needed and can fit the therapy around 
their other commitments. The ability of using the device independently means 
they do not need to depend on a helper for their therapy.  
hCAAR seemed to motivate some of the participants. Two participants 
stated that their mood had improved since using the device and they were 
among the most active users. One participant expressed a desire to be part 
of the next clinical study of the device. Two participants reported that being 
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part of a research study in itself motivated them to use the device. This 
encourages the research team to explore whether the motivation element of 
the therapy can be increased in future iterations of the device as it has been 
shown that motivation drives use of the device.  
Participants’ carers, families, relatives and friends seemed to be 
generally enthusiastic about the hCAAR device and were pro-active in 
suggesting future developments. This included feedback on both the 
hardware and software (games). They provided help and encouragement to 
the participants. The carers/families of seven participants had noticed 
improvement in upper limb movements and function and attributed these 
improvements to the device. This included two participants who had not 
noticed improvement themselves and their clinical scores confirmed the 
family perceived gains. 
6.4.2 Matching of participant feedback with objective clinical 
measures 
The matching of individual participant’s perceived impact to objective 
clinical measures has not been undertaken in any robotic study in the current 
literature. Participants’ and carers’ perspectives compare well to the clinician-
scored outcome measures in the hCAAR study. This lends more weight to 
the interpretation of the observed changes in the outcome measures. 
However some participants did not report any benefit in spite of the 
improvements observed in the outcome measures.  This raises the possibility 
that the actual clinically significant values of the outcome measures might be 
much higher than the MCID values reported in the literature. The other 
possibility is that participants did not realise the improvements that had 
occurred. This was particularly observed in two participants where the family 
members reported more usage of the upper limb when participants 
themselves did not notice any improvement.  
6.4.3 Matching of interview concepts and ICF Core Set categories 
Finally, matching of the interview concepts to the Comprehensive ICF 
Core Set categories showed that most concepts were covered within the ICF 
Core Set. This suggests that researchers can use the Comprehensive ICF 
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Core Set for stroke as a tool to structure the content of their various methods 
of gathering feedback in the testing stage of technology development. Some 
interview concepts relate to the personal factors domain in ICF, which are yet 
to be categorised in the Comprehensive ICF Core Set and need to be 
considered in addition to the Core Set categories when using this approach. 
It has already been demonstrated that this approach can be used in the initial 
stages (concept and design stage) of understanding users’ needs (Chapter 
3).  
6.4 Limitations 
There are several limitations to this user-centred design process. 
Firstly, a relatively small sample of end-users and only one healthcare 
professional were included in the interviews. Only therapists providing 
conventional therapy to the participants alongside the device usage could be 
included in this process, hence only one therapist could be involved. The 
feedback received in the process was sufficient to give the researchers a 
flavour of user perspectives and the practical implications of using a home-
based robotic device. The end-users did not include those who are not 
independently mobile and those with severe disability, which limits the 
generalisability of the results on acceptability and usability of the device. 
The lack of researcher/therapist video monitoring meant we did not 
monitor users’ positions when they were using the device. Ideally the device 
would be used as an adjunct to conventional therapy and there would be 
monitoring of hCAAR usage either by the attending therapist or by a remote 
supervision. This interaction would help encourage users to use the device 
for the full recommended usage time.  
The range of games available limited the device usage. The usage time 
was below the recommended levels and users suggested improving the 
content and nature of games to suit their interests and needs. The games will 
need to be updated in future hCAAR studies to explore whether this aspect of 
the system can improve motivation and engagement of the user and lead to 
increased usage. 
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Finally, ideally, meaningful concepts should be linked to the most 
precise third-level ICF category as per the ICF linking rules [257] but we only 
linked them only to the second-level categories available in the 
Comprehensive ICF Core Set. The aim of this experiment was to explore 
only whether the ICF Core Set provides a useful template for user-feedback 
process and not to test the accuracy of the linking process. Hence the linking 
to the available second-level categories of the Comprehensive ICF Core Set 
is justified.  
6.5 Conclusions 
Seventeen stroke survivors with upper limb weakness have used the 
hCAAR device with minimal supervision. The device has been well accepted 
by users and family members in a home setting. Five participants reported a 
perceived therapeutic effect of hCAAR therapy. The participants and a 
healthcare professional have been involved in gathering useful feedback on 
the device that informs the future modifications needed in the device. The 
ICF framework provides a useful template to structure the content of user-
feedback methods in device development.  
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Chapter 7: Conclusions and future directions 
This research project aimed to develop a home-based robotic device to 
aid stroke survivors with upper limb weakness undertake upper limb 
exercises. In addition the project explored the feasibility of using the robotic 
device in the home setting and assessed its effects on upper limb function. 
This final chapter will present an overview of the results of this research, 
analyse the findings in the context of the current literature, discuss the 
limitations of this research and explore the potential research questions 
arising from the work described in this thesis. 
7.1 Summary of research findings 
Chapter 1 provided an overview of restorative rehabilitation robotic 
technology for upper limb rehabilitation exercises after stroke. Robotic 
technology has the potential to provide repetitive training of meaningful tasks 
in a stimulating and engaging environment. Previous studies involving upper 
limb robotic devices have demonstrated that robotic therapy can be as 
effective as intensive conventional physiotherapy, and can be used to 
overcome lack of resources in today’s healthcare services. Most of the 
robotic devices tested so far have been used in hospital or research centre 
settings. Very few home-based devices are described in the current 
literature. There are clinical and technical challenges to overcome in the 
development of a technology that is acceptable to, and usable by, this 
population. There was an identified need to develop and test a home-based 
robotic device that can be used by stroke survivors either independently or 
under minimal supervision.  
The future of any novel robotic device depends on its usability and its 
impact on upper limb function. An accurate measurement of its efficacy is a 
difficult task because of the moderate responsiveness of the outcome 
measures used in robot studies. So far there is a lack of consensus on the 
outcome measures that should be used in robot studies. In Chapter 2, all the 
outcome measures that have been used in all previous (upper limb) robot 
studies were systematically reviewed. They were categorised based on the 
ICF framework domains and a new algorithm for the selection of outcome 
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measures was proposed. Based on this algorithm, a combination of 
kinematic and clinical outcome measures was selected to be used in the 
feasibility study involving the home-based robotic device. 
In Chapter 3, the user-centred design process to develop hCAAR was 
explored. Nine individuals with upper limb weakness after stroke and six 
healthcare professionals were involved in the semi-structured interviews. 
User needs and expectations were analysed and incorporated into the design 
of the device. The user-feedback interview content was mapped to the ICF 
Core Set categories to demonstrate the usefulness of the ICF framework 
template in the design and testing stage of device development process. The 
hardware and software components of hCAAR enable the individual to 
undertake assisted reach and retrieve movements with the hand (end-
effector) moving in a single horizontal plane. The device provides therapeutic 
movements to the shoulder and elbow group of muscles of the affected upper 
limb. The unaffected upper limb also contributes to the computer tasks by 
operating a separate switch during game play.  
Chapter 4 described the feasibility study materials and methods. 
Nineteen participants were recruited to undertake a clinical study involving 8-
week home use of hCAAR. The study outcomes involved a combination of a) 
body function measures: kinematic measurements using the Optotrak and 
Optokat systems, MAS, MRC and FM-UE; b) activity-based measures: 
ARAT, CAHAI, ABILHAND; and c) personal, family and therapist impressions 
using semi-structured interviews. The kinematic and clinical outcome 
assessments were undertaken in the research laboratory at three points: 
baseline A0, post-use A1, and one month follow-up A2. The user-feedback 
interviews were conducted at A1. The statistical and clinical significance of 
the results were determined. Movement time and ABILHAND logit scores 
were used in multiple regression analyses to test the relationships between 
the predictive variables and the outcomes.  
The feasibility study results described in Chapter 5 demonstrated that 
stroke survivors with upper limb weakness could safely use hCAAR in home 
settings. Two participants could not use the device in the home setting: one 
of them had severe upper limb weakness and was unable to generate active 
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movements to complete tasks even using at full assistance of the system. 
The other participant could not accommodate the device in his home and 
withdrew from the study. Seventeen participants completed the home use of 
the device for 8 weeks. A full set of kinematic and clinical assessments at all 
the three assessments points A0, A1 and A2 were available for 15 
participants in total. 
There was a statistically significant improvement in clinical and 
kinematic outcomes at A1 when compared to A0. The median improvement 
of clinical scores at A1 was 1 point in the FM-UE score, 3 points in the ARAT 
score, 5.5 points in CAHAI, 3 points in ABILHAND, 1.5 points in the total 
MAS score and 2 points in the total MRC. The kinematic scores showed a 
median improvement of 19% in movement time, 15% in path length and 19% 
in jerk scores at A1 in the far reach task. The clinical and kinematic 
improvements (except path length) were maintained at A2 suggesting the 
improvements were retained for 1 month after the use of hCAAR finished. 
Three participants showed clinically significant improvement in all the four 
clinical outcomes FM-UE, ARAT, CAHAI and ABILHAND. 
Chapter 6 described the user-centred design qualitative feedback on 
hCAAR from the participants of the feasibility study and the healthcare 
professional involved with three participants in the study. The device was well 
accepted by users and family members in their home settings. Five 
participants and family members of seven participants reported a beneficial 
therapeutic effect of hCAAR therapy. Their qualitative feedback was 
comparable to the clinical outcome measure changes observed in the study. 
The users feedback on the device will inform the future modifications needed 
in the device. The matching of interview concepts to ICF Core Set categories 
confirmed that the ICF framework provides a useful template to structure the 
content of user-feedback methods in the testing stage of the device 
development process.  
In summary, the research described in this thesis has led to the 
development of a robotic upper limb rehabilitation exercise device hCAAR 
that can be safely used in a home setting by stroke survivors with upper limb 
weakness. The feasibility study demonstrated the potential for the therapeutic 
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effect of improving upper limb movement and function. hCAAR is being re-
designed and a larger scale clinical study is planned in the future. 
7.2 Discussion 
This research demonstrates that the hCAAR robotic device can be used 
safely in a home setting. Most of the previous robot studies have been 
conducted in research centres or hospitals and have had a therapist present 
with the patient in each treatment session. This is the first clinical study of its 
kind (excluding clinical case studies) in the literature in which the participants 
used a robotic device on their own in their homes with minimal supervision 
from healthcare professionals.  
There is currently a paucity of home-based robotic devices that have 
been proven to be safe and able to be used independently by individuals with 
upper limb weakness. The spectrum of robotic devices in the current 
literature includes a) complex exoskeleton robotic devices that can carry out 
three- dimensional movement of the upper limb (such as ARMin) b) complex 
end-effector devices with low friction and high back-drivability (such as MIT-
Manus) and c) simple low-cost planar devices with no back-drivability that 
can be used in home settings. Most of the robotic device research so far has 
been focused on developing and testing complex exoskeleton and complex 
end-effector devices. There is, however, an increasing need for simple low-
cost robotic devices for home use. The stroke survivor population is 
expanding and there is an increased emphasis on moving rehabilitation 
resources from acute settings to the community. Resources in the community 
are however limited and time constrained. hCAAR has shown the potential to 
fill this gap in therapy resources for stroke survivors.   
The musculoskeletal adverse events (shoulder pain, wrist pain) noted in 
this study are comparable to those seen in other robot studies [70]. General 
advice on the appropriate positioning of upper limb, rest, and using the 
available pain-free range of movements is the standard approach adopted in 
these studies. These musculoskeletal problems are also encountered in 
conventional therapy as well and similar management approaches are used. 
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The hCAAR study showed statistically significant improvement in two 
functional activity-based outcome measures CAHAI and ABILHAND, and at 
least five participants reported changes in functional activities. This is 
contrary to findings in the systematic review of robot studies that did not find 
evidence of changes in functional activities (based on changes in the FIM 
score) [118]. Two reasons could be identified for this finding; first, CAHAI and 
ABILHAND are more responsive measures than the FIM motor in upper limb 
motor recovery; and second, previous robot studies do not often include 
patient impressions of the impact of interventions as outcomes.  
The hCAAR feasibility study demonstrated significant changes across 
all the domains of the ICF framework for stroke. A diagram with some 
examples of the changes in the various domains of the ICF framework is 
shown in Figure 33. The changes across the different outcome measures are 
not necessarily highly correlated as they represent different domains of the 
ICF framework. The different domains of ICF framework i.e., body function, 
activities, participation, personal and environmental factors, are related but 
do not have a causal relationship between them. The correlations between 
the outcome measures representing different domains are, therefore, at best, 
only moderate [278]. This emphasises the fact that measurement of change 
must occur across the different domains of ICF. 
Most robot studies so far have involved high-cost complex devices with 
therapists being involved in delivering each session of robot therapy. The 
only large-scale economic analysis study involving the MIT-Manus robotic 
device concluded that there was no increased cost-effectiveness with robot 
therapy when compared to intensive conventional therapy [120]. The cost of 
the robotic device was $ 230,750 with additional maintenance costs 
($15,000) and cost of therapist time ($120 for 15 min of therapist contact time 
per session) [120]. The cost of the hCAAR device is much lower (approx 
5000 GBP) compared to this and there is no therapist time involved for each 
session. A cost-effectiveness analysis in comparison to conventional therapy 
needs to be done in future hCAAR studies in the home setting. 
  
Figure 33. WHO’s ICF framework diagram showing examples of the impact of hCAAR 
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7.3 Limitations 
The user-centred design process had limitations. Users were involved 
in the initial stages but not every user feedback was incorporated in the final 
hCAAR device. The suggestion of movements being made more functional 
incorporating distal movements is difficult to include in a low-cost device for 
home use. The suggestions for games to be based on daily activities or sport 
could not be easily adapted as the resources available to create software 
programmes linked to the assistive joystick were limited in this study. The 
linking of interview concepts to ICF Core Set categories in this thesis was a 
retrospective exercise and future studies should use the Core Set categories 
to plan the interviews and explore the limitations and advantages of this 
approach.  
hCAAR therapy is limited by the nature of the device. It is a planar robot 
providing exercises only to the proximal muscles of the upper limb. The 
current literature suggests that the benefits to proximal muscles from 
exercises do not extend to the distal muscles in the chronic stage of 
recovery. The device was designed with home use in mind and there was a 
need to keep the device as simple as possible. The provision of additional 
attachments/modules might provide additional therapy to distal muscles, but 
would make the device bigger and more complex making it less appealing for 
home use.  
The concept of bilateral therapy has been incorporated in hCAAR; its 
actual contribution to motor recovery in this study is, however, inconclusive. 
Evidence on the amount and type of involvement of the unaffected limb in 
bilateral therapy is lacking. Most robotic devices promoting bilateral therapy 
such as MIME, BATRAC, BFIAMT, provide symmetrical bilateral therapy and 
one robot study did not show any benefit of bilateral therapy over unilateral 
therapy [60]. It is difficult to establish whether the activity of the unaffected 
upper limb had any role in the gains observed in the hCAAR study. 
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There was no mandatory minimum recommended usage time planned 
for this study. Even though participants were advised to use the device for at 
least 30 min every day for five days a week, the device software did not 
provide feedback on usage time to the participants during the study period. 
Lack of such reminders could have influenced device usage time in the 
study. Several participants suggested that the games lacked complexity and 
did not match their preferences. This could be one of the reasons for the low 
device usage time when compared to other robot studies.  
Participants in the hCAAR study, even though they had a wide range of 
impairments, did not include individuals with significant visual field defects, 
severe language impairments, or those with severe mobility limitations. The 
selection of participants was influenced by the nature of the study in which 
the participants needed to be able to attend the research laboratory (using 
their own transport) for the introduction to the device and the outcome score 
assessments. Future hCAAR studies must include individuals with greater 
disability and older individuals to test usability in these population groups. 
Suitable outcome measures need to be chosen so that they can be 
completed at homes and avoid participants having to visit the research 
laboratory for the assessments. 
The sample size of the feasibility study was not large enough to derive 
any definite conclusions on the efficacy of hCAAR therapy. The feasibility 
study however showed that some participants did benefit and the trends in 
changes between A0, A1 and A2 suggested the changes observed in this 
study were due to hCAAR usage. This suggests the therapy provided by the 
device has the potential to improve upper limb function and the actual effect 
size needs to be further explored in a larger sample of participants.   
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7.4 Future directions 
It is believed that robotic therapy could fill the gap caused by resource 
constraints by providing intense practice of useful movements [119, 279]. 
The findings in various robot studies that robotic therapy can be as equally 
effective as intensive conventional physiotherapy support this view [53, 70]. 
The professionals involved in the hCAAR user-centred design process see 
the future of hCAAR as a useful adjunct to conventional therapy in the 
community. Community therapy in the current NHS is constrained, with many 
patients unable to get the intensity of therapy they need. The concept of 
telerehabilitation with robotic devices has been tried in only a few studies so 
far [93, 280].  hCAAR has shown the potential to provide such therapy in the 
future. 
hCAAR, even though has been developed with stroke survivors in mind, 
can be used in other conditions resulting in upper limb weakness. Acquired 
brain injury (traumatic and non-traumatic), high cervical spinal cord injury, 
multiple sclerosis, and muscular dystrophy are some conditions where there 
is scope for using hCAAR to improve upper limb movement. For future 
research, it might be prudent to establish the efficacy of hCAAR in a larger 
stroke survivor population before exploring its use in other conditions. 
7.4.1 Device modifications 
The games of hCAAR need further development. The type of 
movements generated by the games will be limited by the planar nature of 
the device. However the content of the games could be improved and made 
more interesting and engaging. They could be based on the user’s leisure 
interests, on sport, puzzles, word formation etc. Having a wider range of 
games will provide more options to the user. The drawback of planar 
movement can be overcome by extending the exercise prescription to include 
real life functional tasks in addition to the standard hCAAR therapy.  
The performance feedback options should include giving feedback to 
the user over the entire usage time period and the option of a therapist 
remotely providing additional professional feedback using a webcam. The 
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device software could also prompt the user on usage time and encourage the 
user to meet the recommended usage time. 
7.4.2 Research study design 
7.4.2.1 Patient selection 
hCAAR therapy needs to target individuals with moderate severity of 
upper limb weakness, i.e., a score between 15 and 40 on the FM-UE score. 
These individuals, particularly the individuals with scores between 15 and 30 
are likely to engage the most and reap the most benefit from hCAAR therapy, 
as observed in the feasibility study. Individuals with severe weakness (FM-
UE score less than 12 in this study) will experience difficulty in using the 
current version of the device even in full assistance mode. These individuals 
would also need additional support to hold up their upper limbs against 
gravity. Individuals with mild weakness (more than 40 FM-UE score) will have 
reasonable active upper limb movement and hCAAR might not be sufficiently 
challenging and appealing enough for them. They need the more complex 
functional tasks that are very well provided in conventional physiotherapy. 
hCAAR therapy can be used in the subacute and chronic stages of 
recovery after stroke. In the current healthcare services, there seems to be 
gaps in the availability of therapy of sufficient intensity and duration in both 
the subacute and chronic stages of recovery. hCAAR can complement 
conventional physiotherapy and increase the intensity of practice of upper 
limb exercises.  It also provides independence in ones own therapy and has 
the advantage of providing long-term therapy in people’s homes. 
7.4.2.2 Study design 
A controlled study in a home environment is needed to compare a 
combination of hCAAR therapy and intensive conventional therapy with 
intensive conventional therapy alone. Such a comparison has already been 
done for complex hospital-based robotic devices. A crossover study can also 
be considered where every participant is assured the advantage of additional 
hCAAR therapy. 
Multiple baseline assessment prior to study recruitment will ensure 
there is estimation of ongoing natural recovery prior to starting hCAAR 
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therapy. A previous robot study used a cut-off of 3 points difference in FM-UE 
scores between baseline assessments as an exclusion criterion to ensure 
that natural recovery did not influence the outcome [70]. This approach is 
needed in future hCAAR studies, particularly with participants in the subacute 
stage of recovery. 
The long-term effects of hCAAR therapy needs further research. The 
feasibility study showed retention of gains at 1 month after stopping the use 
of hCAAR, but long-term benefits to upper limb function are unknown. 
Follow-up assessments at 6 months and 1 year will help understand the long-
term benefits, such assessments have rarely been done in previous robot 
studies [281].   
7.4.2.3 Intervention 
The true efficacy of intervention will be known only when the device 
usage time improves in future studies. The total therapy time in a future study 
needs to exceed at least 1200 min, which is approximately 30 min therapy 
per session each day, 5 days a week for 8 weeks. The device software could 
prompt the user to meet the recommended therapy time. Remote connection 
to a therapist via the web will help monitor the therapy, maintain motivation 
and provide professional feedback to the user. 
7.4.2.4 Outcomes 
The hCAAR feasibility study had a carefully selected combination of 
outcome measures spanning the different domains of the ICF framework. 
FM-UE is the most commonly used outcome measure in robot studies and 
must continue to be used in future studies to enable comparison and meta-
analysis of the data. Kinematic measurements using optical tracking 
mechanisms in a research laboratory is time consuming, resource intensive 
and needs participants to attend the laboratory for assessments. The robotic 
device records joystick movement characteristics and can provide 
assessment of some kinematic variables such as movement time, path 
length and jerk. These measures can be used instead of external kinematic 
assessments using optical tracking equipment. 
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ARAT is a standard activity measure that is gaining popularity in 
stroke rehabilitation research studies. The kit is transportable, does not need 
to be cleaned prior to use and the tests can be completed in the home 
setting. The only problem with this outcome measure is its floor effect, and its 
poor discrimination between participants at baseline, which means it cannot 
be used as a screening measure. Both ABILHAND and CAHAI are activity 
measures and were found to be similarly responsive in this study. ABILHAND 
is a patient-reported outcome and can be completed without needing any 
equipment. CAHAI, however, needs a standard kit and involves a 
considerable amount of cloth used in various items. The cloth material needs 
cleaning prior to each use and this could limit its use in large samples of 
participants. A combination of ARAT and ABILHAND seems to be the most 
sensible combination of activity measures for future use. 
Measures to capture changes at the participation level (or health-related 
quality of life level) such as EQ-5D or SF-36 were not included in this study 
as this was not felt necessary at the stage of testing feasibility of hCAAR use. 
These measures will need to be considered in future larger scale studies. 
This needs to be combined with participant, family and carer qualitative 
feedback on usability and impact on upper limb function, as was done in the 
feasibility study. The user feedback was via semi-structured interviews in this 
study. The use of Likert scales for structured feedback is an alternative 
option that could be considered in the future. 
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7.5 Summary 
In conclusion, a home-based restorative rehabilitation robotic device 
hCAAR has been developed using a user-centred design process that 
involved stroke survivors, carers and healthcare professionals. The hCAAR 
feasibility study was the first clinical study of its kind reported in the literature; 
in this study, 17 participants used the robotic device independently for eight 
weeks in their own homes with minimal supervision from healthcare 
professionals. Statistically significant improvements were observed in the 
kinematic and clinical outcomes in the study.  
In the future, the hCAAR games could be improved and the feedback 
the device provides to the user on their results and performance needs to be 
developed. Internet linkage to a remote therapist to monitor the therapy and 
provide professional feedback must also be considered. A future clinical 
study would need to explore the use of hCAAR in a larger, more 
heterogeneous sample of participants in the home setting. A study design 
comparing the combination of conventional therapy and hCAAR with 
conventional therapy alone needs to be explored. A combination of outcome 
measures that span the domains of the ICF framework needs to be included 
in any future study. 
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Appendix A. The Comprehensive ICF Core Set for stroke 
Table 30. Comprehensive ICF Core Set for stroke (Reproduced from Geyh   
et al. 2004) [236] 
 
 
International Classification of Functioning, Disability and Health (ICF) – 
categories of the component body functions included in the 
Comprehensive ICF Core Set for stroke  
 
Code Category title 
b110  Consciousness functions 
b114  Orientation functions 
b117  Intellectual functions 
b126  Temperament and personality functions 
b130  Energy and drive functions 
b134  Sleep functions 
b140  Attention functions 
b144  Memory functions 
b152  Emotional functions 
b156  Perceptual functions 
b164  Higher-level cognitive functions 
b167  Mental functions of language 
b172  Calculation functions 
b176  Mental function of sequencing complex movements 
b180  Experience of self and time functions 
b210  Seeing functions 
b215  Functions of structures adjoining the eye 
b260  Proprioceptive function 
b265  Touch function 
b270  Sensory functions related to temperature and other stimuli 
b280  Sensation of pain 
b310  Voice functions 
b320  Articulation functions 
b330  Fluency and rhythm of speech functions 
b410  Heart functions 
b415  Blood vessel functions 
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b420  Blood pressure functions 
b455  Exercise tolerance functions 
b510  Ingestion functions 
b525  Defecation functions 
b620  Urination functions 
b640  Sexual functions 
b710  Mobility of joint functions 
b715  Stability of joint functions 
b730  Muscle power functions 
b735  Muscle tone functions 
b740  Muscle endurance functions 
b750  Motor reflex functions 
b755  Involuntary movement reaction functions 
b760  Control of voluntary movement functions 
b770  Gait pattern functions 
 
International Classification of Functioning, Disability and Health (ICF) – 
categories of the component body structures included in the 
Comprehensive ICF Core Set for stroke  
 
Code Category title 
s110  Structure of brain 
s410  Structure of cardiovascular system 
s720  Structure of shoulder region 
s730  Structure of upper extremity 
s750  Structure of lower extremity 
 
International Classification of Functioning, Disability and Health (ICF) – 
categories of the component activities and participation included in the 
Comprehensive ICF Core Set for stroke  
 
Code Category title 
d115  Listening 
d155  Acquiring skills 
d160  Focusing attention 
d166  Reading 
d170  Writing 
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d172  Calculating 
d175  Solving problems 
d210 Undertaking a single task 
d220  Undertaking multiple tasks 
d230  Carrying out daily routine 
d240  Handling stress and other psychological demands 
d310  Communicating with – receiving – spoken messages 
d315  Communicating with – receiving – non-verbal messages 
d325  Communicating with – receiving – written messages 
d330  Speaking 
d335  Producing non-verbal messages 
d345  Writing messages 
d350  Conversation 
d360  Using communication devices and techniques 
d410  Changing basic body position 
d415  Maintaining a body position 
d420  Transferring oneself 
d430  Lifting and carrying objects 
d440  Fine hand use 
d445  Hand and arm use 
d450  Walking 
d455  Moving around 
d460  Moving around in different locations 
d465  Moving around using equipment 
d470  Using transportation 
d475  Driving 
d510  Washing oneself 
d520  Caring for body parts 
d530  Toileting 
d540  Dressing 
d550  Eating 
d570  Looking after one’s health 
d620  Acquisition of goods and services 
d630  Preparing meals 
d640  Doing housework 
d710  Basic interpersonal interactions 
d750  Informal social relationships 
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d760  Family relationships 
d770  Intimate relationships 
d845  Acquiring, keeping and terminating a job 
d850  Remunerative employment 
d855  Non-remunerative employment 
d860  Basic economic transactions 
d870  Economic self-sufficiency 
d910  Community life 
d920  Recreation and leisure 
 
International Classification of Functioning, Disability and Health (ICF) – 
categories of the component environmental factors included in the 
Comprehensive ICF Core Set for stroke  
 
Code Category title 
e110  Products or substances for personal consumption 
e115  Products and technology for personal use in daily living 
e120  Products and technology for personal indoor and outdoor mobility and     
          transportation 
e125  Products and technology for communication 
e135  Products and technology for employment 
e150  Design, construction and building products and technology of buildings  
          for public use 
e155  Design, construction and building products and technology of buildings  
          for private use 
e165  Assets 
e210  Physical geography 
e310  Immediate family 
e315  Extended family 
e320  Friends 
e325  Acquaintances, peers, colleagues, neighbours and community  
          members 
e340  Personal care providers and personal assistants 
e355  Health professionals 
e360  Health-related professionals 
e410  Individual attitudes of immediate family members 
e420  Individual attitudes of friends 
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e425  Individual attitudes of acquaintances, peers, colleagues, neighbours    
          and community members 
e440  Individual attitudes of personal care providers and personal assistants 
e450  Individual attitudes of health professionals 
e455  Individual attitudes of health-related professionals 
e460  Societal attitudes 
e515  Architecture and construction services, systems and policies 
e525  Housing services, systems and policies 
e535  Communication services, systems and policies 
e540  Transportation services, systems and policies 
e550  Legal services, systems and policies 
e555  Associations and organizational services, systems and policies 
e570  Social security services, systems and policies 
e575  General social support services, systems and policies 
e580  Health services, systems and policies 
e590  Labour and employment services, systems and policies 
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Appendix B. Patient interview topics checklist – concept 
stage of device development 
Table 31. End-user interview topics checklist - concept stage 
 
Time of stroke, type of stroke, weak side 
Dominant side 
Motor/sensory problems 
Vision/speech/cognitive problems/seizures 
Perception problems – Inattention/neglect 
Pain and its impact on activities 
Mood 
Employment, medications, other medical problems 
Therapy received as inpatient/outpatient 
Home exercises – characteristics 
Impression on therapy received and expectations 
Reasons for not getting needed therapy 
Usage of weak arm in bilateral activities 
Compensatory strategies to perform ADL 
Functional goals 
Support available for performing exercises at home 
Cost of technology and affordability 
Concept of computer-based device in home - impressions 
Suitability of home setting 
Suggestions on features of home device 
Home computer 
Computer usage/experience/skills 
Experience of computer games 
Leisure interests – games based on interests and engagement 
Experience of using technology-based device for exercises – e.g., Wii 
Belief/impressions about technology for arm exercises 
Independence and control in therapy program 
Advantages and drawbacks of technology based exercises when compared to 
conventional hands-on physiotherapy 
Preference of environment for usage of technology 
Any other comments/suggestions 
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Appendix C. Healthcare professional interview topics 
checklist – concept stage of device development 
Table 32. Professional user interview topics checklist - concept stage 
 
 
 
 
 
 
 
 
 
 
 
Therapy received by stroke patients as inpatients – characteristics 
Outpatient therapy – characteristics/ duration/ intensity etc. 
Criteria for outpatient therapy 
Home exercises program - characteristics 
Compliance of patients with home exercises 
Impressions on duration and intensity of therapy for affected arm 
Optimal time period for maximum recovery  
Therapy based on computer games - impressions  
Design spec. of such technology  
Exercises for neglect/ perception problems  
Exercise recommendations if pain in the affected arm  
Exercise recommendations for stiffness in the affected arm 
Advice given to patients on involving weak arm in bilateral activities  
Therapy based on functional activities – Impressions/ recommendations 
Functional activities targeted 
Beliefs/Impressions about technology delivering arm exercises 
Independence of patients in rehabilitation program 
Drawbacks of technology over conventional hands-on physiotherapy  
Home-based computer device for arm exercises - impressions 
Features of such a device 
Exercise preferences – individual/ group for technology-based exercises 
Deployment in community centres such as stroke club 
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Appendix D. Clinical and Kinematic measurements of 
individual participants 
Participant ID 1 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 1 are shown in the tables below. The 
scores improved across most clinical outcome measures and all three kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 1) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM-UE 
 
33 33 30 0 - 3 
ARAT 
 
37 41 47 4 10 
CAHAI 
 
51 60 65 9 14 
ABILHAND 
(Logit score) 
22 
(- 0.008) 
25 
(0.263) 
32 
(1.199) 
3 10 
Total MAS 
 
12 8.5 11 - 3.5 - 1 
Total MRC 
 
34 NA 40 NA 6 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 1) 
 A0 A1 A2 
A1 - A0 
% change 
A2 - A0 
% change 
 
 
Near  
reach 
Far  
reach 
Near  
reach 
Far  
reach 
Near  
reach  
Far  
reach 
NR FR  NR FR 
MT 
 
0.46 0.50 0.25 0.27 0.26 0.30 -45 -47 -44 -40 
PL 
 
205.44 218.00 150.41 132.16 125.66 138.09 -27 -39 -39 -37 
NJ 
 
186.21 260.39 56.72 122.14 143.33 149.87 -70 -53 -23 -42 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
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Participant ID 2 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 2 are shown in the tables below. 
CAHAI, ABILHAND and MRC improved at A1 and were maintained at A2. The 
kinematic parameters improved except for jerk in the far reach task. 
 
Table. Changes in clinical outcome scores (participant ID 2) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM-UE 
 
12 12 11 0 - 1 
ARAT 
 
0 1 0 1 0 
CAHAI 
 
16 19 26 3 10 
ABILHAND 
(Logit score) 
7 
(- 2.322) 
18 
(- 0.635) 
17 
(- 0.769) 
11 10 
Total MAS 
 
15.5 15 16.5 - 0.5 1 
Total MRC 
 
33 37 35 4 2 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 2) 
 A0 A1 A2 
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.35 0.44 0.29 0.40 0.33 0.41 -15 -9 -4 -8 
PL 
 
185.92 241.31 127.80 173.09 130.12 180.69 -31 -28 -30 -25 
NJ 
 
414.03 200.06 213.84 551.41 199.87 445.01 -48 176 -52 122 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 
 
 
  
 
- 218 -    
 
 
Participant ID 3 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 3 are shown in the tables below. Most 
clinical measures showed improvement with improved performance of kinematic 
parameters (with the exception of the far reach task at A2). 
 
Table. Changes in clinical outcome scores (participant ID 3) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM-UE 
 
36 33 34 - 3 - 2 
ARAT 
 
52 53 56 1 4 
CAHAI 
 
54 59 68 5 14 
ABILHAND 
(Logit score) 
12 
(- 1.329) 
13 
(- 1.247) 
12 
(- 1.407) 
1 0 
Total MAS 
 
6 5.5 5.5 - 0.5 - 0.5 
Total MRC 
 
39 39 40 0 1 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 3) 
 A0 A1 A2 
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.4 0.5 0.27 0.33 0.3 0.52 -31 -34 -24 4 
PL 
 
128.43 164.94 123.57 145.52 120.56 182.81 -4 -12 -6 11 
NJ 
 
355.54 381.41 270.93 294.39 187.38 384.15 -24 -23 -47 1 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
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Participant ID 4 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 4 are shown in the tables below. 
Kinematic measurements show deterioration of most parameters in both near reach 
and far reach tasks. 
 
Table. Changes in clinical outcome scores (participant ID 4) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM-UE 
 
30 32 29 2 - 1 
ARAT 
 
20 24 24 4 4 
CAHAI 
 
30 NA 46 NA 16 
ABILHAND 
(Logit score) 
15 
(- 0.511) 
19 
(- 0.462) 
19 
(- 0.377) 
4 4 
Total MAS 
 
8.5 NA 6.5 NA - 2 
Total MRC 
 
37 NA 40 NA 3 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
 
Table. Percentage changes in kinematic parameters (participant ID 4) 
 A0  A1  A2  
A1 - A0            
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.36 0.44 0.49 0.70 0.41 0.62 34 60 13 43 
PL 
 
112.03 138.63 108.49 197.02 111.28 165.94 -3 42 -1 20 
NJ 
 
308.80 488.81 502.32 715.66 604.40 517.88 63 46 96 6 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 5 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 5 are shown in the tables below. Only 
A1 assessment results were available; these show improvements in the clinical 
scores at A1 that did not match with the variable changes of the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 5) 
 
 
A0 A1 A2 A1 – A0 
FM-UE 
 
32 36 - 4 
ARAT 
 
20 32 - 12 
CAHAI 
 
44 59 - 15 
ABILHAND 
(Logit score) 
12 
(- 1.428) 
17 
(- 0.539) 
- 5 
Total MAS 
 
13 6 - - 7 
Total MRC 
 
31 40 - 9 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 5) 
 A0 A1 
A1 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR 
MT 
 
0.40 0.47 0.42 0.47 7 0 
PL 
 
143.66 158.88 116.91 137.93 -19 -13 
NJ 
 
252.76 383.55 324.40 317.93 28 -17 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 6 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 6 are shown in the tables below. The 
clinical scores improved by marginal amount across all outcome measures and are 
accompanied by increase in all kinematic parameters in both near reach and far 
reach tasks at A1 and A2. 
 
Table. Changes in clinical outcome scores (participant ID 6) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
37 38 41 1 4 
ARAT 
 
42 42 44 0 2 
CAHAI 
 
78 79 79 1 1 
ABILHAND 
(Logit score) 
35 
(1.962) 
36 
(2.151) 
36 
(2.510) 
1 1 
Total MAS 
 
14.5 9.5 7.5 - 5 - 7 
Total MRC 
 
38 40 40 2 2 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 6) 
 A0  A1  A2  
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.35 0.45 0.34 0.36 0.33 0.38 -2 -19 -7 -16 
PL 
 
124.11 145.29 119.07 144.25 109.13 133.67 -4 -1 -12 -8 
NJ 
 
715.49 648.92 182.15 189.53 260.12 339.30 -75 -71 -64 -48 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 7 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 7 are shown in the tables below. Only 
A2 results were available; these show marginal improvement in the clinical scores 
but deterioration of the kinematic parameters movement time and path length. 
 
Table. Changes in clinical outcome scores (participant ID 7) 
 
 
A0 A1 A2 A2 – A0 
FM 
 
32 - 36 4 
ARAT 
 
37 - 37 0 
CAHAI 
 
44 - 46 2 
ABILHAND 
(Logit score) 
16 
(- 0.826) 
- 
19 
(- 0.194) 
3 
Total MAS 
 
10 - 9 - 1 
Total MRC 
 
42 - 43 1 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
 
Table. Percentage changes in kinematic parameters (participant ID 7) 
 
 A0  A2  
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR 
MT 
 
0.57 0.64 0.80 0.74 40 16 
PL 
 
145.96 175.94 191.33 192.86 31 10 
NJ 
 
294.48 386.52 130.27 312.10 -56 -19 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 8 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 8 are shown in the tables below. The 
results suggest significant improvements of clinical and kinematic scores at both A1 
and A2. 
 
Table. Changes in clinical outcome scores (participant ID 8) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
19 24 31 5 12 
ARAT 
 
9 19 27 10 18 
CAHAI 
 
24 44 59 20 35 
ABILHAND 
(Logit score) 
11 
(- 1.496) 
15 
(- 0.777) 
20 
(- 0.046) 
4 9 
Total MAS 
 
16 N/A 10.5 N/A - 5.5 
Total MRC 
 
31 N/A 39 N/A 8 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 8) 
 A0  A1  A2  
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
1.15 1.57 0.49 0.59 0.27 0.60 -57 -63 -76 -62 
PL 
 
303.33 321.62 174.04 184.65 97.49 191.59 -43 -43 -68 -40 
NJ 
 
370.38 601.58 393.99 450.88 216.76 392.50 6 -25 -41 -35 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
 
 
 
  
 
- 224 -    
 
 
Participant ID 9 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 9 are shown in the tables below. The 
results suggest small improvements in clinical scores and in most of the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 9) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
42 43 44 1 2 
ARAT 
 
53 54 54 1 1 
CAHAI 
 
80 81 81 1 1 
ABILHAND 
(logit score) 
29 
(1.958) 
31 
(2.001) 
34 
(2.065) 
2 5 
Total MAS 
 
2 1 0 - 1 - 2 
Total MRC 
 
40 40 41 0 1 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 9) 
 A0  A1  A2  
A1 - A0 % 
change 
A2 - A0 % 
change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.40 0.46 0.44 0.38 0.27 0.42 8 -17 -32 -9 
PL 
 
175.78 203.05 156.80 168.35 133.07 181.37 -11 -17 -24 -11 
NJ 
 
267.92 326.57 258.17 433.11 205.52 351.20 -4 33 -23 8 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 10 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 10 are shown in the tables below. The 
results suggest improvements in clinical scores and most of the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 10) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
20 29 32 9 12 
ARAT 
 
23 37 40 14 17 
CAHAI 
 
44 51 54 6 10 
ABILHAND 
(logit score) 
13 
(- 0.324) 
33 
(1.915) 
33 
(2.359) 
20 20 
Total MAS 
 
15.5 15 13.5 - 0.5 - 2 
Total MRC 
 
35 37 39 2 4 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 10) 
 A0  A1  A2  
A1 - A0 % 
change 
A2 - A0 % 
change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.55 0.79 0.41 0.47 0.31 0.42 -26 -40 -43 -47 
PL 
 
131.49 190.00 133.39 152.98 111.84 149.74 1 -19 -15 -21 
NJ 
 
396.88 379.00 226.41 391.79 263.08 363.64 -43 3 -34 -4 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 11 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participants eleven are shown in the tables below. 
The results suggest improvements in clinical scores and in most of the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 11) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
15 17 20 2 5 
ARAT 
 
2 5 5 3 3 
CAHAI 
 
37 41 47 4 10 
ABILHAND 
(Logit score) 
5 
(- 2.849) 
6 
(- 2.603) 
13 
(- 1.335) 
1 8 
Total MAS 
 
14.5 12 13 - 2.5 - 1.5 
Total MRC 
 
31 37 40 6 9 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
 
Table. Percentage changes in kinematic parameters (participant ID 11) 
 A0  A1  A2  
A1 - A0 % 
change 
A2 - A0 % 
change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.49 0.61 0.48 0.37 0.65 0.44 -1 -39 33 -28 
PL 
 
93.97 143.38 99.08 114.61 155.86 133.62 5 -20 66 -7 
NJ 
 
339.00 461.85 270.12 388.65 233.26 378.49 -20 -16 -31 -18 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
 
 
  
 
- 227 -    
 
 
Participant ID 13 
 
The total scores for the clinical outcome measures and kinematic parameters at 
three assessment points for participant ID 13 are shown in the tables below. The 
results suggest improvements in clinical scores and in most of the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 13) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
18 28 28 10 10 
ARAT 
 
5 8 12 3 7 
CAHAI 
 
32 42 53 10 21 
ABILHAND 
(logit score) 
17 
(- 0.582) 
24 
(0.410) 
22 
(0.127) 
7 5 
Total MAS 
 
18.5 14.5 10.5 - 4 - 8 
Total MRC 
 
25 40 40 15 15 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage change in kinematic parameters (participant ID 13) 
 A0  A1  A2  
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.43 0.56 0.28 0.50 0.43 0.45 -35 -11 -2 -20 
PL 
 
132.85 149.20 107.24 155.95 129.68 165.95 -19 5 -2 11 
NJ 
 
610.27 939.37 228.34 379.03 353.59 391.28 -63 -60 -42 -58 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 14 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 14 are shown in the tables below. The 
results suggest improvements in most clinical scores and most of the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 14) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
29 32 28 3 - 1 
ARAT 
 
10 18 11 8 1 
CAHAI 
 
56 65 68 9 12 
ABILHAND 
(Logit score) 
27 
(0.888) 
31 
(1.700) 
31 
(1.745) 
4 4 
Total MAS 
 
11 9.5 7.5 - 1.5 - 3.5 
Total MRC 
 
38 40 40 2 2 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 14) 
 A0  A1  A2  
A1 - A0 % 
change 
A2 - A0 % 
change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.54 1.30 0.53 0.62 0.49 0.58 -2 -52 -9 -56 
PL 
 
149.98 219.58 200.95 187.74 141.83 162.98 34 -14 -5 -26 
NJ 
 
294.61 447.75 258.87 301.12 399.50 433.65 -12 -33 36 -3 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 16 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 16 are shown in the tables below. The 
results suggest small improvements in some clinical scores and in some of the 
kinematic parameters. 
 
Table. Changes in clinical outcome scores (participant ID 16) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
43 44 44 1 1 
ARAT 
 
55 56 55 1 0 
CAHAI 
 
69 74 69 5 0 
ABILHAND 
(Logit score) 
31 
(1.418) 
34 
(1.662) 
31 
(1.057) 
3 0 
Total MAS 7.5 5.5 6 - 2 
- 1.5 
 
Total MRC 
 
40 40 40 0 0 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 16) 
 A0  A1  A2  
A1 - A0 % 
change 
A2 - A0 % 
change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.40 0.53 0.36 0.44 0.42 0.46 -10 -18 3 -14 
PL 
 
160.35 206.70 151.63 176.17 162.67 175.89 -5 -15 1 -15 
NJ 
 
390.01 483.22 500.36 512.30 257.71 282.67 28 6 -34 -42 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 17 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 17 are shown in the tables below. The 
results suggest small improvements in clinical scores at A1 but these are not 
maintained at A2. The kinematic parameters show variable results. 
 
Table. Changes in clinical outcome scores (participant ID 17) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
28 29 28 1 0 
ARAT 
 
12 14 8 2 - 4 
CAHAI 
 
23 28 23 5 0 
ABILHAND 
(Logit score) 
21 
(- 0.141) 
22 
(- 0.008) 
22 
(0.088) 
1 0 
MAS 
 
13 12.5 10 - 0.5 - 3 
MRC 
 
36 39 40 3 4 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
 
 
Table. Percentage changes in kinematic parameters (participant ID 17) 
 A0  A1  A2  
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.52 0.64 0.92 0.94 0.43 0.67 78 48 -18 5 
PL 
 
168.28 187.12 241.50 273.02 137.92 177.76 44 46 -18 -5 
NJ 
 
734.81 488.05 240.02 486.26 586.63 332.39 -67 0 -20 -32 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 18 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 18 are shown in the tables below. The 
results suggest small improvements in most clinical scores and in some of the 
kinematic parameters. 
 
Table. Changes in clinical outcome scores (participant ID 18) 
 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
29 30 30 1 1 
ARAT 
 
29 31 33 2 4 
CAHAI 
 
40 47 46 7 6 
ABILHAND 
(Logit score) 
7 
(- 2.322) 
3 
(- 2.930) 
8 
(- 2.109) 
- 4 1 
Total MAS 
 
9.5 8.0 5.5 - 1.5 - 4 
Total MRC 
 
39 40 40 1 1 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 18) 
 
 A0  A1  A2  
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.29 0.53 0.46 0.47 0.37 0.42 57 -11 27 -21 
PL 
 
117.87 150.57 113.15 128.50 109.80 133.33 -4 -15 -7 -11 
NJ 
 
127.49 349.40 253.62 283.90 174.89 279.12 99 -19 37 -20 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Participant ID 19 
The total scores for the clinical outcome measures and kinematic parameters 
at three assessment points for participant ID 19 are shown in the tables below. The 
results suggest improvement in most of the clinical scores and in all the kinematic 
parameters. 
 
Table. Changes in clinical outcome scores (participant ID 19) 
 
 
A0 A1 A2 A1 – A0 A2 – A0 
FM 
 
37 42 39 5 2 
ARAT 
 
47 51 51 4 4 
CAHAI 
 
79 85 85 6 6 
ABILHAND 
(Logit score) 
21 
(- 0.141) 
27 
(0.888) 
27 
(0.888) 
6 6 
Total MAS 
 
4 1.5 4 - 2.5 0 
Total MRC 
 
40 40 40 0 0 
    
FM-UE Fugl Meyer Upper Extremity motor subscale 
ARAT Action Research Arm Test 
CAHAI Chedok Arm and Hand Activity Inventory  
MAS Modified Ashworth Scale 
MRC Medical Research Council 
 Improvement  
 Deterioration  
 
 
Table. Percentage changes in kinematic parameters (participant ID 19) 
 A0  A1  A2  
A1 - A0 
% change 
A2 - A0 
% change 
 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
Near 
reach 
Far 
reach 
NR FR NR FR 
MT 
 
0.48 0.51 0.34 0.35 0.24 0.28 -30 -32 -50 -45 
PL 
 
120.24 148.57 112.51 136.54 113.29 142.36 -6 -8 -6 -4 
NJ 
 
386.61 351.03 295.92 284.16 149.16 203.99 -23 -19 -61 -42 
 
MT Movement Time 
PL Path Length 
NJ Normalised Jerk 
NR Near Reach 
FR Far Reach 
 Improvement 
 Deterioration  
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Appendix E. Participant interview checklist (feasibility study) 
Table 33. Participant interview topics checklist (feasibility study) 
 
ID 
General views about the device 
Suggestions for improvements 
Hardware 
Views on computer/ joystick/ chair/ seating/ height 
Size of the device 
Room in which device installed 
Problems encountered while using the device at home 
Used independently/ help needed 
Software 
Views on assistance provided by joystick 
Games 
Score display after game 
Suggestions for developing games in the future 
Exercise 
Views on the concept of therapy based on games 
Usage 
Suggestions 
Impact 
Change in arm movement ability/ROM/sensation/pain/stiffness 
ADL/functional ability/employment 
Personal goals 
Mood and cognition 
Others 
Using device at home alone vs. multi-user mode 
Views of friends, family, carers about the device 
Views of therapists/ professionals about the device 
Others views on impact on arm movement/ function 
Use in community (stroke centre etc) 
Commercial aspect of the device 
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Appendix F. Healthcare professional interview checklist 
(feasibility study) 
Table 34. Healthcare professional interview topics checklist (feasibility study) 
 
ID 
Involved with ? participants using device  
General views about the device 
Suggestions for improvements 
Hardware 
Views on computer/joystick/chair/seating/height 
Size of the device 
Problems encountered while patients using the device at home 
Suggestions for the future 
Software 
Views on assistance provided by the joystick 
Games 
Score display after game 
Suggestions on developing games in the future 
Exercise 
Views on the concept of therapy based on games 
Therapy delivered by device 
Concept of bimanual therapy 
Usage/ compliance 
Suggestions 
Impact 
Change in arm movement/ROM/sensation/pain/stiffness 
ADLs/functional ability/personal goals 
Mood and cognition 
Others 
Views on single user at home / multi-user mode in community 
Commercial aspect of device 
Future research – trial design 
Patient selection 
Time after stroke 
 
